10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

__________________________

FORM 10-Q

S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013

Or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the transition period from _________ to ________

Commission File Number:  None

GWG HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware	26-2222607
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

220 South Sixth Street, Suite 1200

Minneapolis, MN  55402

(Address of principal executive offices, including zip code)

(612) 746-1944

(Registrant’s telephone number, including area code)

________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

T Yes   £ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    x Yes   £ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

£ Yes    T No

As of August 14, 2013, GWG Holdings, Inc. had 9,124,000 shares of common stock outstanding.

GWG HOLDINGS, INC.

Index to Form 10-Q

for the Quarter Ended June 30, 2013

		Page No.
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets as of June 30, 2013, and December 31, 2012	3
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2013 and 2012	4
	Condensed Consolidated Statements of Cash Flows for the three and six months ended June 30, 2013 and 2012	5
	Condensed Consolidated Statement of Changes in Equity	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 4.	Controls and Procedures	49
PART II.	OTHER INFORMATION
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	50
Item 6.	Exhibits	51
SIGNATURES		52

Page 2

PART I—FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2013			December 31, 2012
	(unaudited)
A S S E T S
Cash and cash equivalents	$	38,240,633		$	27,497,044
Restricted cash		4,463,867			2,093,092
Investment in life settlements, at fair value		193,891,894			164,317,183
Other assets		7,041,894			4,040,716
TOTAL ASSETS	$	243,638,288		$	197,948,035
L I A B I L I T I E S & E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	79,000,000		$	71,000,000
Series I Secured notes payable		34,505,914			37,844,711
Renewable secured debentures		93,684,735			55,718,950
Interest payable		5,771,063			3,477,320
Accounts payable and accrued expenses		1,642,728			1,761,558
Deferred taxes, net		7,868,201			5,501,407
TOTAL LIABILITIES		222,472,641			175,303,946
CONVERTIBLE, REDEEMABLE PREFERRED STOCK
(par value $0.001; shares authorized 40,000,000; shares issued and outstanding 3,356,787 and 3,361,076; liquidation preference of $25,176,000 and $25,208,000, respectively)		24,322,651			23,905,878
EQUITY
Common stock (par value $0.001: shares authorized  210,000,000; shares issued and outstanding is  9,124,000 and 9,989,000 on June 30, 2013 and December 31, 2012, respectively)		9,124			9,989
Additional paid-in capital		3,253,670			6,971,844
Accumulated deficit		(6,419,798	)		(8,243,622	)
TOTAL EQUITY (DEFICIT)		(3,157,004	)		(1,261,789	)
TOTAL LIABILITIES & EQUITY (DEFICIT)	$	243,638,288		$	197,948,035

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Page 3

GWG HOLDINGS, INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended				Six Months Ended
	June 30, 2013		June 30, 2012		June 30, 2013		June 30, 2012
REVENUE
Gain on life settlements, net	$	7,733,245	$	4,867,478	$	16,073,601	$	5,469,246
Interest and other income		3,274,323		47,563		3,441,994		48,894
TOTAL REVENUE		11,007,568		4,915,041		19,515,595		5,518,140
EXPENSES
Employee compensation and benefits		1,063,923		583,338		3,001,343		1,117,084
Legal and professional fees		351,910		337,179		789,200		701,403
Interest expense		4,941,942		2,379,578		9,409,157		4,817,991
Other expenses		1,091,132		703,659		2,124,277		1,262,652
TOTAL EXPENSES		7,448,907		4,003,754		15,323,977		7,899,130
INCOME (LOSS) BEFORE INCOME TAXES		3,558,661		911,287		4,191,618		(2,380,990	)
INCOME TAX EXPENSE (BENEFIT)		1,801,971		609,588		2,367,794		(529,860	)
NET INCOME (LOSS)	$	1,756,690	$	301,699	$	1,823,824	$	(1,851,130	)
NET INCOME (LOSS) PER SHARE
Basic	$	0.18	$	0.03	$	0.19	$	(0.19	)
Diluted	$	0.12	$	0.03	$	0.13	$	(0.19	)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic		9,969,989		9,989,000		9,548,205		9,989,000
Diluted		15,022,198		9,989,000		14,580,506		9,989,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Page 4

GWG HOLDINGS, INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

	Three Months Ended						Six Months Ended
	June 30, 2013			June 30, 2012			June 30, 2013			June 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	1,756,690		$	301,699		$	1,823,824		$	(1,851,130	)
Adjustments to reconcile net income (loss) to net
cash flows from operating activities:
Gain on life settlements		(7,449,180	)		(4,575,941	)		(18,943,905	)		(10,990,249	)
Amortization of deferred financing and issuance costs		837,133			342,297			1,930,880			909,457
Deferred income taxes		1,802,920			609,588			2,366,794			(529,860	)
Convertible, redeemable preferred stock dividends payable		178,235			294,935			261,937			421,010
(Increase) decrease in operating assets:
Other assets		(4,164,004	)		(298,060	)		(3,614,132	)		1,057,285
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		402,739			101,452			1,694,797			659,134
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(6,635,467	)		(3,224,030	)		(14,479,805	)		(10,324,353	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		(2,972,944	)		(1,468,770	)		(12,885,993	)		(2,622,030	)
Proceeds from settlement of life settlements		1,382,152			416,665			2,872,152			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		(1,590,792	)		(1,052,105	)		(10,013,841	)		(2,205,365	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			3,500,000			8,000,000			6,000,000
Proceeds from issuance of Series I Secured notes payable		-			-			-			50,000
Payments for redemption of Series I Secured notes payable		(2,423,052	)		(1,918,420	)		(3,930,876	)		(3,468,957	)
Proceeds from issuance of renewable secured debentures		18,588,867			12,695,213			42,439,661			15,757,086
Payments for redemption and issuance of renewable secured debentures		(3,033,303	)		(712,587	)		(5,336,571	)		(712,587	)
Proceeds from restricted cash		2,160,333			(3,282,199	)		(2,370,775	)		(57,361	)
Repurchase of common stock		(3,252,400	)		-			(3,252,400	)		-
Issuance (redemptions) of convertible, redeemable preferred stock		(125,135	)		1,350,910			(311,804	)		5,787,375
Payments of issuance cost for preferred stock					(810,722	)		-			(1,609,362	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		11,915,310			10,822,195			35,237,235			21,746,194
NET INCREASE IN CASH AND CASH EQUIVALENTS		3,689,051			6,546,060			10,743,589			9,216,476
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD		34,551,582			4,548,765			27,497,044			1,878,349
END OF PERIOD	$	38,240,633		$	11,094,825		$	38,240,633		$	11,094,825

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Page 5

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS – CONTINUED

(unaudited)

	Three Months Ended				Six Months Ended
	June 30, 2013		June 30, 2012		June 30, 2013		June 30, 2012
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	3,214,000	$	1,313,000	$	6,512,000	$	2,462,000
NON-CASH INVESTING AND FINANCING ACTIVITIES
Series I secured notes:
Non-cash conversion of accrued interest  and commissions payable to principal	$	86,000	$	4,000	$	150,000	$	8,000
Renewable secured debentures:
Non-cash conversion of accrued interest and commission payable to principal	$	59,000	$	37,000	$	100,000	$	70,000
Convertible, redeemable preferred stock
Non-cash conversion of dividends payable	$	178,000	$	138,000	$	262,000	$	250,000
Non-cash accretion of convertible, redeemable preferred stock to redemption value	$	209,000	$	435,000	$	467,000	$	775,000
Non-cash conversion of Series I secured notes	$	-	$	1,130,000	$	-	$	4,220,000
Investment in life settlements included in accounts payable	$	262,000	$	108,000	$	262,000	$	108,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Page 6

GWG HOLDINGS, INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

(unaudited)

	Common			Common Stock			Additional Paid-in			Accumulated
	Shares			(par)			Capital			Deficit			Total Equity
Balance, December 31, 2011		9,989,000		$	9,989		$	8,169,303		$	(7,230,723	)	$	948,569
Net income		-			-			-			(1,012,899	)		(1,012,899	)
Issuance of warrants to purchase common   stock		-			-			380,946			-			380,946
Accretion of preferred stock to liquidation value		-			-			(1,578,405	)		-			(1,578,405	)
Balance, December 31, 2012		9,989,000			9,989			6,971,844			(8,243,622	)		(1,261,789	)
Net income											1,823,824			1,823,824
Repurchase of common stock		(865,000	)		(865	)		(3,251,535	)					(3,252,400	)
Accretion of preferred stock to liquidation value								(466,639	)					(466,639	)
Balance, June 30, 2013		9,124,000		$	9,124		$	3,253,670		$	(6,419,798	)	$	(3,157,004	)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Page 7

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

( 1 )       Nature of business and summary of significant accounting policies

Nature of business - GWG Holdings, Inc. (Holdings) (previously GWG Holdings, LLC) and Subsidiaries, located in Minneapolis, Minnesota, facilitates the purchase of life insurance policies for its own investment portfolio through its wholly owned subsidiary, GWG Life Settlements, LLC (GWG Life), and its subsidiaries, GWG Trust, LLC (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II). Holdings converted from a limited liability company into a corporation effective June 10, 2011 and as a result of this change all member units were converted into common stock.  Holdings finances the acquisition of life insurance policies, and pays policy premiums, through funds available on its line of credit and the issuance of debt and equity securities. GWG Member, LLC a wholly owned subsidiary formed November 2010 to facilitate the acquisition of policies, has not commenced operations as of June 30, 2013.  The entities were legally organized in Delaware and are collectively referred herein to as GWG, or the Company.

On July 11, 2011 the Company entered into a Purchase and Sale Agreement with Athena Securities Group, LTD and Athena Structured Funds PLC. Under this agreement, Holdings issued to Athena Securities Group, LTD (Athena) 989,000 shares of common stock, which was equal to 9.9% of the outstanding shares in the Company in exchange for shares equal to 9.9% of the outstanding shares in Athena Structured Funds, PLC (Athena Funds) and cash of $5,000. In accordance with Accounting Standards Codification (ASC) 505-50, the Company recorded the share-based payment transaction with Athena at the fair value of the Company’s 989,000 shares of common stock issued as it was the most reliable measurable form of consideration in this exchange the total value ascribed to the common stock issued to Athena was $3.6 million. The $5,000 cash paid by Athena, which represents the fair value of the shares of Athena Funds, is included in financing activities of the Consolidated Statement of Cash Flows.

On June 28, 2013, GWG Holdings, Inc. entered into a new Purchase and Sale Agreement with Athena Securities Limited and Athena Securities Group Limited. The June 28, 2013 agreement terminated the parties’ original Purchase and Sale Agreement dated July 11, 2011. Under the new agreement, GWG Holdings appointed Athena Securities Group Limited (i) as GWG Holdings’ exclusive representative for the offer and sale of GWG Holdings’ Renewable Secured Debentures in Ireland, and (ii) as a distributor for the offer and sale of those debentures in Europe and the Middle East, in each case until May 8, 2014. Any compensation payable to Athena Securities Group Limited will be in accordance with the compensation disclosures set forth in GWG Holdings’ prospectus for the offering filed with the SEC on dated June 4, 2013. In addition, the new agreement effected the sale by Athena Securities Limited to GWG Holdings of 865,000 shares of GWG Holdings’ common stock, and GWG Holdings’ sale back to Athena Securities Group Limited of certain shares of GWG Securities International Public Limited Company (formerly known as Athena Structured Funds PLC) originally transacted under the original July 11, 2011 agreement. The Company recorded a non-cash gain on the transaction of $3,252,000.

Basis of presentation - The condensed consolidated balance sheet as of June 30, 2013 and December 31, 2012, the condensed consolidated statements of operations for the three and six months ended June 30, 2013 and 2012, the condensed consolidated statements of cash flows for the three and six months ended June 30, 2013 and 2012, the condensed consolidated statement of changes in equity for the twelve months ended December 31, 2012 and six months ended June 30, 2013, and the related information presented in these notes, have been prepared by management in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, without audit. To the extent that information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements are contained in or are consistent with the consolidated audited financial statements in the Company’s Form 10-K for the year ended December 31, 2012, such information and notes have not been duplicated herein. In the opinion of management, all adjustments considered necessary for a fair presentation of results have been included. The condensed consolidated balance sheet at December 31, 2012 was derived from the audited consolidated financial statements as of that date. Operating results for the three and six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1)  the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Page 8

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1)           Receipt of death notice or verified obituary of insured

2)           Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized.  In an event of a sale of a policy the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company.  Such deposits and direct cost advances were $431,000 and $785,000 at June 30, 2013 and December 31, 2012, respectively.

Deferred financing and issuance costs – Financing costs incurred to obtain financing under the revolving credit facility, as described in note 6, have been capitalized and are amortized using the straight-line method (which approximated the interest method) over the term of the revolving credit facility.  Amortization of deferred financing costs was $89,000 and $58,000 for the three months ended June 30, 2013 and 2012, respectively, and $276,000 and $116,000 for the six months ended June 30, 2013 and 2012, respectively.  The future amortization is $179,000 and $358,000 for the six months ending December 31, 2013 and the year ending December 31, 2014, respectively.  The Series I Secured notes payable, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Renewable Secured Debentures, as described in note 8, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Series A preferred stock, as described in note 9, is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Page 9

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Earnings (loss) per share – Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period.  Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock and outstanding warrants.

Recently adopted pronouncements - In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS”, which amends disclosure requirements related to categorization within the fair value hierarchy. This update results in common principles and requirements for measuring fair value and disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. The guidance became effective for the annual period beginning January 1, 2012. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company.

( 2 )       Restrictions on cash

The Company is required by its lenders to maintain collection and escrow accounts. These accounts are used to pay annual premiums of insurance policies, pay interest and other charges under the revolving credit facility, and collect policy benefits. DZ Bank AG, as agent for Autobahn Funding Company, LLC, the lender for the revolving credit facility as described in note 6, authorizes the disbursements from these accounts. At June 30, 2013 and December 31, 2012 there was a balance of $4,464,000, and $2,093,000, respectively, maintained in these restricted cash accounts.

( 3 )       Investment in life insurance policies

The life insurance policies (Level 3 fair value measurements) are valued based on unobservable inputs that are significant to the overall fair value measurement. Changes in the fair value of these instruments are recorded in gain or loss on life insurance policies in the consolidated statements of operations (net of the cash premiums paid on the policies). The fair value is determined on a discounted cash flow basis that incorporates life expectancy assumptions.  Life expectancy reports have been obtained from widely accepted life expectancy providers. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. As a result of management’s analysis, discount rates of 11.84% and 12.08% were applied to the portfolio as of June 30, 2013 and December 31, 2012, respectively.

A summary of the Company’s life insurance policies accounted for under the fair value method and their estimated maturity dates, based on remaining life expectancy, is as follows:

	As of June 30, 2013						As of December 31, 2012
Years Ending December 31,	Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2013		-	$	-	$	-		-	$	-	$	-
2014		-		-		-		-		-		-
2015		2		1,239,000		2,000,000		2		1,163,000		2,000,000
2016		10		7,059,000		12,729,000		13		11,608,000		22,229,000
2017		18		25,099,000		56,173,000		17		21,155,000		53,439,000
2018		31		32,382,000		77,629,000		31		28,252,000		75,668,000
2019		40		34,198,000		99,668,000		35		26,947,000		84,579,000
Thereafter		140		93,915,000		402,456,000		113		75,192,000		334,331,000
Totals		241	$	193,892,000	$	650,655,000		211	$	164,317,000	$	572,246,000

The Company recognized death benefits of $6,600,000 and $4,500,000 during the three-month periods ended June 30, 2013 and 2012, respectively, related to policies with a carrying value of $1,382,000 and $417,000, respectively.  The Company recorded realized gains of $5,218,000 and $4,083,000 on such policies.  The Company recognized death benefits of $10,600,000 and $4,500,000 during the six-month periods ended June 30, 2013 and 2012, respectively, related to policies with a carrying value of $2,872,000 and $417,000, respectively.  The Company recorded realized gains of $7,728,000 and $4,083,000 on such policies.  Subsequent to June 30, 2013, two policies with an aggregate death benefit of $2,500,000 have matured.

Page 10

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Reconciliation of gain on life settlements:

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Change in fair value	$	7,449,000		$	4,576,000		$	18,944,000		$	9,367,000
Premiums and other annual fees		(4,934,000	)		(3,792,000	)		(10,598,000	)		(7,981,000	)
Policy maturities		5,218,000			4,083,000			7,728,000			4,083,000
Gain on life settlements, net	$	7,733,000		$	4,867,000		$	16,074,000		$	5,469,000

The estimated expected premium payments to maintain the above life insurance policies in force for the next five years, assuming no mortalities, are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	10,272,000
2014		21,206,000
2015		22,986,000
2016		25,222,000
2017		27,757,000
	$	107,443,000

Management anticipates funding the estimated premium payments as noted above with proceeds from the DZ Bank revolving credit facility and through additional debt and equity financing as well as from cash proceeds from maturities of life insurance policies. The proceeds of these capital sources are also intended to be used for the purchase, financing, and maintenance of additional life insurance policies.

( 4 )       Fair value definition and hierarchy

ASC 820 establishes a hierarchical disclosure framework which prioritizes and ranks the level of market price observability used in measuring assets and liabilities at fair value. Market price observability is affected by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace including the existence and transparency of transactions between market participants. Assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices in an orderly market generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. ASC 820 establishes a three-level valuation hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The hierarchy is broken down into three levels based on the observability of inputs as follows:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.  Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

● Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Page 11

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The availability of observable inputs can vary by types of assets and liabilities and is affected by a wide variety of factors, including, for example, whether an instrument is established in the marketplace, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for assets and liabilities categorized in Level 3.

Level 3 Valuation Process

The estimated fair value of the Company’s life settlements are determined on a quarterly basis by the Company’s portfolio management committee, taking into consideration changes in discount rate assumptions, estimated premium payments and life expectancy assumptions, as well as any changes in economic and other relevant conditions.  These inputs are then used to estimate the discounted cash flows using the MAPS probabilistic portfolio pricing model, which estimates the cash flows using various probabilities and scenarios.  The valuation process includes a review by senior management as of each valuation date.  Management will also engage a third party expert to independently test the accuracy of the valuations using the inputs provided by management.

Life insurance policies represent financial instruments recorded at fair value on a recurring basis. The following table reconciles the beginning and ending fair value of the Company’s Level 3 investments in life insurance policies for the three and six month periods ending June 30, as follows:

	Three month ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Beginning balance	$	185,020,000		$	128,112,000		$	164,317,000		$	122,169,000
Purchases		2,805,000			1,576,000			13,503,000			2,728,000
Maturities (cash in excess of carrying value)		(1,382,000	)		(416,000	)		(2,872,000	)		(416,000	)
Net change in fair value		7,449,000			4,576,000			18,944,000			9,367,000
Ending balance (June 30)	$	193,892,000		$	133,848,000		$	193,892,000		$	133,848,000

The fair value of a portfolio of life insurance policies is based on information available to the Company at the reporting date. Fair value is based upon a discounted cash flow model that incorporates life expectancy assumptions.  Life expectancy reports are obtained from independent and third-party widely accepted life expectancy providers at policy acquisition. The life expectancy values of each policy holder, as determined at policy acquisition, are rolled down monthly for the passage of time by the MAPS actuarial software the Company uses for ongoing valuation of its portfolio of life insurance policies.  The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium an investor in the portfolio of life insurance policies would require.

On January 22, 2013, one of the independent medical actuarial underwriting firms we utilize, 21st Services, announced advancements in its underwriting methodology, resulting in revised estimated life expectancy mortality tables for life settlement transactions.  We have been advised by 21st Services that the changes are very granular and relate to both specific medical conditions and lifestyles of insureds.  These changes are the result of the application of additional medical information that has been gathered by 21st Services over a period of time, and which has now been applied to the inputs and methodologies used to develop the actuarial life expectancies.   While we do not believe these revised methodologies indicate the previous estimated life expectancies were inaccurate, we believe the revised methodologies provide additional information that should be considered in updating our estimate of the life expectancies of the insureds within our portfolio of life settlement contracts as of June 30, 2013 and December 31, 2012.  Based upon our evaluation and analysis of data made available by 21st Services, as well as information regarding the insureds within our portfolio, we have estimated the impact of the changes in 21st Services’ methodologies for determining life expectancies on a policy-by-policy basis within our portfolio and applied such changes to the life expectancy inputs used to estimate fair value.  We have adjusted the original life expectancies provided by 21st Services based on four factors, the impact of each analyzed individually for each insured in the GWG portfolio.  The four factors are gender, anti-selection, age, and primary impairment.  While the analysis and adjustments were applied on an individual policy basis, the result was an average overall increase in the original life expectancy estimates of 8.67%.  We have a standard practice of obtaining two third-party life expectancy estimates for each policy in our portfolio.  As a result, the effective change in life expectancy on the portfolio was an average of approximately 4.33%, which resulted in an aggregate decrease in the fair value of our life settlements portfolio of $12.4 million as of December 31, 2012.  Life expectancy reports by their very nature are estimates.  Due to the estimating changes made by 21st Services, and because refinement in estimating methods is on-going, we plan to obtain new life expectancy reports for all policies purchased where we used a life expectancy report from 21st Services.  As part of our on-going process to maintain current information regarding the insureds included in our portfolio, we are updating the life expectancy estimates in our portfolio valuation process as new information becomes available.

Page 12

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The fair value of life insurance policies is estimated using present value calculations of estimated cash flows based on the data specific to each individual life insurance policy. Estimated future policy premium payments are calculated based on the terms of the policy and the premium payment history. The following summarizes the unobservable inputs utilized in estimating the fair value of the portfolio of life insurance policies:

	As of  June 30, 2013			As of December 31, 2012
Weighted average age of insured		81.7			81.3
Weighted average life expectancy, months*		90.4			91.6
Average face amount per policy	$	2,699,814		$	2,712,063
Discount rate		11.84	%		12.08	%
* Standard life expectancy as adjusted for insured’s specific circumstances.

These assumptions are, by their nature, inherently uncertain and the effect of changes in estimates may be significant. The techniques used in estimating the present value of estimated cash flows are derived from valuation techniques generally used in the industry that include inputs for the asset that are not based on observable market data. The extent to which the fair value could reasonable vary in the near term has been quantified by evaluating the effect of changes in significant underlying assumptions used to estimate the fair value. If the life expectancies were increased or decreased by 4 and 8 months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables are held constant, the fair value of the investment in life insurance policies would increase or (decrease) by the  amounts summarized below:

	Change in life expectancy
	plus 8 months				minus 8 months			plus 4 months				minus 4 months
June 30, 2013		$	(28,173,000	)		$	29,545,000		$	(14,258,000	)		$	14,601,000
December 31, 2012		$	(24,072,000	)		$	25,268,000		$	(12,185,000	)		$	12,484,000
	Change in discount rate
	plus 2%				minus 2%			plus 1%				minus 1%
June 30, 2013		$	(19,390,000	)		$	23,002,000		$	(10,098,000	)		$	10,998,000
December 31, 2012		$	(16,811,000	)		$	19,978,000		$	(8,759,000	)		$	9,547,000

Carrying value of receivables, prepaid expenses, accounts payable and accrued expenses approximate fair value due to their short-term maturities and low credit risk. The estimated fair value of the Company’s Series I Secured notes payable is approximately $35,703,000 based on a weighted-average market interest rate of 7.45% based on an income approach. The Company began issuing Renewable Secured Debentures in the first quarter of 2012. The current interest rates on the Renewable Secured Debentures approximate market rates. The carrying value of the Renewable Secured Debentures approximates fair value. The carrying value of the revolving credit facility reflects interest charged at the commercial paper rate plus an applicable margin. The margin represents our credit risk, and the strength of the portfolio of life insurance policies collateralizing the debt. The overall rate reflects market, and the carrying value of the revolver approximates fair value. All of the financial instruments are level 3 fair value measurements.

Page 13

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The Company has issued warrants to purchase common stock in connection with the issuance of its convertible, redeemable preferred stock. Warrants were determined by the Company as permanent equity. The fair value measurements associated with the warrants, measured at issuance represent level 3 instruments.

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		137,874	$	0.11		0.42	%		25.25	%	3 years
March 2012		76,260	$	0.26		0.38	%		36.20	%	3 years
June 2012		323,681	$	0.58		0.41	%		47.36	%	3 years
July 2012		289,093	$	0.58		0.41	%		47.36	%	3 years
September 2012		5,000	$	0.36		0.31	%		40.49	%	3 years
		831,908

Volatility is based upon the weekly percentage change in the stock price of selected comparable insurance companies. In June 2012, we evaluated the comparable companies used, and made certain changes to those used.  The percentage change is calculated on the average price of those selected stocks at the weekly close of business for the year preceding the balance sheet date.  We compare annual volatility based on this weekly information. 

( 5 )       Notes receivable from related parties

As of June 30, 2013 and December 31, 2012, the Company had receivables totaling $5,000,000 due from an affiliate, Opportunity Finance, LLC, which were fully reserved. Opportunity Finance ceased operations in 2008.

 ( 6 )       Credit facilities

Revolving credit facility – Autobahn Funding Company LLC

On July 15, 2008, DLP II and United Lending entered into a revolving credit facility pursuant to a Credit and Security Agreement (Agreement) with Autobahn Funding Company LLC (Autobahn), providing the Company with a maximum borrowing amount of $100,000,000. Autobahn is a commercial paper conduit that issues commercial paper to investors in order to provide funding to DLP II and United Lending.  DZ Bank AG acts as the agent for Autobahn. The original Agreement was to expire on July 15, 2013.  On January 29, 2013, Holdings, together with GWG Life and DLP II, entered into an Amended and Restated Credit and Security Agreement with Autobahn, extending the facility expiration date to December 31, 2014, and removing United Lending as a party to the amended and restated Agreement.  The amount outstanding under this facility as of June 30, 2013 and December 31, 2012, was $79,000,000 and $71,000,000, respectively.

The Agreement requires DLP II to pay, on a monthly basis, interest at the commercial paper rate plus an applicable margin, as defined in the Agreement. The effective rate was 6.27% and 2.02% at June 30, 2013 and December 31, 2012, respectively.  The weighted-average effective interest rate was 6.26% and 2.12% (excluding the unused line fee) for the three months ended June 30, 2013 and 2012, respectively, and 6.06% and 2.19% for the six months ended June 30, 2013 and 2012, respectively.  The Agreement also requires payment of an unused line fee on the unfunded amount under the revolving credit facility. The note is secured by substantially all of DLP II assets, which consist primarily of life settlement policies.

The Agreement has certain financial and nonfinancial covenants. The Company was in compliance with these covenants at June 30, 2013 and December 31, 2012. The Agreement generally prohibits the Company from:

● changing its corporate name, offices, and jurisdiction of incorporation

● changing any deposit accounts or payment instructions to insurers;

● changing any operating policies and practices such that it would be reasonably likely to adversely affect the collectability of any asset in any material respect;

● merging or consolidating with, or selling all or substantially all of its assets to, any third party;

● selling any collateral or creating or permitting to exist any adverse claim upon any collateral;

● engaging in any other business or activity than that contemplated by the Agreement;

● incurring or guaranteeing any debt for borrowed money;

● amending the Company’s certificate of incorporation or bylaws, making any loans or advances to, investments in, or paying any dividends to, any person unless both before and after any such loan, advance, investment or dividend there exists no actual event of default, potential event of default or termination event;

Page 14

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

● removing an independent director on the board of directors except for cause or with the consent of the lender; or

● making payment on or issuing any subsidiary secured notes or debentures, or amending any agreements respecting such notes or debentures, if an event of default, potential event of default or termination event exists or would arise from any such action.

In addition, the Company has agreed to maintain (i) a positive consolidated net income (as defined and calculated under the Agreement) for each complete fiscal year and (ii) a tangible net worth (again, as defined and calculated under the Agreement) of not less than $15 million, and (iii) maintain a borrowing base surplus or cash cushion sufficient to pay three to twelve months (increasing throughout 2013) of premiums and facility fees.

Consolidated net income and tangible net worth as of and for the 4 quarter period ended June 30, 2013, as calculated under the agreement, were $5,905,000 and $44,233,000, respectively.

Advances under the Agreement are subject to a borrowing base formula, which limits the availability of advances on the borrowing base calculation based on attributes of policies pledged to the facility. Over-concentration of policies by insurance carrier, over-concentration of policies by insurance carriers with ratings below a AA- rating, and the premiums and facility fees reserve are the three primary factors with the potential of limiting availability of funds on the facility. Total funds available for additional borrowings under the borrowing base formula criteria at June 30, 2013 and December 31, 2012, were $667,000 and $15,043,000 respectively.

On July 15, 2008, Holdings delivered a performance guaranty in favor of Autobahn pursuant to which it guaranteed the obligations of GWG Life, in its capacity as the seller and master servicer, under the Credit and Security Agreement and related documents.  On January 29, 2013 and in connection with the Amended and Restated Credit and Security Agreement, Holdings delivered a reaffirmation of its performance guaranty.  The obligations of Holdings under the performance guaranty and subsequent reaffirmation do not extend to the principal and interest owed by DLP II as the borrower under the credit facility.

( 7 )       Series I Secured notes payable

Series I Secured notes payable have been issued in conjunction with the GWG Series I Secured notes private placement memorandum dated August 25, 2009 (last revised November 15, 2010). On June 14, 2011 the Company closed the offering to additional investors, however, existing investors may elect to continue advancing amounts outstanding upon maturity subject to the Company’s option. Series I Secured notes have maturity dates ranging from six months to seven years with fixed interest rates varying from 5.65% to 9.55% depending on the term of the note. Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note. At June 30, 2013 and December 31, 2012 the weighted-average interest rates of Series I Secured notes were 8.27%, and 8.22% respectively. The notes are secured by assets of GWG Life. The principal amount outstanding under these Series I Secured notes was $35,299,000 and $38,570,000 at June 30, 2013, and December 31, 2012, respectively.  The difference between the amount outstanding on the Series I Secured notes and the carrying amount on the consolidated balance sheet is due to netting of unamortized deferred issuance costs. Overall, interest expense includes amortization of deferred financing and issuance costs of $161,000 and $217,000 for the three and six months ended June 30, 2013, respectively, and $237,000 and $746,000 for the three and six months ended June 30, 2012, respectively.  Future expected amortization of deferred financing costs is $793,000 over the next six years.

On November 15, 2010, the holders of a majority of the membership interests in the company (then a limited liability company), Messrs. Jon R. Sabes and Steven F. Sabes, pledged their ownership interests in the Company to the Series I Trust as security for advances under the Series I Trust arrangement.

The use of proceeds from the issuances of Series I Secured notes was limited to the following: (1) payment of commissions of Series I Secured note sales, (2) purchase life insurance policies, (3) pay premiums of life insurance policies, (4) pay principal and interest to Senior Liquidity Provider (DZ Bank), (5) pay portfolio or note operating fees or costs, (6) pay trustee (Wells Fargo Bank, N.A.), (7) pay servicer and collateral fees, (8) pay principal and interest on Series I Secured notes, (9) make distributions to equity holders for tax liability related to portfolio, (10) purchase interest rate caps, swaps, or hedging instruments, (11) pay GWG Series I Trustee fees, and (12) pay offering expenses.

On November 1, 2011, GWG entered into a Third Amended and Restated Note Issuance and Security Agreement with Lord Securities Corporation after receiving majority approval from the holders of Series I Secured notes. Among other things, the amended and restated agreement modified the use of proceeds and certain provisions relating to the distribution of collections and subordination of cash flow. Under the amended and restated agreement, GWG is no longer restricted as to its use of proceeds or subject to restrictions on certain distributions of collections and subordination of cash flows. 

Page 15

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Future contractual maturities of Series I Secured notes payable at June 30, 2013 are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	9,358,000
2014		12,561,000
2015		6,675,000
2016		1,802,000
2017		4,085,000
Thereafter		818,000
	$	35,299,000

 ( 8 )       Renewable secured debentures

The Company has registered with the Securities and Exchange Commission, effective January 2012, the offer and sale of $250,000,000 of secured debentures. Renewable Secured Debentures have maturity dates ranging from six months to seven years with fixed interest rates varying from 4.75% to 9.50% depending on the term of the note. Interest is payable monthly, annually or at maturity depending on the terms of the debenture. At June 30, 2013 and December 31, 2012, the weighted-average interest rate of Renewable Secured Debentures was 7.58% and 7.65%, respectively. The debentures are secured by assets of GWG Life and GWG Holdings. The amount outstanding under these Renewable Secured Debentures was $95,858,000 and $57,609,000 at June 30, 2013 and December 31, 2012, respectively. The difference between the amount outstanding on the Renewable Secured Debentures and the carrying amount on the consolidated balance sheets is due to netting of unamortized deferred issuance costs and cash receipts for new issuances in process.  Amortization of deferred issuance costs was $344,000 and $622,000 for the three and six months ended June 30, 2013, respectively, and $44,000 and $47,000 for the three and six months ended June 30, 2012, respectively.  Future expected amortization of deferred financing costs is $4,114,000. Subsequent to June 30, 2013, the Company has issued approximately an additional $10,300,000 in principal amount of these secured debentures.

The use of proceeds from the issuances of Renewable Secured Debentures is limited to the following: (1) payment of commissions on sales of Renewable Secured Debentures, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) Payment of premiums on life insurance policies, (5) payment of principal and interest on Renewable Secured Debentures, (6) payment of portfolio operations expenses, and (7) for general working capital.

Future contractual maturities of Renewable Secured Debentures at June 30, 2013 are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	11,839,000
2014		15,272,000
2015		30,085,000
2016		16,359,000
2017		6,529,000
Thereafter		15,774,000
	$	95,858,000

The Company entered into an indenture effective October 19, 2011 with Holdings as obligor, GWG Life as guarantor, and Bank of Utah as trustee for the benefit of the debenture holders.  The indenture has certain financial and nonfinancial covenants.  The Company was in compliance with these covenants at June 30, 2013 and December 31, 2012.

Page 16

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

( 9 )       Convertible, redeemable preferred stock

The Company began offering 3,333,333 shares of convertible redeemable preferred stock (Series A preferred stock) for sale to accredited investors in a private placement on July 31, 2011. The offering of Series A preferred stock concluded on September 2, 2012 and resulted in 3,278,000 shares being issued for gross consideration of $24,582,000. As of June 30, 2013, 121,000 shares have been issued as a result of conversion of $846,000 in dividends into shares of Series A preferred stock.  The Series A preferred stock was sold at an offering price of $7.50 per share. Series A preferred stock has a preferred yield of 10% per annum, and each share has the right to convert into 1.5 shares of the Company’s common stock. The Company may elect to automatically convert the Series A preferred stock to common stock as described below. Series A preferred shareholders also received three-year warrants to purchase, at an exercise price per share of $6.25, one share of common stock for every 20 shares of Series A preferred stock purchased.  The warrants are exercisable immediately. In the Certificate of Designations for the Series A preferred stock dated July 31, 2011, the Company has agreed to permit preferred shareholders to sell their shares back to the Company for the stated value of $7.50 per share, plus accrued dividends, according to the following schedule:

● Up to 33% of the holder’s unredeemed shares one year after issuance:

● Up to 66% of the holder’s unredeemed shares two years after issuance; and

● Up to 100% of the holder’s unredeemed shares three years after issuance.

The Company’s obligation to redeem Series A preferred shares will terminate upon the Company completing a registration of its common stock with the SEC. The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time after December 15, 2012.

At the election of the Company, the Series A preferred shares may be automatically converted into the common stock of the Company in the event of either (1) a registered offering of the Company’s common stock with the SEC aggregating gross proceeds of at least $5.0 million at a price equal to or greater than $5.50 per share of common stock, or (2) the consent of shareholders holding at least a majority of the then-outstanding shares of Series A preferred stock. As of June 30, 2013, the Company had issued 3,400,000 preferred shares resulting in gross consideration of $25,437,000 (including cash proceeds, conversion of Series I Secured notes and accrued interest on Series I notes, and conversion of preferred dividends payable). In 2013, the Company redeemed 43,000 shares valued at $322,000 resulting in 3,357,000 shares outstanding with the gross value of $25,115,000. The Company incurred Series A preferred stock issuance costs of $2,838,000, of which $2,045,000 was amortized to additional paid in capital as of June 30, 2013, resulting in a carrying amount of $24,323,000.

The Company determined that the grant date fair value of the outstanding warrants attached to the Series A preferred stock was $395,000 for warrants issued through June 30, 2013. The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted average sale price per share of common stock equals or exceeds $7.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption. Total warrants outstanding as of June 30, 2013, were 831,909 with a weighted average remaining life of 1.85 years. Total warrants outstanding at December 31, 2012, were 831,909 with a weighted average remaining life of 2.34 years.

Dividends on the Series A preferred stock may be paid in either cash or additional shares of Series A preferred stock at the election of the holder and approval of the Company. The dividends are reported as an expense and included in the caption interest expense in the consolidated statements of operations.

The Company declared and accrued dividends of $628,000 and $573,000 during the three months ended June 30, 2013 and 2012, respectively, and $1,263,000 and $990,000 during the six months ended June 30, 2013 and 2012, respectively, pursuant to a board resolution declaring the dividend.  25,000 and 20,000 shares of Series A preferred stock were issued in lieu of cash dividends in the three month periods ended June 30, 2013 and 2012, and 37,000 and 35,000 shares of Series A preferred stock were issued in lieu of cash dividends in the six month periods ended June 30, 2013 and 2012 respectively. The shares issued in lieu of cash dividends were issued at $7.00 per share.  As of June 30, 2013, Holdings has $628,000 of accrued preferred dividends which were paid or converted to shares of Series A preferred stock on July 15, 2013.

(10)       Income taxes

For the three and six months ended June 30, 2013, the Company recorded income tax expense of $1,802,000 and $2,368,000, or 50.6% and 56.5%, respectively, of income before taxes, compared to the recognition of an income tax expense of $610,000, or 66.9% for the three months ended June 30, 2012 and recognizing an income tax benefit of $530,000, or 22.3% for the six months ended June 30, 2012.  The primary differences between the Company’s June 30, 2013 effective tax rate and the statutory federal rate are the accrual of preferred stock dividend expense, state taxes, and other non-deductible expenses.

Page 17

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

( 11 )     Earnings per share and proforma information

The Company began issuing Series A preferred stock September, 1, 2011, as described in note 9.  The Series A preferred stock is dilutive to the earnings per share calculation at June 30, 2013 and 2012.  The Company has also issued warrants to purchase common stock in conjunction with the sale of convertible preferred stock, as discussed in note 9.  The warrants are anti-dilutive at June 30, 2013 and 2012 and have not been included in the fully diluted earnings per share calculation.

( 12 )     Commitments

The Company entered into an office lease with U.S. Bank National Association as the landlord. The lease was effective April 22, 2012 with a term through August 31, 2015. The lease is for 8,881 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Rent expenses under this and previous agreements were $98,000 and $73,000 during the six-month periods ended June 30, 2013 and 2012, respectively.  Rent expenses under this and previous agreements were $50,000 and $36,000 during the three-month periods ended June 30, 2013 and 2012, respectively.  Minimum lease payments under the lease agreement effective April 22, 2012 are as follows:

Six months ending December 31, 2013	$	49,000
2014		104,000
2015		70,000
Total	$	223,000

( 13 )     Contingencies

Litigation - In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from such proceedings would not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Opportunity Finance, LLC, owned by Jon Sabes and Steven Sabes, is subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments that may have been deemed preference payments. In addition, Jon Sabes and Steven Sabes are subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments received from Opportunity Finance that may have been deemed preference payments. If the parties are unsuccessful in defending against these claims, their equity ownership in the Company may be sold or transferred to other parties to satisfy such claims. In addition, the Company loaned $1,000,000 to Opportunity Finance, LLC in 2006, and was repaid in full plus interest of $177,000. This investment amount may also be subject to clawback claims by the bankruptcy court. These matters may also distract management and reduce the time and attention that they are able to devote to the Company’s operations.

( 14 )     Guarantees of secured debentures

Holdings has registered with the Securities and Exchange Commission the offer and sale $250,000,000 of secured debentures as described in note 8. The secured debentures are secured by the assets of Holdings as described in note 8 and a pledge of all the common stock by the largest shareholders. Obligations under the debentures are guaranteed by Holding’s subsidiary GWG Life. This guarantee involves the grant of a security interest in all the assets of GWG Life. GWG Life is a wholly owned subsidiary of Holdings and the payment of principal and interest on the secured debentures is fully and unconditionally guaranteed by GWG Life. Substantially all of the Company’s life insurance policies are held by DLP II, a wholly owned subsidiary of GWG Life. The policies held by DLP II are not collateral for the debenture obligations as such policies are collateral for the credit facility.

Page 18

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The consolidating financial statements are presented in lieu of separate financial statements and other related disclosures of the subsidiary guarantors and issuer because management does not believe that separate financial statements and related disclosures would be material to investors. There are currently no significant restrictions on the ability of Holdings or GWG Life, the guarantor subsidiary, to obtain funds from its subsidiaries by dividend or loan, except as follows. DLP II is a borrower under a credit agreement with Autobahn, with DZ Bank AG as agent, as described in note 6. The significant majority of insurance policies owned by the Company are subject to a collateral arrangement with DZ Bank AG described in notes 3 and 6. Under this arrangement, collection and escrow accounts are used to fund premiums of the insurance policies and to pay interest and other charges under the revolving credit facility. DZ Bank AG and Autobahn must authorize all disbursements from these accounts, including any distributions to GWG Life. Distributions are limited to an amount that would result in the borrowers (GWG DLP Funding II, LLC, GWG Life Settlements, LLC, and GWG Holdings, Inc.) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by DZ Bank AG. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made.

The following represents consolidating financial information as of June 30, 2013 and December 31, 2012, with respect to the financial position, and for the three and six months ended June 30, 2013 and 2012 with respect to results of operations and cash flows of Holdings and its subsidiaries. The parent column presents the financial information of Holdings, the primary obligor of the secured debentures. The guarantor subsidiary column presents the financial information of GWG Life, the guarantor subsidiary of the secured debentures, presenting its investment in DLP II and Trust under the equity method. The non-guarantor subsidiaries column presents the financial information of all non-guarantor subsidiaries including DLP II and Trust.

Condensed Consolidating Balance Sheets

June 30, 2013	Parent				Guarantor Sub			Non-Guarantor Sub			Eliminations				Consolidated
A S S E T S
Cash and cash equivalents		$	36,989,169			$	1,251,464		$	-		$	-			$	38,240,633
Restricted cash			-				2,501,500			1,962,367			-				4,463,867
Investment in life settlements, at fair value			-				-			193,891,894			-				193,891,894
Other assets			263,555				328,363			6,449,976			-				7,041,894
Investment in subsidiaries			88,702,942				122,020,978			-			(210,723,920	)			-
TOTAL ASSETS		$	125,955,666			$	126,102,305		$	202,304,237		$	(210,723,920	)		$	243,638,288
L I A B I L I T I E S & S T O C K H O L D E R S ' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility		$	-			$	-		$	79,000,000		$	-			$	79,000,000
Series I Secured notes payable			-				34,505,914			-			-				34,505,914
Secured renewable debentures			93,684,735				-			-							93,684,735
Interest payable			2,577,524				2,686,747			506,792			-				5,771,063
Accounts payable and accrued expenses			659,559				206,702			776,467			-				1,642,728
Deferred taxes, net			7,868,201				-			-			-				7,868,201
TOTAL LIABILITIES			104,790,019				37,399,363			80,283,259			-				222,472,641
CONVERTIBLE, REDEEMABLE PREFERRED STOCK			24,322,651				-			-			-				24,322,651
EQUITY (DEFICIT)
Member capital			-				88,702,942			122,020,978			(210,723,920	)			-
Common stock			9,124				-			-			-				9,124
Additional paid-in capital			3,253,670				-			-			-				3,253,670
Accumulated deficit			(6,419,798	)			-			-			-				(6,419,798	)
TOTAL EQUITY (DEFICIT)			(3,157,004	)			88,702,942			122,020,978			(210,723,920	)			(3,157,004	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)		$	125,955,666			$	126,102,305		$	202,304,237		$	(210,723,920	)		$	243,638,288

Page 19

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Balance Sheets (continued)

December 31, 2012	Parent				Guarantor Sub			Non-Guarantor Sub			Eliminations				Consolidated
A S S E T S
Cash and cash equivalents		$	25,035,579			$	2,461,465		$	-		$	-			$	27,497,044
Restricted cash			-				1,748,700			344,392							2,093,092
Investment in life settlements, at fair  value			-				-			164,317,183			-				164,317,183
Other assets			96,994				211,592			3,732,130			-				4,040,716
Investment in subsidiaries			60,608,585				96,914,613			-			(157,523,198	)			-
TOTAL ASSETS		$	85,741,158			$	101,336,370		$	168,393,705		$	(157,523,198	)		$	197,948,035
L I A B I L I T I E S & S T O C K H O L D E R S ' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility		$	-			$	-		$	71,000,000		$	-			$	71,000,000
Series I Secured notes payable			-				37,844,711			-			-				37,844,711
Secured renewable debentures			55,718,950				-			-							55,718,950
Interest payable			905,017				2,444,097			128,206			-				3,477,320
Accounts payable and accrued expenses			971,695				490,497			302,366			-				1,761,558
Deferred taxes, net			5,501,407				-			-			-				5,501,407
TOTAL LIABILITIES			63,097,069				40,776,305			71,430,572			-				175,303,946
CONVERTIBLE, REDEEMABLE PREFERRED STOCK			23,905,878				-			-			-				23,905,878
EQUITY (DEFICIT)
Member capital			-				60,560,065			96,963,133			(157,523,198	)			-
Common stock			9,989				-			-			-				9,989
Additional paid-in capital			6,971,844				-			-			-				6,971,844
Accumulated deficit			(8,243,622	)			-			-			-				(8,243,622	)
TOTAL EQUITY (DEFICIT)			(1,261,789	)			60,560,065			96,963,133			(157,523,198	)			(1,261,789	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)		$	85,741,158			$	101,336,370		$	168,393,705		$	(157,523,198	)		$	197,948,035

Page 20

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Operations

For the six months ended June 30, 2013	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	1,814,202		$	-	$	(1,814,202	)	$	-
Gain on life settlements, net		-			-			16,073,601		-			16,073,601
Interest and other income		3,267,454			977,855			37,620		(840,935	)		3,441,994
TOTAL REVENUE		3,267,454			2,792,057			16,111,221		(2,655,137	)		19,515,595
EXPENSES
Origination and servicing fees		-			-			1,814,202		(1,814,202	)		-
Employee compensation and benefits		2,213,056			788,287			-		-			3,001,343
Legal and professional fees		672,317			116,883			-		-			789,200
Interest expense		4,976,599			1,849,861			2,582,697		-			9,409,157
Other expenses		1,283,269			816,009			865,934		(840,935	)		2,124,277
TOTAL EXPENSES		9,145,241			3,571,040			5,262,833		(2,655,137	)		15,323,977
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(5,877,787	)		(778,983	)		10,848,388		-			4,191,618
EQUITY IN INCOME OF SUBSIDIARIES		10,069,405			10,896,907			10,848,388		(20,966,312	)		-
INCOME BEFORE INCOME TAXES		4,191,618			10,117,924			10,848,388		(20,966,312	)		4,191,618
INCOME TAX EXPENSE		2,367,794			-			-		-			2,367,794
NET INCOME	$	1,823,824		$	10,117,924		$	10,848,388	$	(20,966,312	)	$	1,823,824

For the six months ended June 30, 2012	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	438,250		$	-	$	(438,250	)	$	-
Gain on life settlements, net		-			229,277			5,239,969		-			5,469,246
Interest and other income		3,049			3,192			42,653		-			48,894
TOTAL REVENUE		3,049			670,719			5,282,622		(438,250	)		5,518,140
EXPENSES
Origination and servicing fees		-			(6,500	)		444,750		(438,250	)		-
Employee compensation and benefits		-			1,117,084			-		-			1,117,084
Legal and professional fees		655,600			45,803			-		-			701,403
Interest expense		1,268,211			2,696,548			853,232		-			4,817,991
Other expenses		534,100			703,552			25,000		-			1,262,652
TOTAL EXPENSES		2,457,911			4,556,487			1,322,982		(438,250	)		7,899,130
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(2,454,862	)		(3,885,768	)		3,959,640		-			(2,380,990	)
EQUITY IN INCOME OF SUBSIDIARIES		73,872			4,017,864			-		(4,091,736	)		-
INCOME BEFORE INCOME TAXES		(2,380,990	)		132,096			3,959,640		(4,091,736	)		(2,380,990	)
INCOME TAX BENEFIT		(529,860	)		-			-		-			(529,860	)
NET INCOME (LOSS)	$	(1,851,130	)	$	132,096		$	3,959,640	$	(4,091,736	)	$	(1,851,130	)

Page 21

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Operations (continued)

For the three months ended June 30, 2013	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	536,100		$	-	$	(536,100	)	$	-
Gain on life settlements, net		-			-			7,733,245		-			7,733,245
Interest and other income		3,259,362			841,286			14,610		(840,935	)		3,274,323
TOTAL REVENUE		3,259,362			1,377,386			7,747,855		(1,377,035	)		11,007,568
EXPENSES
Origination and servicing fees		-			-			536,100		(536,100	)		-
Employee compensation and benefits		666,354			397,569			-		-			1,063,923
Legal and professional fees		272,794			79,116			-		-			351,910
Interest expense		2,655,430			942,686			1,343,826		-			4,941,942
Other expenses		649,112			429,520			853,435		(840,935	)		1,091,132
TOTAL EXPENSES		4,243,690			1,848,891			2,733,361		(1,377,035	)		7,448,907
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(984,328	)		(471,505	)		5,014,494		-			3,558,661
EQUITY IN INCOME OF SUBSIDIARIES		4,543,289			5,014,494			-		(9,557,783	)		-
INCOME BEFORE INCOME TAXES		3,558,961			4,542,989			5,014,494		(9,557,783	)		3,558,661
INCOME TAX EXPENSE (BENEFIT)		1,802,271			(300	)		-		-			1,801,971
NET INCOME	$	1,756,690		$	4,543,289		$	5,014,494	$	(9,557,783	)	$	1,756,690

For the three months ended June 30, 2012	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	290,050		$	-	$	(290,050	)	$	-
Gain on life settlements, net		-			79,307			4,788,171		-			4,867,478
Interest and other income		2,745			2,237			42,581		-			47,563
TOTAL REVENUE		2,745			371,594			4,830,752		(290,050	)		4,915,041
EXPENSES
Origination and servicing fees		-			-			290,050		(290,050	)		-
Employee compensation and benefits		-			583,338			-		-			583,338
Legal and professional fees		364,698			(27,519	)		-		-			337,179
Interest expense		814,038			1,140,239			425,301		-			2,379,578
Other expenses		387,691			303,468			12,500		-			703,659
TOTAL EXPENSES		1,566,427			1,999,526			727,851		(290,050	)		4,003,754
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(1,563,682	)		(1,627,932	)		4,102,901		-			911,287
EQUITY IN INCOME OF SUBSIDIARIES		2,474,969			4,132,013			-		(6,606,982	)		-
INCOME BEFORE INCOME TAXES		911,287			2,504,081			4,102,901		(6,606,982	)		911,287
INCOME TAX EXPENSE		609,588			-			-		-			609,588
NET INCOME	$	301,699		$	2,504,081		$	4,102,901	$	(6,606,982	)	$	301,699

Page 22

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Cash Flows

For the six months ended June 30, 2013	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	1,823,824		$	10,117,924		$	10,848,388		$	(20,966,312	)	$	1,823,824
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(982,826	)		(867,920	)		-			1,850,746			-
Gain on life settlements		-			-			(18,943,905	)		-			(18,943,905	)
Amortization of deferred financing and issuance costs		737,959			434,431			758,490			-			1,930,880
Deferred income taxes		2,366,794			-			-			-			2,366,794
Preferred stock issued for dividends		261,937			-			-			-			261,937
(Increase) decrease in operating assets:
Other assets		(27,278,091	)		(24,355,215	)		(3,330,802	)		51,349,976			(3,614,132	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		1,485,107			119,503			90,187			-			1,694,797
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(21,585,296	)		(14,551,277	)		(10,577,642	)		32,234,410			(14,479,805	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(12,885,993	)		-			(12,885,993	)
Proceeds from settlement of life settlements		-			-			2,872,152			-			2,872,152
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(10,013,841	)		-			(10,013,841	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			8,000,000			-			8,000,000
Payments for redemption of Series I Secured notes payable		-			(3,930,876	)		-			-			(3,930,876	)
Proceeds from issuance of debentures		42,439,661			-			-			-			42,439,661
Payments from issuance and redemption of debentures		(5,336,571	)		-			-			-			(5,336,571	)
Payments from restricted cash		-			(752,800	)		(1,617,975	)		-			(2,370,775	)
Issuance of member capital		-			18,024,952			14,209,458			(32,234,410	)		-
Repurchase of common stock		(3,252,400	)		-			-			-			(3,252,400	)
Payments for redemption of preferred stock		(311,804	)		-			-			-			(311,804	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		33,538,886			13,341,276			20,591,483			(32,234,410	)		35,237,235
NET INCREASE IN CASH AND CASH EQUIVALENTS		11,953,590			(1,210,001	)		-			-			10,743,589
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		25,035,579			2,461,465			-			-			27,497,044
END OF THE PERIOD	$	36,989,169		$	1,251,464		$	-		$	-		$	38,240,633

Page 23

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the six months ended June 30, 2012	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	(1,851,130	)	$	132,096		$	3,949,640		$	(4,091,736	)	$	(1,851,130	)
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(8,985,743	)		(238,602	)		5,132,609			4,091,736			-
(Gain) loss on life settlements		-			999,677			(11,989,926	)		-			(10,990,249	)
Amortization of deferred financing and issuance costs		46,622			746,387			116,448			-			909,457
Deferred income taxes		(529,860	)		-			-			-			(529,860	)
Preferred stock issued for dividends		421,010			-			-			-			421,010
(Increase) decrease in operating assets:
Other assets		(13,027	)		1,217,186			(146,874	)		-			1,057,285
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		606,991			39,087			13,056			-			659,134
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(10,305,137	)		2,895,831			(2,915,047	)		-			(10,324,353	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,622,030	)		-			(2,622,030	)
Proceeds from settlement of life settlements		-			-			416,665			-			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(2,205,365	)		-			(2,205,365	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			6,000,000			-			6,000,000
Proceeds from issuance of Series I Secured notes payable		-			50,000			-			-			50,000
Payments for redemption of Series I Secured notes payable		-			(3,468,957	)		-			-			(3,468,957	)
Proceeds from issuance of debentures		15,757,086			-			-			-			15,757,086
Payments from issuance of debentures		(712,587	)		-			-			-			(712,587	)
Proceeds (payments) from restricted cash		-			822,227			(879,588	)		-			(57,361	)
Proceeds from issuance of preferred stock		5,787,375			-			-			-			5,787,375
Payments for redemption of preferred stock		(1,609,362	)		-			-			-			(1,609,362	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		19,222,512			(2,569,730	)		5,120,412			-			21,746,194
NET INCREASE IN CASH AND CASH EQUIVALENTS		8,917,375			299,101			-			-			9,216,476
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		1,746,456			131,893			-			-			1,878,349
END OF THE PERIOD	$	10,663,831		$	430,994		$	-		$	-		$	11,094,825

Page 24

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the three months ended June 30, 2013	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	1,756,690		$	4,543,289		$	5,014,494		$	(9,557,783	)	$	1,756,690
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		4,543,289			5,014,494			-			(9,557,783	)		-
(Gain) loss on life settlements		-			-			(7,449,180	)		-			(7,449,180	)
Amortization of deferred financing and issuance costs		344,482			161,926			330,725			-			837,133
Deferred income taxes		1,802,920			-			-			-			1,802,920
Preferred stock issued for dividends		178,235			-			-			-			178,235
(Increase) decrease in operating assets:
Other assets		(13,002,552	)		(13,654,889	)		(4,000,000	)		26,493,437			(4,164,004	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		639,763			(12,024	)		(225,000	)		-			402,739
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(3,737,173	)		(3,947,204	)		(6,328,961	)		7,377,871			(6,635,467	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,972,944	)		-			(2,972,944	)
Proceeds from settlement of life settlements		-			-			1,382,152			-			1,382,152
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(1,590,792	)		-			(1,590,792	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured notes payable		-			(2,423,052	)		-			-			(2,423,052	)
Proceeds from issuance of debentures		18,588,867			-			-			-			18,588,867
Payments from issuance and redemption of debentures		(3,033,303	)		-			-			-			(3,033,303	)
Proceeds (payments) from restricted cash		-			(2,222,476	)		4,382,809			-			2,160,333
Issuance of member capital		-			3,840,927			3,536,944			(7,377,871	)		-
Repurchase of common stock		(3,252,400	)		-			-			-			(3,252,400	)
Payments for redemption of preferred stock		(125,135	)		-			-			-			(125,135	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,178,029			(804,601	)		7,919,753			(7,377,871	)		11,915,310
NET INCREASE IN CASH AND CASH EQUIVALENTS		8,440,856			(4,751,805	)		-			-			3,689,051
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		28,548,313			6,003,269			-			-			34,551,582
END OF THE PERIOD	$	36,989,169		$	1,251,464		$	-		$	-		$	38,240,633

Page 25

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the three months ended June 30, 2012	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	301,699		$	2,504,081		$	4,102,901		$	(6,606,982	)	$	301,699
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(7,602,533	)		(352,750	)		1,348,301			6,606,982			-
Gain on life settlements		-			(66,551	)		(4,509,390	)		-			(4,575,941	)
Amortization of deferred financing and issuance costs		46,622			237,451			58,224			-			342,297
Deferred income taxes		609,588			-			-			-			609,588
Preferred stock issued for dividends		294,935			-			-			-			294,935
(Increase) decrease in operating assets:
Other assets		(42,969	)		(95,216	)		(159,875	)		-			(298,060	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		152,299			(44,990	)		(5,857	)		-			101,452
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(6,240,359	)		2,182,025			(834,304	)		-			(3,224,030	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(1,468,770	)		-			(1,468,770	)
Proceeds from settlement of life settlements		-			-			416,665			-			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(1,052,105	)		-			(1,052,105	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			3,500,000			-			3.500,000
Proceeds from issuance of Series I Secured notes payable		-			-			-			-			-
Payments for redemption of Series I Secured notes payable		-			(1,918,420	)		-			-			(1,918,420	)
Proceeds from issuance of debentures		12,695,213			-			-			-			12,695,213
Payments from issuance of debentures		(712,587	)		-			-			-			(712,587	)
Payments from redemption of debentures		-			-			-			-			-
Payments from restricted cash		-			-			(3,282,199	)		-			(3,282,199	)
Proceeds from issuance of preferred stock		1,350,910			-			-			-			1,350,910
Payments for redemption of preferred stock		(810,722	)		-			-			-			(810,722	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,522,814			(1,918,420	)		217,801			-			10,822,195
NET INCREASE IN CASH AND CASH EQUIVALENTS		6,282,455			263,605			-			-			6,546,060
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		4,381,376			167,389			-			-			4,548,765
END OF THE PERIOD	$	10,663,831		$	430,994		$	-		$	-		$	11,094,825

Page 26

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

( 15 )     Concentrations

GWG purchases life insurance policies written by life insurance companies having investment grade ratings by independent rating agencies.  As a result, there may be certain concentrations of contracts with life insurance companies.  The following summarizes the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company.

	June 30, 2013		December 31, 2012
Life insurance company	%		%
Company A		15.18		16.96
Company B		12.14		13.80
Company C		10.33		11.36

The following summarizes the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company:

	June 30, 2013		December 31, 2012
State of residence	%		%
California		29.88		28.44
Florida		12.45		11.85
New York		12.03		13.27

Page 27

ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

You should read the following discussion in conjunction with the consolidated financial statements and accompanying notes and the information contained in other sections of this report. This discussion and analysis is based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. The statements in this discussion and analysis concerning expectations regarding our future performance, liquidity and capital resources, as well as other non-historical statements, are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties.  Our actual results could differ materially from those suggested or implied by any forward-looking statements. Please see the caption "Risk Relating to Forward-Looking Statements" below.

Overview

We are engaged in the emerging secondary market for life insurance policies.  We acquire life insurance policies in the secondary market from policy owners desiring to sell their policies at a discount to the face value of the insurance benefit.  Once we purchase a policy, we continue paying the policy premiums in order to ultimately collect the face value of the insurance benefit.  We generally hold the individual policies to maturity, in order to ultimately collect the policy’s face value upon the insured’s mortality.  Our strategy is to build a profitable and large (greater than 300 policies) portfolio of policies that is diversified in terms of insurance carriers and the medical conditions of insureds.  We believe that diversification among insurers and medical conditions will lower our overall risk exposure, and that a larger number of individual policies (diversification in overall number) will provide our portfolio with greater actuarial stability.

In the first six months of 2013, we recognized $7,728,000 of revenue from the receipt of $10,600,000 in policy benefits.  In addition, we recognized revenue from the change in fair value of our life insurance policies, net of premiums and carrying costs, of $8,346,000.  Interest expense, including amortization of the deferred financing costs and preferred stock dividends, was $9,409,000 for the six months ended June 30, 2013, and selling, general and administrative expenses for the six months ended June 30, 2013 were $5,915,000.  Income tax expense for the six months ended June 30, 2013 was $2,368,000.  Our net income for the six months ended June 30, 2013 was $1,824,000.

Critical Accounting Policies

Critical Accounting Estimates

The preparation of our consolidated financial statements requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our judgments, estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions and conditions. We evaluate our judgments, estimates and assumptions on a regular basis and make changes accordingly. We believe that the judgments, estimates and assumptions involved in the accounting for the valuation of investments in life insurance policies have the greatest potential impact on our consolidated financial statements and accordingly believe these to be our critical accounting estimates. Below we discuss the critical accounting policies associated with these estimates as well as certain other critical accounting policies.

Ownership of Life Insurance Policies—Fair Value Option

Our primary business involves the purchasing and financing of life insurance policies. As such, we account for the purchase of life insurance policies in accordance with ASC 325-30, Investments in Insurance Contracts, which requires us to use either the investment method or the fair value method. The election is made on an instrument-by-instrument basis and is irrevocable. We have elected to account for these life insurance policies as investments using the fair value method.

We initially record our purchase of life insurance policies at the transaction price, which is the amount paid for the policy, inclusive of all fees and costs associated with the acquisition. The fair value of the investment in insurance policies is evaluated at the end of each reporting period. Changes in the fair value of the life insurance policies are based on periodic evaluations and are recorded as changes in fair value of life insurance policies in our consolidated and combined statement of operations. The fair value is determined as the net present value of the life insurance portfolio’s future expected cash flows that incorporates current life expectancy and discount rate assumptions.

Page 28

In addition to reporting our results of operations and financial condition based on the fair value of our life insurance policies as required by GAAP, management also makes calculations based on the weighted average expected internal rate of return of the policies. See “Non-GAAP Financial Measures” below.

Valuation of Insurance Policies

Unobservable inputs, as discussed below, are a critical component of our estimate for the fair value of our investments in life insurance policies. We currently use a probabilistic method of valuing life insurance policies, which we believe to be the preferred and most prevalent valuation method in the industry. In this regard, the most significant assumptions we make are the life expectancy of the insured and the discount rate.

In determining the life expectancy estimate, we generally use actuarial medical reviews from independent medical underwriters. These medical underwriters summarize the health of the insured by reviewing historical and current medical records. The medical underwriters evaluate the health condition of the insured in order to produce an estimate of the insured’s mortality—a life expectancy report. In the case of a small face policy ($250,000 face value or less), we may use one life expectancy report or estimate life expectancy based on a modified methodology. The life expectancy report represents a range of probabilities for the insured’s mortality against a group of cohorts with the same age, sex and smoking status. These mortality probabilities represent a mathematical curve known as a mortality curve, which is then used to generate a series of expected cash flows from the life insurance policy over the expected lifespan of the insured. A discount rate is used to calculate the net present value of the expected cash flows. The discount rate represents the internal rate of return we expect to earn on investments in a policy or in the portfolio as a whole. The discount rate used to calculate fair value of our portfolio incorporates the guidance provided by ASC 820, Fair Value Measurements and Disclosures.

The table below provides the discount rate used to estimate the fair value of the life insurance policies for the period ending:

June 30, 2013	December 31, 2012
11.84%	12.08%

The change in the discount rate incorporates current information about market interest rates, the credit exposure to the issuing insurance companies and our estimate of the risk premium an investor would require to receive the future cash flows derived from our portfolio of life insurance policies.

We engaged a third party, Model Actuarial Pricing Systems (MAPS), to prepare a third-party valuation of our life settlement portfolio. MAPS owns and maintains the portfolio pricing software used by the Company. MAPS processed policy data, future premium data, life expectancy data, and other actuarial information supplied by the Company to calculate a net present value for our portfolio using the specified discount rate of 11.84%. MAPS independently calculated the net present value of our portfolio of 241 policies to be $193,892,000, which is the same fair value estimate used by the Company on the balance sheet as of June 30, 2013, and furnished us with a letter documenting its calculation. A copy of such letter is filed as Exhibit 99.1 to this report.

JOBS Act

On April 5, 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933 for complying with new or revised accounting standards. This means that an “emerging growth company” can make an election to delay the adoption of certain accounting standards until those standards would apply to private companies. We have elected to delay such adoption of new or revised accounting standards and, as a result, we may not comply with new or revised accounting standards at the same time as other public reporting companies that are not “emerging growth companies.” This exemption will apply for a period of five years following our first sale of common equity securities under an effective registration statement or until we no longer qualify as an “emerging growth company” as defined under the JOBS Act, whichever is earlier.

Page 29

Deferred Income Taxes

FASB ASC 740, Income Taxes, requires the Company to recognize deferred tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. A valuation allowance is established for any portion of deferred tax assets that is not considered more likely than not to be realized.

The Company has provided a valuation allowance against the deferred tax asset related to a note receivable because it believes that, when realized for tax purposes, it will result in a capital loss that will not be utilized because the Company has no expectation of generating a capital gain within the applicable carry-forward period. Therefore, the Company does not believe that it is more likely than not that the deferred tax asset will be realized.

The Company has also provided a valuation allowance against the deferred tax asset related to a tax basis capital loss generated with respect to its settlement and subsequent disposal of its investment in Athena Structured Funds.  As there is no expectation of the Company generating capital gains within the applicable carry-forward period, the Company does not believe that it is more likely than not that the deferred asset will be realized.

A valuation allowance is required to be recognized to reduce deferred tax assets to an amount that is more likely than not to be realized. Realization of deferred tax assets depends upon having sufficient past or future taxable income in periods to which the deductible temporary differences are expected to be recovered or within any applicable carryback or carryforward periods. The Company believes that it is more likely than not that it will be able to realize all of its deferred tax assets other than that which is expected to result in a capital loss.

Deferred Financing and Issuance Costs

Financing costs incurred to obtain financing under the revolving credit facility have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility.  The Series I Secured note obligations  are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Renewable Secured Debentures are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Series A preferred stock is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Risk Relating to Forward-Looking Statements

Certain matters discussed in this section of this report, and elsewhere in this report, are forward-looking statements.  We have based these forward-looking statements on our current expectations and projections about future events.  Nevertheless, these forward-looking statements are subject to risks, uncertainties and assumptions about our operations and the investments we make, including, among other things, factors discussed in the “Risk Factors” section of this report and the following:

● changes in the secondary market for life insurance;

● our limited operating history;

● the valuation of assets reflected on our financial statements;

● the reliability of assumptions underlying our actuarial models;

● our reliance of debt financing;

● risks relating to the validity and enforceability of the life insurance policies we purchase;

● our reliance on information provided and obtained by third parties;

● federal and state regulatory matters;

Page 30

● additional expenses, not reflected in our operating history, related to being a public reporting company;

● competition in the secondary life insurance market;

● the relative illiquidity of life insurance policies;

● life insurance company credit exposure;

● economic outlook;

● performance of our investments in life insurance policies;

● financing requirements;

● litigation risks; and

● restrictive covenants contained in borrowing agreements.

Forward-looking statements can generally be identified by the use of words like “believes,” “could,” “possibly,” “probably,” “anticipates,” “estimates,” “projects,” “expects,” “may,” “will,” “should,” “seek,” “intend,” “plan,” “expect” or “consider,” or the negative of these expressions or other variations, or by discussions of strategy that involve risks and uncertainties.  All forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual transactions, results, performance or achievements to be materially different from any future transactions, results, performance or achievements expressed or implied by such forward-looking statements. We caution you that the forward-looking statements in this report are only estimates and predictions, or statements of current intent.  Actual results or outcomes, or actions that we ultimately undertake, could differ materially from those anticipated in the forward-looking statements due to risks, uncertainties or actual events differing from the assumptions underlying these statements.

Principal Revenue and Expense Items

We earn revenues from three primary sources as described below.

● Policy Benefits Realized.  We recognize the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized.  We generally collect the face value of the life insurance policy from the insurance company within 45 days of the insured’s mortality.

● Sale of a Life Insurance Policy or a Portfolio of Life Insurance Policies.  In an event of a sale of a policy the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

● Change in Fair Value of Life Insurance Policies.  We have elected to carry our investments in life insurance policies at fair value in accordance with ASC 325-30,Investments in Life Insurance Contracts. Accordingly, we value our investments in life insurance policies each reporting period in accordance with the fair value principles discussed herein, which includes the expected payment of premiums for future periods.

Our main components of expense are summarized below.

● Selling, General and Administrative Expenses.  We recognize and record expenses incurred in the operations of the purchasing and servicing of life insurance policies.  These expenses include professional fees, salaries, and sales and marketing expenditures.

Page 31

● Interest Expense.  We recognize and record interest expenses associated with the costs of financing our life insurance portfolio for the current period.  These expenses include interest paid to our senior lender under our revolving credit facility, as well as all interest paid on our debentures and other outstanding indebtedness such as our subsidiary secured notes and dividends on convertible, redeemable preferred stock.  When we issue long-term indebtedness, we amortize the issuance costs associated with such indebtedness over the outstanding term of the financing, and classify it as interest expense.

Results of Operations — Three and Six Months Ended June 30, 2013 Compared to the Same Periods in 2012

The following is our analysis of the results of operations for the periods indicated below.  This analysis should be read in conjunction with our consolidated financial statements and related notes.

Revenue. Revenue recognized from the receipt of policy benefits was $5,218,000 and $7,728,000 during the three and six months ended June 30, 2013. Revenue recognized from the receipt of policy benefits was $4,083,000 during the three and six months ended June 30, 2012.  Revenue recognized from the change in fair value of our life insurance policies, net of premiums and carrying costs, was $2,515,000 and $8,346,000 for the three and six month ended June 30, 2013 and $784,000 and 1,386,000 for the three and six months ended June 30, 2012.  During the six-month period ended June 30, 2013, we purchased a higher volume of life insurance policies than we did during the same period in 2012. The change in fair value related to new policies acquired during the three and six month periods ended June 30, 2013 was $2,471,000 and $8,770,000 respectively, and $1,100,000 and $1,414,000 for those acquired during the three and six month periods ended June 30, 2012, respectively.  In each case, the increases in fair value were due to changes in the discount rates we use to calculate the net present value of cash flows expected from our portfolio of life insurance policies, change in fair value of policies acquired during the period, and aging of the policies. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the portfolio would require. The discount rate used to estimate the fair value of the life insurance policies we own was 11.84% as of June 30, 2013, compared to 12.08% for the same date in 2012. The decrease in discount rate was due to an increase in the size and diversity of policies held in our portfolio of life insurance policies that resulted in lower risk premium to a potential buyer of the portfolio in its entirety. The carrying value of policies acquired during each quarterly reporting period are adjusted to their current value using the fair value discount rate applied to the portfolio as of that reporting date.

Expenses. Interest expense, including amortization of the deferred financing costs, was $4,942,000 for the second quarter of 2013 and $9,409,000 for the six months ended June 30, 2013, $2,380,000 for the second quarter of 2012 and $4,818,000 for the six months ended June 30, 2012. Year-to-date interest expense for the first six months of 2013 has increased $4,591,000 compared to the same period in 2012. The increase in interest expense was due to increased average debt outstanding, increased Series A preferred stock, and higher interest rate associated with the revolving line of credit.  Selling, general, and administrative expenses were $2,507,000, and $1,624,000 for the second quarter of 2013 and 2012, respectively, and $5,915,000 and $3,081,000 for the six months ended June 30, 2013 and 2012, respectively.  This represents an increase of $2,834,000 in selling, general, and administrative expenses during the first six months of 2013 compared to the same period of 2012.  The increase is mostly due to employee expenses and benefits as well as higher sales and marketing costs associated with raising funds through renewable secured debentures.

Income Tax Expense. For the three and six months ended June 30, 2013, the Company recorded income tax expense of $1,802,000, or 50.6% of income before taxes, and $2,368,000 or 56.5% of income before taxes, compared to income tax expense of $610,000 or 66.9% of income before taxes for the three month ended June 30, 2012 and income tax benefit of $530,000, or 22.3% for the six months ended June 30, 2012.  The primary differences between the Company’s June 30, 2013 effective tax rate and the statutory federal rate are the accrual of preferred stock dividend expense, state taxes, and other non-deductible expenses.  Excluding the impact of the dividends and other permanent differences, the effective tax rate for the three months ended June 30, 2013 would have been 40.5%.

The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

Page 32

Liquidity and Capital Resources

We finance our business through a combination of policy benefit revenues, origination fees, equity offerings, debt offerings, and a credit facility. We have used our debt offerings and credit facility primarily for a combination of policy acquisition, policy servicing and portfolio related financing expenditures. We charge an intercompany origination fee in the amount of one to four percent of the face value of a life insurance policy’s benefit when we acquire the related life insurance policy.  The origination fee we charge is included in the total purchase price we pay for a life insurance policy for purposes of our valuation and expected internal rate of return calculations, but is not netted against the purchase price we pay to a seller of an insurance policy. We generated cash flows of $536,000 and $290,000 from origination fees during the three months ended June 30, 2013 and 2012 respectively, and $1,814,000 and $438,000 during the six months ended June 30, 2013 and 2012 respectively.  The higher amount in 2013 was due to a higher volume of purchases of life insurance policies compared to that in the same period of 2012.  Profit from intra-company origination fees for life insurance policies retained by the Company is eliminated from our consolidated statements of operations. As such, the origination fees collected under our life insurance policy financing arrangements are reflected in our consolidated statements of cash flows as cash flows from financing activities as they are paid in the form of borrowings used to finance the acquisition. Our revolving bank line allows GWG DLP Funding II to borrow the funds necessary to pay origination fees to GWG Life Settlements, LLC.  Our borrowing agreements allow us to use net proceeds of the Renewable Secured Debentures for policy acquisition, which includes origination fees. If the policy acquisition is not financed, no fees are included in the consolidated cash flows.  See “—Cash Flows” below for further information. We determine the purchase price of life insurance policies in accordance with ASC 325-30, Investments in Insurance Contracts, using the fair value method. Under the fair value method, the initial investment is recorded at the transaction price.  Since the origination fees are paid from a wholly owned subsidiary to the parent company, these fees are not included in the transaction price for our consolidated financial statements. For further discussion on our accounting policies for life settlements, please refer to note 1 to our consolidated financial statements.

As of June 30, 2013, we had approximately $39.0 million in combined available cash and available borrowing base surplus capacity under our revolving credit facility for the purpose of paying premiums on existing policies, paying portfolio servicing expenses, and paying principal and interest on our outstanding financing obligations.

In September 2012, we concluded a Series A preferred stock offering, receiving an aggregate $24.6 million in subscriptions for our Series A preferred stock. These subscriptions consisted of $14.0 million in conversions of outstanding Series I subsidiary secured notes and $10.6 million of new investments. We have used the proceeds from the sale of our Series A preferred stock, together with the origination fees we received to purchase and finance life insurance policies to fund our operational expenditures.

In June 2011, we registered a $250.0 million debt offering of our Renewable Secured Debentures with the SEC, which registration became effective on January 31, 2012. As of June 30, 2013, we had received $97.8 million in subscriptions for our Renewable Secured Debentures, including $1.9 million of subscriptions in process.

Additionally, our wholly owned subsidiary, GWG Life Settlements, LLC, or GWG Life, issued Series I Securred notes beginning in November 2009 on a private placement basis to accredited investors only. As of June 30, 2013, we had approximately $35.3 million in principal amount of Series I Secured notes outstanding.  This offering was closed in November 2011.

The weighted-average interest rate of our outstanding Series I Secured notes as of June 30, 2013 was 8.27% and the weighted-average maturity at that date was 2.61 years.  The Series I Secured notes have renewal features.  Since we first issued our Series I Secured notes, we have experienced $98,592,000 in maturities, of which $76,849,000 has renewed for an additional term as of June 30, 2013. This has provided us with an aggregate renewal rate of approximately 78% for investments in our subsidiary secured notes. Future contractual maturities of Series I Secured notes payable at June 30, 2013 are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	9,358,000
2014		12,561,000
2015		6,675,000
2016		1,802,000
2017		4,085,000
Thereafter		818,000
	$	35,299,000

Page 33

The weighted-average interest rate of our outstanding Renewable Secured Debentures as of June 30, 2013 was 7.58% and the weighted-average maturity at that date was 3.92 years.  Our Renewable Secured Debentures have renewal features.  Since we first issued our Renewable Secured Debentures, we have experienced $10,557,000 in maturities, of which $7,336,000 has renewed for an additional term as of June 30, 2013.  This has provided us with an aggregate renewal rate of approximately 69% for investments in our Renewable Secured Debentures. Future contractual maturities of Renewable Secured Debentures at June 30, 2013 are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	11,839,000
2014		15,272,000
2015		30,085,000
2016		16,359,000
2017		6,529,000
Thereafter		15,774,000
	$	95,858,000

The Renewable Secured Debentures and Series I Secured notes are secured by all our assets, and are subordinate to our revolving credit facility with Autobahn/DZ Bank.  The Renewable Secured Debentures and Series I Secured notes are pari passu with respect to our assets pursuant to an inter-creditor agreement (see notes 7 and 8 to our consolidated financial statements).

We maintain a $100 million revolving credit facility with Autobahn/DZ Bank through our wholly owned subsidiary GWG DLP Funding II, or DLP Funding II. As of June 30, 2013, we had $79.0 million outstanding under the revolving credit facility and maintained an available borrowing base surplus of $0.7 million (see note 6 to our consolidated financial statements).

We expect to meet our ongoing operational capital needs through a combination of policy benefit revenues, origination fees, and proceeds from financing transactions. We expect to meet our policy acquisition, servicing, and financing capital needs principally from the receipt of policy benefit revenues from our portfolio of life insurance policies, net proceeds from our offering of Renewable Secured Debentures, and from our revolving credit facility. Because we only receive origination fees when we purchase a policy, our receipt of those fees is contingent upon our consummation of policy purchases, which is, in turn, contingent upon our receipt of external funding. Despite recent adverse capital market conditions, including a prolonged credit crisis, we have demonstrated continued access to credit and financing markets.  Furthermore, we expect to begin receiving insurance benefit payments on our portfolio of life insurance policies as the average age of the insureds increase and mortality events occur over time—which we expect to begin more significantly in 2015 and steadily increasing until 2018. As a result of the foregoing, we estimate that our liquidity and capital resources are sufficient for our current and projected financial needs. Nevertheless, if we are unable to continue our offering of Renewable Secured Debentures for any reason, and we are unable to obtain capital from other sources, we expect that our business would be materially and adversely affected. In addition, our business would be materially and adversely affected if we did not receive the policy benefits we forecast and if holders of our Renewable Secured Debentures or Series I Secured notes failed to renew with the frequency we have historically experienced. In such a case, we could be forced to sell our investments in life insurance policies, in order to service or satisfy our debt-related obligations and continue to pay policy premiums.

Capital expenditures have historically not been material and we do not anticipate making material capital expenditures in 2013 or beyond.

Debt Financings Summary

We had the following outstanding debt balances as of June 30, 2013:

Issuer/Borrower	Principal Amount Outstanding		Weighted Average Interest Rate
GWG Holdings, Inc. - Renewable Secured Debentures	$	95,858,000		7.58	%
GWG Life Settlements, LLC -Series I Notes, secured		35,299,000		8.27	%
GWG DLP Funding II, LLC - Revolving credit facility		79,000,000		6.25	%
Total	$	210,157,000		7.20	%

Page 34

Our total revolving credit facility and other indebtedness balance as of June 30, 2013 was $210,157,000. The total outstanding face amount under our Series I Secured notes outstanding at June 30, 2013 was $35,299,000, less unamortized selling costs of $793,000, resulting in a carrying amount of $34,506,000.  The total outstanding face amount of Renewable Secured Debentures outstanding at June 30, 2013 was $95,858,000 plus $1,940,000 of subscriptions in process, less unamortized selling costs of $4,113,000, resulting in a carrying amount of $93,685,000.  The total outstanding under our revolving credit facility at June 30, 2013 was $79,000,000. The fair value of our investments in life insurance assets of $193,892,000 plus our cash balance of $38,240,000 and our restricted cash balance of $4,464,000, totaled $236,596,000, representing an excess of life insurance assets over secured indebtedness of $26,439,000 at June 30, 2013. The Renewable Secured Debentures and Series I Secured notes are secured by all our assets and are structurally subordinate to our ownership of DLP Funding II, and the revolving credit facility with Autobahn/DZ Bank.  The Renewable Secured Debentures and Series I Secured notes are pari passu with respect to shared collateral pursuant to an inter-creditor agreement.

The following forward-looking table seeks to illustrate the impact of the sale of our portfolio of life insurance assets at various discount rates in order to satisfy our debt obligations as of June 30, 2013.  In all cases, the sale of the life insurance assets owned by DLP Funding II will be used to satisfy all amounts owing under the revolving credit facility with Autobahn/ DZ Bank.  The net sale proceeds remaining after satisfying all obligations under the revolving credit facility would be applied to Renewable Secured Debentures and Series I Secured Notes on a pari passu basis.

As of June 30,  2013
Portfolio Discount Rate		11%		12%		13%		14%		15%
Value of portfolio	$	203,065,367	$	192,218,326	$	182,255,258	$	173,084,553	$	164,625,845
Cash and cash equivalents		42,704,500		42,704,500		42,704,500		42,704,500		42,704,500
Total assets		245,769,867		234,922,826		224,959,758		215,789,053		207,330,345
Revolving credit facility Autobahn/DZ Bank		79,000,000		79,000,000		79,000,000		79,000,000		79,000,000
Net after revolving credit facility		166,769,867		155,922,826		145,959,758		136,789,053		128,330,345
Series I Secured notes and Renewable Secured Debentures		131,157,025		131,157,025		131,157,025		131,157,025		131,157,025
Net after Series I Secured notes and Renewable Secured Debentures		35,612,842		24,765,801		14,802,733		5,632,028		(2,827,430	)
Impairment to Series I Secured notes and Renewable Secured Debentures	No impairment		No impairment		No impairment		No impairment		Impairment

The table illustrates that our ability to fully satisfy amounts owing under the Renewable Secured Debentures and Series I Secured Notes would likely be impaired upon the sale of all our life insurance assets at a price equivalent to a discount rate of approximately 14.66% or higher.  The discount rates used to calculate the fair value of our portfolio for mark-to-market accounting were 11.84% as of June 30, 2013, and 12.08% as of December 31, 2012.  The table does not include any allowance for transactional fees and expenses associated with a portfolio sale (which expenses and fees could be substantial), and is provided to demonstrate how various discount rates used to value our portfolio could affect our ability to satisfy amounts owing under our debt obligations (including the debentures), in light of our senior secured lender’s right to priority payments. You should read the above table in conjunction with the information contained in other sections of this report. This discussion and analysis is based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. The forward-looking presentation above is subject to numerous risks and uncertainties.  Our actual results could differ materially from those suggested or implied by the above table.  Please see the caption “Risk Relating to Forward-Looking Statements” above.

Cash Flows

The payment of premiums and servicing costs to maintain life insurance policies represents our most significant requirement for cash disbursement. When a policy is purchased, we are able to calculate the minimum premium payments required to maintain the policy in-force. Over time as the insured ages, premium payments will increase; however, the probability of actually needing to pay the premiums decreases since mortality becomes more likely. These scheduled premiums and associated probabilities are factored into our expected internal rate of return and cash-flow modeling. Beyond premiums, we incur policy servicing costs, including annual trustee and tracking costs, and debt servicing costs, including principal and interest payments. Until we receive a stable amount of proceeds from the policy benefits, we intend to pay these costs from our credit facility and through the issuance of debt securities. We presently expect that by 2015, the cash inflows from the receipt of policy benefits will exceed the premium obligations on the remaining life insurance policies held within the portfolio.  

We expect to begin servicing and paying down our outstanding indebtedness from these cash flows when we receive payments from the policy benefits.  See “Business—Portfolio Management.”

Page 35

The amount of payments that we will be required to make over the next five years to cover the payment of premiums and servicing costs to maintain the current portfolio of life insurance policies is set forth in the table below.

Year	Premiums and Servicing
Six months ending December 31, 2013	$	10,561,000
2014		21,495,000
2015		23,275,000
2016		25,511,000
2017		28,046,000
Total	$	108,888,000

Most of the insurance policies owned by our wholly owned subsidiary, GWG DLP Funding II, are subject to a collateral arrangement with the agent to our revolving credit lender, as described in note 6 to the consolidated financial statements. Under this arrangement, collection and escrow accounts are used to fund purchases and premiums of the insurance policies and to pay interest and other charges under our revolving credit facility. The lender and its agent must authorize all disbursements from these accounts, including any distributions to GWG Life or Holdings. Distributions are limited to an amount that would result in the borrowers (GWG DLP Funding II, LLC, GWG Life Settlements, LLC, and GWG Holdings, Inc.) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by the agent. After such amount is reached, the credit agreement requires that excess funds be used to fund repayments or a reserve account in a certain amount before any additional distributions may be made. In the future, these arrangements may restrict the cash flows available for payment of principal and interest on our debt obligations.

Inflation

Changes in inflation do not necessarily correlate with changes in interest rates. We presently do not foresee any material impact of inflation on our results of operations in the periods presented in our consolidated financial statements.

Off-Balance Sheet Arrangements

Operating Lease - The Company entered into an office lease with U.S. Bank National Association as the landlord. The lease was effective April 22, 2012 with a term through August 31, 2015. The lease is for 8,881 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Minimum lease payments under the lease are as follows:

Six months ending December 31, 2013	$	49,000
2014	$	104,000
2015	$	70,000
Total	$	223,000

Credit Risk

We review the credit risk associated with our portfolio of life insurance policies when estimating its fair value. In evaluating the policies’ credit risk we consider insurance company solvency, credit risk indicators, economic conditions, ongoing credit evaluations, and company positions. We attempt to manage our credit risk related to life insurance policies typically by purchasing policies issued only from companies with an investment grade credit rating by either Standard & Poor’s, Moody’s, or A.M. Best Company.  As of June 30, 2013, 99.04% of our life insurance policies, by face value benefits, were issued by companies that maintained an investment grade rating (BBB- or better) by Standard & Poor’s.

Interest Rate Risk

Our credit facility is floating-rate financing. In addition, our ability to offer interest rates that attract capital (including in the offer and sale of Renewable Secured Debentures) is generally impacted by prevailing interest rates. Furthermore, while our other indebtedness provides us with fixed-rate financing, our debt coverage ratio is calculated in relation to our total cost of financing. Therefore, fluctuations in interest rates impact our business by increasing our borrowing costs, and reducing availability under our debt financing arrangements. Furthermore, we calculate our portfolio earnings based upon the spread generated between the return on our life insurance portfolio and the cost of our financing. As a result, increases in interest rates will reduce the earnings we expect to achieve from our investments in life insurance policies.

Page 36

Non-GAAP Financial Measures

We use non-GAAP financial measures when evaluating our financial results, for planning and forecasting purposes, and for maintaining compliance with covenants contained in our borrowing agreements. Non-GAAP financial measures disclosed by management are provided as additional information to investors in order to provide them with an alternative method for assessing our financial condition and operating results. These non-GAAP financial measures are not in accordance with GAAP and may be different from non-GAAP measures used by other companies, including other companies within our industry.  This presentation of non-GAAP financial information is not meant to be considered in isolation or as a substitute for comparable amounts prepared in accordance with GAAP. See the notes to our consolidated financial statements and our audited financial statements contained herein.

We have elected to carry our investments in life insurance policies at fair value in accordance with ASC 325-30, Investments in Life Insurance Contracts. Accordingly, we value our investments in life insurance policies at the conclusion of each reporting period in accordance with GAAP fair value accounting principles.  In addition to GAAP, we are required to report non-GAAP financial measures to Autobahn/DZ Bank under certain financial covenants made to that lender under our revolving credit facility. As indicated above, we also use non-GAAP financial reporting to manage and evaluate the financial performance of our business.

GAAP-based fair value requires us to mark-to-market our investments in life insurance policies, which by its nature, is based upon Level 3 measurements that are unobservable.  As a result, this accounting treatment imports financial market volatility and subjective inputs into our financial reporting. We believe this type of accounting reporting is at odds with one of the key attractions for purchasing life insurance policies: The non-correlated nature of the returns to be derived from such policies. Therefore, in contrast to a GAAP-based fair valuation, we seek to measure the accrual of the actuarial gain occurring within life insurance policies at their expected internal rate of return based on statistical mortality probabilities for an insured (using primarily the insured’s age, sex and smoking status). The expected internal rate of return tracks actuarial gain occurring within the policies according to a mortality table as the insureds’ age increases.  By comparing the actuarial gain accruing within our life insurance policies against our costs during the same period, we can estimate, manage and evaluate the overall financial profitability of our business without regard to mark-to-market volatility. We use this information to balance our life insurance policy purchasing and manage our capital structure, including the issuance of debt and utilization of our other sources of capital, and to monitor our compliance with borrowing covenants. We believe that these non-GAAP financial measures provide information that is useful for investors to understand period-over-period operating results separate and apart from fair value items that may, or could, have a disproportionately positive or negative impact on results in any particular period.

Our credit facility requires us to maintain a “positive net income” and “tangible net worth” each of which are calculated on an adjusted non-GAAP basis on the method described above, without regard to GAAP-based fair value measures.  In addition, our revolving credit facility requires us to maintain an “excess spread,” which is the difference between (i) the weighted average of our expected internal rate of return of our portfolio of life insurance policies and (ii) the weighted average of our credit facility’s interest rate.  These calculations are made using non-GAAP measures in the method described below, without regard to GAAP-based fair value measures.

In addition, our Renewable Secured Debentures and Series I subsidiary secured notes require us to maintain a “debt coverage ratio” designed to ensure that the expected cash flows from our portfolio of life insurance policies is able to adequately service our total outstanding indebtedness. In addition, our Renewable Secured Debentures requires us to maintain a “subordination ratio” which limits the total amount of indebtedness that can be issued senior in rank to the Renewable Secured Debentures and Series I subsidiary secured notes.  These ratios are calculated using non-GAAP measures in the method described below, without regard to GAAP-based fair value measures.

Adjusted Non-GAAP Net Income.  Our credit facility requires us to maintain a positive net income calculated on an adjusted non-GAAP basis. We calculate the adjusted net income by recognizing the actuarial gain accruing within our life insurance policies at the expected internal rate of return of the policies we own without regard to fair value.  We net this actuarial gain against our costs during the same period to calculate our net income on a non-GAAP basis.

Page 37

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
GAAP net income (loss)	$	1,757,000		$	302,000		$	1,824,000		$	(1,851,000	)
Unrealized fair value gain (1)		(7,449,000	)		(4,576,000	)		(18,944,000	)		(9,367,000	)
Adjusted cost basis increase (2)		8,641,000			5,540,000			18,897,000			11,309,000
Accrual of unrealized actuarial gain (3)		5,165,000			3,783,000			10,198,000			7,839,000
Total adjusted non-GAAP income (4)	$	8,114,000		$	5,049,000		$	11,975,000		$	7,930,000

(1)	Reversal of unrealized fair value gain of life insurance policies for current period.
(2)	Adjusted cost basis is increased to include those acquisition and servicing expenses which are not capitalized by GAAP.
(3)	Accrual of actuarial gain at expected internal rate of return based on investment cost basis for the period.
(4)	We must maintain an annual positive consolidated net income, calculated on a non-GAAP basis, to maintain compliance with our revolving credit facility with DZ Bank/Autobahn.

Below is a full non-GAAP statement of operations in the form that we prepare and use internally to assess our performance, and that we provide to Autobahn/DZ Bank in satisfaction of certain covenants under our revolving credit facility.

Non-GAAP statement of operations:

	Three months ended June 30,					Six months ended June 30,
	2013		2012		2013		2012
Income
Investments in life settlement contracts (Unrealized)	$	5,165,000	$	3,783,000		10,198,000		7,839,000
Investments in life settlement contracts (Realized)		5,218,000		4,083,000		7,728,000		4,083,000
Origination fees and other income		3,265,000		337,000		4,711,000		487,000
Total Income		13,648,000		8,203,000		22,637,000		12,409,000
Expenses
Operations		1,873,000		2,144,000		5,915,000		4,100,000
Facility, Series I secured notes and renewable secured debentures marketing and deferred financing costs		1,859,000		400,000		2,379,000		909,000
Total Expenses		3,732,000		2,544,000		8,294,000		5,009,000
Net income before tax		9,916,000		5,659,000		14,343,000		7,400,000
Income tax expense (benefit)		1,802,000		610,000		2,368,000		(530,000	)
Net Income		8,114,000		5,049,000		11,975,000		7,930,000
Income per share
Basic and diluted	$	0.81	$	0.51	$	1.25	$	0.79
Fully diluted assuming conversion of preferred stock	$	0.54	$	0.51	$	0.82	$	0.79
Weighted average shares outstanding
Basic and diluted		9,969,989		9,989,000		9,548,205		9,989,000
Fully diluted assuming conversion of preferred stock		15,022,198		9,989,000		14,580,506		9,989,000

Page 38

Adjusted Non-GAAP Tangible Net Worth.  Our revolving credit facility requires us to maintain a tangible net worth in excess of $15 million calculated on an adjusted non-GAAP basis.  We calculate the adjusted tangible net worth by recognizing the actuarial gain accruing within our life insurance policies at the expected internal rate of return of the policies we own without regard to fair value.  We net this actuarial gain against our costs during the same period to calculate our tangible net worth on a non-GAAP basis.

	As of June 30, 2013			As of December 31, 2012
GAAP net worth (1)	$	21,166,000		$	22,644,000
Less intangible assets		(6,033,000	)		(3,650,000	)
GAAP tangible net worth		15,133,000			18,994,000
Unrealized fair value gain (2)		(94,350,000	)		(75,406,000	)
Adjusted cost basis increase (3)		85,408,000			67,123,000
Accrual of unrealized actuarial gain (4)		38,042,000			27,845,000
Total adjusted non-GAAP tangible net worth (5)	$	44,233,000		$	38,556,000

(1)	Includes termination of redeemable member’s interest prior to corporate conversion and preferred stock classified as temporary equity.
(2)	Reversal of cumulative unrealized fair value gain or loss of life insurance policies.
(3)	Adjusted cost basis is increased by acquisition and servicing expenses which are not capitalized under GAAP.
(4)	Accrual of cumulative actuarial gain at expected internal rate of return based on investment cost basis.
(5)	We must maintain a total adjusted non-GAAP tangible net worth of $15 million to maintain compliance with our revolving credit facility with DZ Bank/Autobahn.

Excess Spread. Our revolving credit facility requires us to maintain a 2.00% “excess spread” between our weighted-average expected internal rate of return of our portfolio of life insurance policies and the credit facility’s interest rate. A presentation of our excess spread and our total excess spread is set forth below. Management uses the “total excess spread” to gauge expected profitability of our investments, and uses the “excess spread” to monitor compliance with our borrowing.

	As of June 30, 2013			As of December 31, 2012
Weighted-average expected IRR (1)		12.54	%		12.84	%
Weighted-average revolving credit facility interest rate (2)		6.27	%		2.02	%
Excess spread (3)		6.27	%		10.82	%
Total weighted-average interest rate on indebtedness for borrowed money (4)		7.20	%		5.39	%
Total excess spread		5.34	%		7.45	%

(1) This represents the weighted-average expected internal rate of return of the life insurance policies as of the measurement date based upon our investment cost basis of the insurance policies and the expected cash flows from the life insurance portfolio. The expected internal rate of return as of December 31, 2012 includes an adjustment to increase, by an average of 8.67%, any life expectancy provided by 21st Services.  As a result of this adjustment, our expected internal rate of return at December 31, 2012 decreased from 14.27% to 12.84%. Our investment cost basis is calculated as our cash investment in the life insurance policies, without regard to GAAP-based fair value measurements, and is set forth below:

Investment Cost Basis	As of June 30, 2013			As of December 31, 2012
GAAP fair value	$	193,892,000		$	164,317,000
Unrealized fair value gain (A)		(94,350,000	)		(75,406,000	)
Adjusted cost basis increase (B)		85,407,000			67,123,000
Investment cost basis (C)	$	184,949,000		$	156,034,000

(A)	This represents the reversal of cumulative unrealized GAAP fair value gain of life insurance policies.
(B)	Adjusted cost basis is increased to include those acquisition and servicing expenses that are not capitalized by GAAP.
(C)	This is the full cash investment cost basis in life insurance policies from which our expected internal rate of return is calculated.

Page 39

(2)	This is the weighted-average revolving credit relating to our revolving credit facility interest rate as of the measurement date.
(3)	We must maintain an excess spread of 2.00% relating to our revolving credit facility to maintain compliance under such facility.
(4)	Represents the weighted-average interest rate paid on all outstanding indebtedness as of the measurement date, determined as follows:

Outstanding Indebtedness	As of June 30, 2013		As of December 31, 2012
Revolving credit facility	$	79,000,000	$	71,000,000
Series I Subsidiary secured notes		35,299,000		38,570,000
Renewable Secured Debentures		95,858,000		57,609,000
Total	$	210,157,000	$	167,179,000

Interest Rates on Indebtedness
Revolving credit facility	6.27	%	2.02	%
Series I subsidiary secured notes	8.27	%	8.22	%
Renewable Secured Debentures	7.58	%	7.65	%
Weighted-average interest rates on indebtedness	7.20	%	5.39	%

Debt Coverage Ratio and Subordination Ratio. Our Renewable Secured Debentures and Series I subsidiary secured notes requires us to maintain a “debt coverage ratio” of less than 90%.  The “debt coverage ratio” is calculated by dividing the sum of our total indebtedness by the sum of our cash and cash equivalents and the net present value of the life insurance portfolio. The “subordination ratio” for our Renewable Secured Debentures is calculated by dividing the total indebtedness that is senior to Renewable Secured Debentures and Series I subsidiary secured notes by the sum of the company’s cash and cash equivalents and the net present value of the life insurance portfolio.  The “subordination ratio” must be less than 50%.  For purposes of both ratio calculations, the net present value of the life insurance portfolio is calculated using a discount rate equal to the weighted average interest rate of all indebtedness.

	As of June 30, 2013			As of December 31, 2012
Life insurance portfolio policy benefits	$	650,655,000		$	572,246,000
Discount rate of future cash flows		7.20	%		5.39	%
Net present value of life insurance portfolio policy benefits	$	254,394,000		$	248,702,000
Cash and cash equivalents		42,704,000			29,590,000
Total Coverage		297,098,000			278,292,000
Revolving credit facility		79,000,000			71,000,000
Series I Subsidiary secured notes		35,299,000			38,570,000
Renewable Secured Debentures		95,858,000			57,609,000
Total Indebtedness	$	210,157,000		$	167,179,000
Debt Coverage Ratio		70.74	%		60.07	%
Subordination Ratio		26.59	%		25.51	%

As of June 30, 2013, we were in compliance with both the debt coverage ratio and the subordination ratio as required under our related financing agreements for Renewable Secured Debentures and Series I subsidiary secured notes.

Page 40

Our Portfolio

Our portfolio of life insurance policies, owned by our subsidiaries as of June 30, 2013, is summarized and set forth below:

Life Insurance Portfolio Summary

Total portfolio face value of policy benefits	$	650,655,000
Average face value per policy	$	2,700,000
Average face value per insured life	$	2,958,000
Average age of insured (yrs.) *		81.7
Average life expectancy estimate (yrs.) *		7.53
Total number of policies		241
Demographics	66% Males; 34% Females
Number of smokers	No insureds are smokers
Largest policy as % of total portfolio		1.54	%
Average policy as % of total portfolio		0.41	%
Average Annual Premium as % of face value		3.16	%

*  Averages presented in the table are weighted averages.

Our portfolio of life insurance policies, owned by our subsidiaries as of June 30, 2013, organized by the insured’s current age and the associated policy benefits, is summarized as set forth below:

Distribution of Policy Benefits by Current Age of Insured

Min Age	Max Age	Policy Benefits		Distribution
65	69	$	1,156,000		0.18	%
70	74		50,717,000		7.80	%
75	79		175,961,000		27.04	%
80	84		231,435,000		35.57	%
85	89		183,315,000		28.17	%
90	95		8,071,000		1.24	%
Total		$	650,655,000		100.00	%

Our portfolio of life insurance policies, owned by our subsidiaries as of June 30, 2013, organized by the insured’s current age and number of policies owned, is summarized as set forth below:

Distribution of Policies by Current Age of Insured

Min Age	Max Age	Policies		Distribution
65	69		3		1.24	%
70	74		18		7.47	%
75	79		60		24.90	%
80	84		90		37.35	%
85	89		65		26.97	%
90	95		5		2.07	%
Total			241		100.00	%

Page 41

Our portfolio of life insurance policies, owned by our subsidiaries as of June 30, 2013, organized by the insured’s estimated life expectancy and associated policy benefits, is summarized as set forth below:

Distribution of Policy Benefits by Current Life Expectancies of Insured

Min LE (Months)	Max LE (Months)	Policy Benefits		Distribution
144	177	$	26,450,000		4.07	%
120	143		62,296,000		9.57	%
96	119		194,159,000		29.84	%
72	95		180,952,000		27.81	%
48	71		156,084,000		23.99	%
24	47		30,714,000		4.72	%
Total		$	650,655,000		100.00	%

We track concentrations of pre-existing medical conditions among insured individuals within our portfolio based on information contained in life expectancy reports. We track these medical conditions with ten primary disease categories: (1) cardiovascular, (2) cerebrovascular, (3) dementia, (4) cancer, (5) diabetes, (6) respiratory disease, (7) neurological disorders, (8) other, no disease, or multiple. Our primary disease categories are summary generalizations based on the ICD-9 codes we track on each insured individuals within our portfolio.  ICD-9 codes, published by the World Health Organization, are used worldwide for medical diagnoses and treatment systems, as well as morbidity and mortality statistics. Currently, cardiovascular is the only primary disease category within our portfolio that represents a concentration over 10%.

Our portfolio of life insurance policies, owned by our subsidiaries as of June 30, 2013, organized by the primary disease categories of the insured and associated policy benefits, is summarized as set forth below:

Distribution of Policy Benefits by Primary Disease Category

Primary Disease Category	Policy Benefits		Distribution
Cancer	$	40,400,000		6.21	%
Cardiovascular		135,338,000		20.80	%
Cerebrovascular		37,485,000		5.76	%
Dementia		26,885,000		4.13	%
Diabetes		35,967,000		5.53	%
Multiple		155,510,000		23.90	%
Neurological Disorders		13,000,000		2.00	%
No Disease		69,986,000		10.76	%
Other		90,384,000		13.89	%
Respiratory Diseases		45,700,000		7.02	%
Total Policy Benefits	$	650,655,000		100.00	%

The primary disease category represents a general category of impairment. Within the primary disease category, there are a multitude of sub-categorizations defined more specifically by ICD-9 codes. For example, a primary disease category of cardiovascular includes subcategorizations such as atrial fibrillation, heart valve replacement, coronary atherosclerosis, etc. In addition, individuals may have more than one ICD-9 code describing multiple medical conditions within one or more primary disease categories. Where an individual’s ICD-9 codes indicate medical conditions in more than one primary disease categories, we categorize the individual as having multiple primary disease categories. We expect to continue to develop and refine our identification and tracking on the insured individuals medical conditions as we manage our portfolio of life insurance policies.

The possible insolvency or loss by a life insurance company is a significant risk to our business. To manage this risk, we seek to purchase policies that are issued by insurance companies with investment-grade ratings from either A.M. Best, Moody’s or Standard & Poor’s. To further mitigate risk, we seek to limit the face value of policy benefits issued by any one life insurance company within the total portfolio to 20%. State guaranty funds generally guaranty policy benefits up to $200,000. In addition, to assure diversity and stability in our portfolio, we regularly review the various metrics of our portfolio relating to credit risk. We track industry rating agency reports and industry journals and articles in order to gain insight into possible financial problems of life insurance companies. Recently, some of the credit ratings on insurance companies were downgraded and we will no longer consider purchasing policies issued by these insurance companies. Finally, we will only purchase those life insurance policies that meet the underwriting standards established in the indenture.

Page 42

As of June 30, 2013,  99.59% of insurance companies in our portfolio hold an investment-grade rating by Standard & Poor’s (BBB- or better), and the face value of policy benefits issued by one life insurance company with in the portfolio was 15.18%.  Of the forty insurance companies that insure the policies we own, ten companies insure approximately 75.52% of total face value of insurance benefits and the remaining thirty insurance companies insure the remaining approximately 24.48% of total face value of insurance benefits. The concentration risk of our ten largest insurance company holdings as of June 30, 2013 is set forth in the table below.

Rank	Policy Benefits		Percentage of Policy Benefit Amt.		Insurance Company	Ins. Co. S&P Rating
1	$	98,780,000		15.18%	AXA Equitable Life Insurance Company	A+
2	$	78,995,000		12.14%	John Hancock Life Insurance Company (U.S.A)	AA-
3	$	67,193,000		10.33%	Transamerica Life Insurance Company	AA-
4	$	55,769,000		8.57%	Jefferson-Pilot Life Insurance Company	AA-
5	$	51,715,000		7.95%	ING Life Insurance and Annuity Company	A-
6	$	39,250,000		6.03%	American General Life Insurance Company	A+
7	$	32,735,000		5.03%	Massachusetts Mutual Life Insurance Company	AA+
8	$	25,450,000		3.91%	West Coast Life Insurance Company	AA-
9	$	22,333,000		3.43%	Metropolitan Life Insurance Company	AA-
10	$	19,200,000		2.95%	Lincoln Benefit Life Company	A+

Life Insurance Portfolio Detail

(as of June 30, 2013)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	1,100,000		M		92		38.7	ING Life Insurance and Annuity Company	A-
$	1,770,726		F		92		47.7	Aviva Life Insurance Company	A-
$	3,200,000		M		92		75.9	West Coast Life Insurance Company	AA-
$	1,000,000		F		91		48.7	Transamerica Life Insurance Company	AA-
$	1,000,000		F		90		25.1	American General Life Insurance Company	A+
$	2,500,000		M		89		52.0	Columbus Life Insurance Company	AA+
$	5,000,000		F		89		74.4	American General Life Insurance Company	A+
$	2,000,000		F		89		36.6	Pruco Life Insurance Company	AA-
$	5,000,000		F		89		41.0	John Hancock Life Insurance Company (U.S.A)	AA-
$	1,000,000		F		89		29.6	Protective Life Insurance Company	AA-
$	5,000,000		M		88		49.5	John Hancock Life Insurance Company (U.S.A)	AA-
$	1,500,000		F		88		69.6	Jefferson-Pilot Life Insurance Company	AA-
$	3,000,000		F		88		52.1	Jefferson-Pilot Life Insurance Company	AA-
$	600,000		F		88		70.1	Columbus Life Insurance Company	AA+

Page 43

Life Insurance Portfolio Detail

(as of June 30, 2013)
(continued)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	1,000,000		F		87		70.1	United of Omaha Life Insurance Company	A+
$	3,500,000		F		87		67.4	John Hancock Life Insurance Company (U.S.A)	AA-
$	2,500,000		F		87		72.3	AXA Equitable Life Insurance Company	A+
$	2,500,000		F		87		72.3	AXA Equitable Life Insurance Company	A+
$	5,000,000		F		87		71.3	ING Life Insurance and Annuity Company	A-
$	5,000,000		F		87		43.6	Lincoln National Life Insurance Company	AA-
$	715,000		F		87		80.8	Jefferson-Pilot Life Insurance Company	AA-
$	1,203,520		M		87		56.8	Columbus Life Insurance Company	AA+
$	1,350,000		F		87		74.6	Jefferson-Pilot Life Insurance Company	AA-
$	2,000,000		F		87		40.7	American General Life Insurance Company	A+
$	3,500,000		F		87		68.9	Lincoln National Life Insurance Company	AA-
$	5,000,000		F		86		53.5	Massachusetts Mutual Life Insurance Company	AA+
$	2,500,000		F		86		66.9	American General Life Insurance Company	A+
$	2,500,000		M		86		53.0	Pacific Life Insurance Company	A+
$	4,000,000		F		86		88.5	Transamerica Life Insurance Company	AA-
$	5,000,000		M		86		83.1	AXA Equitable Life Insurance Company	A+
$	1,500,000		M		86		55.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	1,500,000		M		86		55.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	1,000,000		M		86		75.7	AXA Equitable Life Insurance Company	A+
$	500,000		M		86		70.2	Lincoln National Life Insurance Company	AA-
$	4,785,380		F		86		56.7	John Hancock Life Insurance Company (U.S.A)	AA-
$	8,985,000		M		86		45.6	Massachusetts Mutual Life Insurance Company	AA+
$	1,803,455		F		86		67.8	Metropolitan Life Insurance Company	AA-
$	1,529,270		F		86		67.8	Metropolitan Life Insurance Company	AA-
$	5,000,000		M		86		58.9	John Hancock Life Insurance Company (U.S.A)	AA-
$	2,225,000		F		86		90.4	Transamerica Life Insurance Company	AA-
$	3,000,000		F		86		94.3	Massachusetts Mutual Life Insurance Company	AA+
$	1,500,000		M		86		50.8	Union Central Life Insurance Company	A+
$	100,000		M		86		39.1	Protective Life Insurance Company	AA-
$	100,000		M		86		39.1	Protective Life Insurance Company	AA-
$	100,000		M		86		39.1	Protective Life Insurance Company	AA-
$	2,000,000		M		86		57.0	John Hancock Life Insurance Company (U.S.A)	AA-

$	3,000,000	M	86	54.9	American General Life Insurance Company	A+
$	1,682,773	M	85	84.1	Hartford Life and Annuity Insurance Company	BBB+
$	500,000	F	85	60.0	Sun Life Assurance Company of Canada (U.S.)	BBB
$	5,000,000	F	85	71.9	Transamerica Life Insurance Company	AA-
$	3,000,000	M	85	59.4	Transamerica Life Insurance Company	AA-
$	1,200,000	M	85	79.2	Transamerica Life Insurance Company	AA-
$	250,000	M	85	79.4	Metropolitan Life Insurance Company	AA-
$	3,000,000	M	85	103.1	AXA Equitable Life Insurance Company	A+
$	5,570,000	F	85	65.3	ING Life Insurance and Annuity Company	A-

Page 44

Life Insurance Portfolio Detail

(as of June 30, 2013)
(continued)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	5,570,000		F		85		65.3	ING Life Insurance and Annuity Company	A-
$	1,000,000		F		85		73.9	New York Life Insurance Company	AA+
$	5,000,000		F		85		50.1	Penn Mutual Life Insurance Company	AA-
$	10,000,000		F		85		117.5	West Coast Life Insurance Company	AA-
$	2,500,000		M		85		68.1	Transamerica Life Insurance Company	AA-
$	1,000,000		F		85		57.9	West Coast Life Insurance Company	AA-
$	2,000,000		F		85		57.9	West Coast Life Insurance Company	AA-
$	800,000		M		85		71.0	National Western Life Insurance Company	A
$	200,000		M		85		61.1	Lincoln Benefit Life Company	A+
$	4,445,467		M		85		68.5	Penn Mutual Life Insurance Company	AA-
$	7,500,000		M		85		50.8	Jefferson-Pilot Life Insurance Company	AA-
$	3,600,000		F		85		90.9	AXA Equitable Life Insurance Company	A+
$	1,000,000		M		85		54.1	American General Life Insurance Company	A+
$	5,000,000		M		85		80.8	Lincoln National Life Insurance Company	AA-
$	2,000,000		F		85		98.6	U.S. Financial Life Insurance Company	A+
$	1,000,000		M		84		71.6	John Hancock Life Insurance Company (U.S.A)	AA-
$	2,000,000		M		84		71.6	John Hancock Life Insurance Company (U.S.A)	AA-
$	5,000,000		M		84		67.5	Jefferson-Pilot Life Insurance Company	AA-
$	1,365,000		F		84		116.6	Transamerica Life Insurance Company	AA-
$	1,000,000		F		84		105.0	ING Life Insurance and Annuity Company	A-
$	2,000,000		M		84		102.6	Transamerica Life Insurance Company	AA-
$	8,500,000		M		84		82.8	Massachusetts Mutual Life Insurance Company	AA+
$	500,000		M		84		102.2	Metropolitan Life Insurance Company	AA-
$	2,000,000		M		84		52.4	Jefferson-Pilot Life Insurance Company	AA-
$	1,800,000		M		84		56.2	John Hancock Variable Life Insurance Company	AA-
$	2,000,000		M		84		115.4	ING Life Insurance and Annuity Company	A-
$	2,000,000		M		84		115.4	ING Life Insurance and Annuity Company	A-

$	2,000,000	M	84	115.4	ING Life Insurance and Annuity Company	A-
$	1,500,000	M	83	67.5	Transamerica Life Insurance Company	AA-
$	3,750,000	M	83	94.5	AXA Equitable Life Insurance Company	A+
$	1,000,000	M	83	87.7	John Hancock Life Insurance Company (U.S.A)	AA-
$	2,000,000	F	83	105.0	AXA Equitable Life Insurance Company	A+
$	3,000,000	F	83	95.6	Sun Life Assurance Company of Canada (U.S.)	BBB

$	829,022	F	83	34.5	Hartford Life and Annuity Insurance Company	BBB+
$	1,500,000	M	83	74.1	AXA Equitable Life Insurance Company	A+
$	5,000,000	M	83	90.0	ING Life Insurance and Annuity Company	A-
$	1,500,000	M	83	70.1	ING Life Insurance and Annuity Company	A-
$	1,500,000	M	83	70.1	ING Life Insurance and Annuity Company	A-
$	3,000,000	F	83	114.0	Transamerica Life Insurance Company	AA-
$	750,000	M	83	35.6	ING Life Insurance and Annuity Company	A-
$	750,000	M	83	35.6	ING Life Insurance and Annuity Company	A-

Page 45

Life Insurance Portfolio Detail

(as of June 30, 2013)
(continued)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	1,000,000		M		83		48.2	John Hancock Life Insurance Company (U.S.A)	AA-
$	4,000,000		F		83		61.4	ING Life Insurance and Annuity Company	A-
$	5,000,000		F		83		126.5	American General Life Insurance Company	A+
$	2,000,000		M		83		79.4	AXA Equitable Life Insurance Company	A+
$	1,750,000		M		83		79.4	AXA Equitable Life Insurance Company	A+
$	2,000,000		M		83		46.0	Transamerica Life Insurance Company	AA-
$	5,000,000		F		82		117.6	AXA Equitable Life Insurance Company	A+
$	1,000,000		F		82		97.7	John Hancock Life Insurance Company (U.S.A)	AA-
$	6,000,000		F		82		133.1	American General Life Insurance Company	A+
$	1,500,000		F		82		116.0	Lincoln Benefit Life Company	A+
$	500,000		F		82		116.8	AXA Equitable Life Insurance Company	A+
$	750,000		M		82		112.6	West Coast Life Insurance Company	AA-
$	4,000,000		M		82		54.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	1,000,000		M		82		100.2	John Hancock Life Insurance Company (U.S.A)	AA-
$	2,000,000		F		82		130.7	Lincoln Benefit Life Company	A+
$	1,000,000		M		82		86.2	ING Life Insurance and Annuity Company	A-
$	5,000,000		M		82		73.0	Jefferson-Pilot Life Insurance Company	AA-
$	2,700,000		M		82		69.2	John Hancock Life Insurance Company (U.S.A)	AA-
$	7,600,000		F		82		116.6	Transamerica Life Insurance Company	AA-
$	2,500,000		F		82		80.8	American General Life Insurance Company	A+
$	500,000		M		82		58.4	Genworth Life Insurance Company	A-
$	3,000,000		F		82		59.1	AXA Equitable Life Insurance Company	A+
$	1,703,959		M		82		79.0	Jefferson-Pilot Life Insurance Company	AA-
$	1,000,000		M		82		71.8	Hartford Life and Annuity Insurance Company	BBB+
$	3,500,000		F		82		114.1	Lincoln Benefit Life Company	A+

$	10,000,000	F	82	74.2	American National Insurance Company	A
$	500,000	M	82	58.5	West Coast Life Insurance Company	AA-
$	5,000,000	M	81	75.3	AXA Equitable Life Insurance Company	A+
$	500,000	M	81	119.0	Metropolitan Life Insurance Company	AA-
$	2,000,000	M	81	56.4	National Life Insurance Company	A
$	3,000,000	M	81	71.9	U.S. Financial Life Insurance Company	A+
$	4,200,000	F	81	147.7	Transamerica Life Insurance Company	AA-

$	1,900,000	M	81	85.2	American National Insurance Company	A
$	500,000	M	81	63.3	New York Life Insurance Company	AA+
$	500,000	M	81	63.3	New York Life Insurance Company	AA+
$	5,000,000	M	81	100.3	AXA Equitable Life Insurance Company	A+
$	250,000	M	81	49.0	Jackson National Life Insurance Company	AA
$	1,500,000	M	81	123.5	Jefferson-Pilot Life Insurance Company	AA-
$	3,500,000	F	81	95.8	AXA Equitable Life Insurance Company	AA+
$	750,000	M	81	69.4	John Hancock Life Insurance Company (U.S.A)	AA-
$	4,500,000	M	81	77.2	AXA Equitable Life Insurance Company	AA+
$	2,275,000	M	81	110.4	ING Life Insurance and Annuity Company	A-
$	2,000,000	M	81	83.8	Pacific Life Insurance Company	A+

Page 46

Life Insurance Portfolio Detail

(as of June 30, 2013)
(continued)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	3,500,000		M		81		88.6	AXA Equitable Life Insurance Company	A+
$	6,217,200		F		81		112.5	Phoenix Life Insurance Company	BB-
$	3,000,000		M		81		117.5	Metropolitan Life Insurance Company	AA-
$	2,000,000		F		81		107.4	Jefferson-Pilot Life Insurance Company	AA-
$	3,000,000		M		80		86.2	Protective Life Insurance Company	AA-
$	1,500,000		M		80		86.2	American General Life Insurance Company	A+
$	2,000,000		F		80		123.7	Transamerica Life Insurance Company	AA-
$	3,500,000		F		80		110.8	Jefferson-Pilot Life Insurance Company	AA-
$	1,000,000		M		80		85.7	Lincoln National Life Insurance Company	AA-
$	1,500,000		M		80		72.7	Pacific Life Insurance Company	A+
$	5,000,000		M		80		127.8	American General Life Insurance Company	A+
$	5,000,000		F		80		92.2	Sun Life Assurance Company of Canada (U.S.)	BBB
$	1,995,000		F		80		90.4	Transamerica Life Insurance Company	AA-
$	4,000,000		M		80		90.6	Jefferson-Pilot Life Insurance Company	AA-
$	1,250,000		F		80		93.9	Columbus Life Insurance Company	AA+
$	2,500,000		F		80		92.8	ING Life Insurance and Annuity Company	A-
$	5,000,000		M		80		81.4	Transamerica Life Insurance Company	AA-
$	2,000,000		M		80		96.6	Ohio National Life Assurance Corporation	AA
$	1,000,000		M		80		96.6	Ohio National Life Assurance Corporation	AA
$	350,000		M		80		72.4	Reassure America Life Insurance Company	AA

$	5,000,000	M	80	95.7	Jefferson-Pilot Life Insurance Company	AA-
$	5,000,000	M	79	121.7	AXA Equitable Life Insurance Company	A+
$	8,000,000	M	79	102.9	AXA Equitable Life Insurance Company	A+
$	550,000	M	79	124.0	Genworth Life Insurance Company	A-
$	1,680,000	F	79	89.3	AXA Equitable Life Insurance Company	A+
$	1,000,000	F	79	117.2	Jefferson-Pilot Life Insurance Company	AA-
$	1,250,000	M	79	144.5	Metropolitan Life Insurance Company	AA-
$	1,000,000	M	79	116.0	AXA Equitable Life Insurance Company	A+

$	1,250,000	F	79	94.0	Principal Life Insurance Company	A+
$	1,000,000	M	79	61.0	AXA Equitable Life Insurance Company	A+
$	3,000,000	M	79	112.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	2,000,000	M	79	96.7	Jefferson-Pilot Life Insurance Company	AA-
$	1,750,000	M	79	105.3	AXA Equitable Life Insurance Company	A+
$	5,000,000	M	79	61.7	AXA Equitable Life Insurance Company	A+
$	250,000	M	79	83.3	American General Life Insurance Company	A+
$	10,000,000	M	79	112.6	John Hancock Life Insurance Company (U.S.A)	AA-
$	3,000,000	F	79	116.1	West Coast Life Insurance Company	AA-
$	7,000,000	M	79	111.2	Genworth Life Insurance Company	A-
$	2,000,000	M	78	60.2	Metropolitan Life Insurance Company	AA-
$	130,000	M	78	68.3	Genworth Life Insurance Company	A-
$	1,000,000	M	78	143.0	Empire General Life Assurance Corporation	AA-
$	2,000,000	F	78	108.5	Pacific Life Insurance Company	A+

Page 47

Life Insurance Portfolio Detail

(as of June 30, 2013)
(continued)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	2,000,000		F		78		130.7	Transamerica Life Insurance Company	AA-
$	3,000,000		M		78		132.9	Principal Life Insurance Company	A+
$	5,000,000		M		78		96.0	AXA Equitable Life Insurance Company	A+
$	5,000,000		M		78		96.0	AXA Equitable Life Insurance Company	A+
$	500,000		M		78		89.9	Transamerica Life Insurance Company	AA-
$	3,000,000		M		77		65.7	Pacific Life Insurance Company	A+
$	3,000,000		M		77		65.7	Minnesota Life Insurance Company	A+
$	3,000,000		M		77		65.7	Prudential Life Insurance Company	AA-
$	3,000,000		M		77		115.9	ING Life Insurance and Annuity Company	A-
$	4,000,000		M		77		108.0	Jefferson-Pilot Life Insurance Company	AA-
$	3,601,500		M		77		96.5	Transamerica Life Insurance Company	AA-
$	1,000,000		M		77		114.7	Sun Life Assurance Company of Canada (U.S.)	BBB
$	5,000,000		M		77		138.1	Principal Life Insurance Company	A+
$	5,000,000		M		77		94.2	John Hancock Life Insurance Company (U.S.A)	AA-
$	7,000,000		M		77		105.6	Lincoln Benefit Life Company	A+
$	2,250,000		M		77		80.4	Massachusetts Mutual Life Insurance Company	AA+
$	4,300,000		F		77		126.0	American National Insurance Company	A
$	5,000,000		F		77		150.0	ING Life Insurance and Annuity Company	A-
$	750,000		M		77		83.9	Lincoln National Life Insurance Company	AA-
$	3,000,000		M		77		114.3	Principal Life Insurance Company	A+
$	5,000,000		M		76		108.6	Jefferson-Pilot Life Insurance Company	AA-
$	5,000,000		M		76		96.2	John Hancock Life Insurance Company (U.S.A)	AA-

$	500,000	M	76	78.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	5,000,000	M	76	113.9	John Hancock Life Insurance Company (U.S.A)	AA-
$	1,009,467	M	76	69.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	4,000,000	M	76	91.7	MetLife Investors USA Insurance Company	AA-
$	2,500,000	M	76	107.2	Massachusetts Mutual Life Insurance Company	AA+
$	2,500,000	M	76	107.2	Massachusetts Mutual Life Insurance Company	AA+
$	5,000,000	M	76	83.8	John Hancock Life Insurance Company (U.S.A)	AA-
$	500,000	F	76	115.1	Columbus Life Insurance Company	AA+
$	3,750,000	M	76	81.4	AXA Equitable Life Insurance Company	A+
$	1,000,000	M	76	109.8	Metropolitan Life Insurance Company	AA-
$	2,000,000	F	76	61.6	Transamerica Life Insurance Company	AA-
$	1,000,000	M	75	131.1	Metropolitan Life Insurance Company	AA-
$	2,840,000	M	75	123.4	Transamerica Life Insurance Company	AA-
$	750,000	M	75	135.8	U.S. Financial Life Insurance Company	A+
$	1,750,000	M	75	83.3	John Hancock Life Insurance Company (U.S.A)	AA-
$	5,000,000	M	75	117.2	Transamerica Life Insurance Company	AA-
$	600,000	M	75	106.7	Protective Life Insurance Company	AA-
$	2,000,000	F	74	162.3	Aviva Life Insurance Company	A-
$	7,000,000	F	74	161.7	Pacific Life Insurance Company	A
$	1,000,000	M	74	116.4	Pacific Life Insurance Company	A
$	5,000,000	M	74	93.5	West Coast Life Insurance Company	AA-
$	5,000,000	M	73	176.0	Prudential Life Insurance Company	AA-
$	200,000	M	73	123.8	ING Life Insurance and Annuity Company	A-
$	8,000,000	M	73	126.5	Metropolitan Life Insurance Company	AA-
$	5,000,000	M	73	57.7	Lincoln Benefit Life Company	A+
$	850,000	M	73	89.0	New York Life Insurance Company	AA+

Page 48

Life Insurance Portfolio Detail

(as of June 30, 2013)
(continued)

Face Amount		Sex		Age (1)		LE (2)		Carrier	S&P Rating
$	2,000,000		M		73		115.8	U.S. Financial Life Insurance Company	A+
$	2,000,000		M		72		146.1	American General Life Insurance Company	A+
$	3,000,000		F		72		135.7	General American Life Insurance Company	AA-
$	500,000		M		71		83.2	Midland National Life Insurance Company	A+
$	3,000,000		M		71		116.3	AXA Equitable Life Insurance Company	A+
$	1,000,000		M		71		113.7	United of Omaha Life Insurance Company	A+

$	2,500,000	M	70	130.0	American General Life Insurance Company	A+
$	1,167,000	M	70	49.8	Transamerica Life Insurance Company	AA-
$	1,500,000	M	70	119.5	Metropolitan Life Insurance Company	AA-
$	500,000	M	68	113.0	Transamerica Life Insurance Company	AA-
$	500,000	M	68	113.0	North American Company for Life And Health Insurance	A+
$	156,538	F	65	136.1	New York Life Insurance Company	AA+
$	650,655,277

(1) The insured’s age is current as of the measurement date.

(2) The insured’s life expectancy estimate, other than for a small face value insurance policy benefit, is the average of two life expectancy estimates provided by independent third-party medical actuarial underwriting firms at the time of purchase, actuarially adjusted through the measurement date. This listing includes an adjusting increase of an average of 8.67% to life expectancies provided by 21st Services. Numbers in this column represent months. For more information, please refer to our Annual Report on Form 10-K for the year ended December 31, 2012.

ITEM 4.   CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in our reports filed pursuant to the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance the objectives of the control system are met.

As of June 30, 2013, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of our disclosure controls and procedures as such term is defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures are effective as of June 30, 2013.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Page 49

PART II.  OTHER INFORMATION

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Use of Proceeds

Our Form S-1 registration statement relating to our offer and sale of “Renewable Secured Debentures” (File Nos. 333-174887 and 333-174887-01) was declared effective by the SEC on January 31, 2012, and our offering of debentures commenced on such date. On June 4, 2013, our post-effective amendment to our registration statement was declared effective by the SEC. The debentures are secured in part by a guarantee from our subsidiary GWG Life and an associated grant of a security interest in substantially all of the assets of GWG Life, which guarantee was also registered as a security under the referenced registration statement. Arque Capital Ltd. serves as our managing broker-dealer and underwriter for the offering.

The registration statement covers up to $250 million in principal amount of debentures. From January 31, 2012 through June 30, 2013, we sold a total of $99,053,000 in principal amount of debentures, and incurred, along with other expenses, associated underwriting commissions, and expenses paid or payable to underwriters in the amount of $5,242,000 of which $1,129,000 was amortized. We have an un-papered receipt of $1,940,000 resulting in net proceeds of $94,932,000. None of the payments for offering expenses were directly or indirectly made to directors or officers (or their associates) of the Company, affiliates of the Company, or to persons owning 10% or more of any class of equity securities of the Company. No net proceeds were used for direct or indirect payments to directors or officers (or their associates) of the Company, affiliates of the Company, or to persons owning 10% or more of any class of equity securities of the Company.

Net offering proceeds not immediately applied to the uses summarized above will be invested short-term investments such as money market funds, commercial paper, U.S. Treasury Bills and similar securities investments pending their use.

Our use of proceeds from the sale of Renewable Secured Debentures from January 31, 2012 to June 30, 2013 is as follows:

Gross Offering Proceeds	$	100,956,000
Net Offering Proceeds		94,932,000
Held in Short-Term Investments		35,930,000
Net Offering Proceeds Used	$	59,002,000	100	%
Purchase Policies		32,886,000	56	%
Payment of Premiums		7,972,000	13	%
Payment of Principal and Interest		12,308,000	21	%
Other Expenditures		5,836,000	10	%

Page 50

ITEM 6.   EXHIBITS

Exhibit
10.1	Purchase and Sale Agreement among GWG Holdings, Inc., Athena Securities Group Limited and GWG Securities International Public Limited Company, dated June 28, 2013 (incorporated by reference to Exhibit 10.1 to the registrant's Current Report on Form 8-K filed on July 8, 2013).
31.1	Section 302 Certification of the Chief Executive Officer (filed herewith).
31.2	Section 302 Certification of the Chief Financial Officer (filed herewith).
32.1	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
99.1	Letter from Model Actuarial Pricing Systems, dated April 18, 2013 (filed herewith).

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy ExtensionDefinition Linkbase Document

Page 51

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GWG HOLDINGS, INC.
Date:  August 14, 2013	By:	/s/ Jon R. Sabes
		Chief Executive Officer
Date:  August 14, 2013	By:	/s/ Jon Gangelhoff
		Chief Financial Officer

Page 52

EX-31.1

Exhibit 31.1

SECTION 302 CERTIFICATION

I, Jon R. Sabes, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GWG Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  August 14, 2013                                                                                     /s/  Jon R. Sabes

            Chief Executive Officer

EX-31.2

Exhibit 31.2

SECTION 302 CERTIFICATION

I, Jon Gangelhoff, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GWG Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  August 14, 2013                                                                        /s/ Jon Gangelhoff

Chief Financial Officer

EX-32

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of GWG Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jon R. Sabes, Chief Executive Officer of the Company, and I, Jon Gangelhoff, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/  Jon R. Sabes

Jon R. Sabes

Chief Executive Officer

August 14, 2013

/s/  Jon Gangelhoff

Jon Gangelhoff

Chief Financial Officer

August 14, 2013

EX-99.1

Exhibit 99.1

	1156 West Shure Dr., Suite 130 Arlington Heights, IL 60004 +1 (847) 483-9401
July 25, 2013

Steven Sabes

Chief Operating Officer

GWG Life

220 South Sixth Street, Suite 1200 Minneapolis, MN 55402

Steven:

You have asked that we prepare a quarterly valuation of a GWG portfolio of life insurance settlements. The valuations were prepared under the assumptions described below, which you provided in phone conversations and e-mails. We utilized the revised policy portfolio data you provided on 7/24/2013 to project potential cash flows monthly following the 6/30/2013 valuation date, based on the premiums and other values in the policy records provided.

Data Reliance

In preparing these valuations, we relied upon:

● Policy Data – We have relied on the portfolio data file as provided to us by GWG Life. This file and the policy data contained in it are assumed to have been prepared accurately and reflect current company supported product performance. The 6/30/2013 file had 241 policies with total face amounts of $650,655,277, a net increase of 6 policies and $10,900,000 in face amount over the prior quarter. The 3/31/2013 file had 235 policies with total face amounts of $639,755,277.

● Future Premiums Data – We have relied on GWG Life’s data regarding the future premiums to be paid on each policy. It is our understanding that GWG Life uses the MAPS software package along with data gathered from the actual premium payments to the life insurance carriers for each policy for projecting future minimum premium streams.

● Life Expectancy, Values, plus any adjustments – We have relied on the life expectancy values provided by GWG Life. It is our understanding that GWG Life obtained these LE values using the following industry experts: 21st Services, AVS Underwriting, EMSI, Fasano Associates, and/or ISC Services.

Results

Using the assumptions stated below, we calculated the net present values as of the valuation dates using the specified discount rates of 11.84% and 7.20%. These results will be e-mailed to you in the Excel reports generated, including a Portfolio Summary and List of Policies, from the MAPS Portfolio valuation model.

	GWG Portfolio as of 6/30/2013
Number of Policies		241
Total Net Death Benefit ($)		650,655,277
Discount Rate		11.84	%	7.20	%	12.00	%	15.00	%
Expected Net Present Value ($)		193,891,894		254,393,846		192,218,326		164,625,845
Stochastic Analysis – 10,000 Scenarios
95th Percentile Net Present Value ($)		167,014,585		226,628,953		165,383,503		138,581,985
95% CTE Net Present Value ($)		159,987,471		218,901,684		158,371,458		131,873,313

The Expected Net Present Value is the probabilistic average value of the portfolio. These values are calculated actuarially; assuming that the amount of premiums paid and death benefits received are proportional to the probabilities of survival. Since death will occur at an unknown discrete point in time, the actual return for a policy, and a portfolio of policies, may vary significantly from the Expected Value.

Model Actuarial Pricing Systems, LP

1156 West Shure Dr., Suite 130 Arlington Heights, IL 60004 +1 (847) 483-9401

The Stochastic analysis can return information about the range of values that might be achieved along with probabilities that the results might be better or worse than the Expected or a specified level. The Stochastic analysis creates random scenarios where a discrete date of death is independently projected for each life based on its mortality curve. The net present value of the portfolio for each scenario is calculated as the present value of projected death benefits minus the present value of projected premiums. The scenarios are ranked by value. The 95th Percentile Net Present Value is the portfolio value exceeded by 95% of the stochastic scenarios. The 95% CTE is the Contingent Tail Expectation for the 95th percentile, and is the average of the 5% of scenarios with the lowest net present value.

The valuations (1) do not include premiums paid before the valuation date, and (2) assume that the insured remains alive at the valuation date. The valuations also assume that the policy COIs and policy expense charges remain at current levels in the future. If these charges are increased, the projected values would decrease. The above values do not consider any federal income or other taxes.

Summary of MAPS Model Settings and Assumptions

We used the following assumptions as discussed with you:

 ● Insurance Policy Characteristics: Per portfolio data file as provided.

 ● Policy Issue Date: Per portfolio data file as provided.

 ● Insured Date of Birth and Gender: Per portfolio data file as provided.

 ● Extended Death Benefit After Policy Maturity Age: Per portfolio data file as provided.

 ● Optimized Premium Levels and Timing: Monthly premiums unadjusted per the portfolio data file as provided.

 ● Per Policy and Portfolio Administrative Expenses: None, per the portfolio data file as provided.

 ● Collection of Death Benefit Delay: 0 months, with 0.00% statutory interest credited.

 ● Mortality: 2008 VBT Select & Ultimate Primary tables, by Age, Sex, and Tobacco Use.

 ● Age Basis: Age Nearest Birthday.

 ● Mortality Improvement: None.

 ● Life Expectancy: One blended LE and corresponding UW effective date per life in the portfolio data file as provided.

 ● Adjustment Applied to Stated LE: None.

 ● Improvement Used by Underwriters: No.

 ● Valuation Discount Interest Rates: 11.84% and 7.20% as specified, plus 12% and 15%.

 ● Number of Stochastic Scenarios: 10,000.

 ● Stochastic Random Seed input: 1234567

 ● Stochastic Percentile Ranks and Contingent Tail Expectations: 95%, with additional reporting at 75%, 85%, 90%, 97%, and 99%.

Notice on Mortality and Volatility

Parties engaged in life settlements commonly obtain and use "life expectancies" in their considerations. While life expectancies are provided for individuals, they are developed from expected patterns of mortality of large groups of similar individuals. No one knows exactly when any one individual will die, nor is a life expectancy intended to suggest the time until death will be near the life expectancy. Any one individual may live much longer than his or her estimated life expectancy or that projected by applying a mortality rating to any particular mortality table. Even for a large group of lives, the actual mortality for the group may be less than expected for a variety of reasons (such as improvements in medical technology, unanticipated general mortality improvement, or misestimation of the life expectancy). Stochastic simulation and sensitivity testing can help to quantify these risks, but such tests should not be interpreted as a guarantee of any particular financial outcome. Investors will earn less than expected on the policy of any individual who lives longer than his life expectancy.

Model Actuarial Pricing Systems, LP

1156 West Shure Dr., Suite 130 Arlington Heights, IL 60004 +1 (847) 483-9401

Background

Model Actuarial Pricing Systems, LP is a subsidiary of Cantor Fitzgerald (a leading global financial services firm) providing life settlement software and services worldwide to a variety of customers including life settlement brokers, providers, consultants and investors.

Since its inception in late 1990’s, the MAPS Single Policy Valuation Model, developed by Milliman, Inc., has been the industry standard life settlement valuation model for both single life and joint life insurance contracts. Incorporating sophisticated analysis and valuation algorithms, the MAPS Model transformed the life settlements industry by providing actuarially correct valuation of the premium and death benefit cash flows associated with a life settlement transaction.

Very truly yours,

/s/ Winthrop Georg

Winthrop Georg

Model Actuarial Pricing Systems, LP

Model Actuarial Pricing Systems, LP

XML

Earnings Per Share and Proforma Information

6 Months Ended

Jun. 30, 2013

Earnings per share and proforma information [Abstract]

Earnings per share and proforma information

( 11 )     Earnings per share and proforma information

The Company began issuing Series A preferred stock September, 1, 2011, as described in note 9.  The Series A preferred stock is dilutive to the earnings per share calculation at June 30, 2013 and 2012.  The Company has also issued warrants to purchase common stock in conjunction with the sale of convertible preferred stock, as discussed in note 9.  The warrants are anti-dilutive at June 30, 2013 and 2012 and have not been included in the fully diluted earnings per share calculation.

XML

Guarantees of Secured Debentures (Details 1) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
REVENUE
Contract servicing fees
Gain on life settlements, net	7,733,245	4,867,478	16,073,601	5,469,246
Interest and other income	3,274,323	47,563	3,441,994	48,894
TOTAL REVENUE	11,007,568	4,915,041	19,515,595	5,518,140
EXPENSES
Origination and servicing fees
Employee compensation and benefits	1,063,923	583,338	3,001,343	1,117,084
Legal and professional fees	351,910	337,179	789,200	701,403
Interest expense	4,941,942	2,379,578	9,409,157	4,817,991
Other expenses	1,091,132	703,659	2,124,277	1,262,652
TOTAL EXPENSES	7,448,907	4,003,754	15,323,977	7,899,130
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	3,558,661	911,287	4,191,618	(2,380,990)
EQUITY IN INCOME OF SUBSIDIARIES
INCOME BEFORE INCOME TAXES	3,558,661	911,287	4,191,618	(2,380,990)
INCOME TAX EXPENSE (BENEFIT)	1,801,971	609,588	2,367,794	(529,860)
NET INCOME (LOSS)	1,756,690	301,699	1,823,824	(1,851,130)
Parent [Member]
REVENUE
Contract servicing fees
Gain on life settlements, net
Interest and other income	3,259,362	2,745	3,267,454	3,049
TOTAL REVENUE	3,259,362	2,745	3,267,454	3,049
EXPENSES
Origination and servicing fees
Employee compensation and benefits	666,354		2,213,056
Legal and professional fees	272,794	364,698	672,317	655,600
Interest expense	2,655,430	814,038	4,976,599	1,268,211
Other expenses	649,112	387,691	1,283,269	534,100
TOTAL EXPENSES	4,243,690	1,566,427	9,145,241	2,457,911
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	(984,328)	(1,563,682)	(5,877,787)	(2,454,862)
EQUITY IN INCOME OF SUBSIDIARIES	4,543,289	2,474,969	982,826	8,985,743
INCOME BEFORE INCOME TAXES	3,558,961	911,287	4,191,618	(2,380,990)
INCOME TAX EXPENSE (BENEFIT)	1,802,271	609,588	2,367,794	(529,860)
NET INCOME (LOSS)	1,756,690	301,699	1,823,824	(1,851,130)
Guarantor Subsidiary [Member]
REVENUE
Contract servicing fees	536,100	290,050	1,814,202	438,250
Gain on life settlements, net		79,307		229,277
Interest and other income	841,286	2,237	977,855	3,192
TOTAL REVENUE	1,377,386	371,594	2,792,057	670,719
EXPENSES
Origination and servicing fees				(6,500)
Employee compensation and benefits	397,569	583,338	788,287	1,117,084
Legal and professional fees	79,116	(27,519)	116,883	45,803
Interest expense	942,686	1,140,239	1,849,861	2,696,548
Other expenses	429,520	303,468	816,009	703,552
TOTAL EXPENSES	1,848,891	1,999,526	3,571,040	4,556,487
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	(471,505)	(1,627,932)	(778,983)	(3,885,768)
EQUITY IN INCOME OF SUBSIDIARIES	5,014,494	4,132,013	867,920	238,602
INCOME BEFORE INCOME TAXES	4,542,989	2,504,081	10,117,924	132,096
INCOME TAX EXPENSE (BENEFIT)	(300)
NET INCOME (LOSS)	4,543,289	2,504,081	10,117,924	132,096
Non-Guarantor Subsidiaries [Member]
REVENUE
Contract servicing fees
Gain on life settlements, net	7,733,245	4,788,171	16,073,601	5,239,969
Interest and other income	14,610	42,581	37,620	42,653
TOTAL REVENUE	7,747,855	4,830,752	16,111,221	5,282,622
EXPENSES
Origination and servicing fees	536,100	290,050	1,814,202	444,750
Employee compensation and benefits
Legal and professional fees
Interest expense	1,343,826	425,301	2,582,697	853,232
Other expenses	853,435	12,500	865,934	25,000
TOTAL EXPENSES	2,733,361	727,851	5,262,833	1,322,982
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	5,014,494	4,102,901	10,848,388	3,959,640
EQUITY IN INCOME OF SUBSIDIARIES		1,348,301	10,848,388	5,132,609
INCOME BEFORE INCOME TAXES	5,014,494	4,102,901	10,848,388	3,959,640
INCOME TAX EXPENSE (BENEFIT)
NET INCOME (LOSS)	5,014,494	4,102,901	10,848,388	3,959,640
Eliminations [Member]
REVENUE
Contract servicing fees	(536,100)	(290,050)	(1,814,202)	(438,250)
Gain on life settlements, net
Interest and other income	(840,935)		(840,935)
TOTAL REVENUE	(1,377,035)	(290,050)	(2,655,137)	(438,250)
EXPENSES
Origination and servicing fees	(536,100)	(290,050)	(1,814,202)	(438,250)
Employee compensation and benefits
Legal and professional fees
Interest expense
Other expenses	(840,935)		(840,935)
TOTAL EXPENSES	(1,377,035)	(290,050)	(2,655,137)	(438,250)
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES
EQUITY IN INCOME OF SUBSIDIARIES	(9,557,783)	(6,606,982)	(20,966,312)	(4,091,736)
INCOME BEFORE INCOME TAXES	(9,557,783)	(6,606,982)	(20,966,312)	(4,091,736)
INCOME TAX EXPENSE (BENEFIT)
NET INCOME (LOSS)	$ (9,557,783)	$ (6,606,982)	$ (20,966,312)	$ (4,091,736)

XML

Condensed Consolidated Statements of Operations (unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
REVENUE
Gain on life settlements, net	$ 7,733,245	$ 4,867,478	$ 16,073,601	$ 5,469,246
Interest and other income	3,274,323	47,563	3,441,994	48,894
TOTAL REVENUE	11,007,568	4,915,041	19,515,595	5,518,140
EXPENSES
Employee compensation and benefits	1,063,923	583,338	3,001,343	1,117,084
Legal and professional fees	351,910	337,179	789,200	701,403
Interest expense	4,941,942	2,379,578	9,409,157	4,817,991
Other expenses	1,091,132	703,659	2,124,277	1,262,652
TOTAL EXPENSES	7,448,907	4,003,754	15,323,977	7,899,130
INCOME (LOSS) BEFORE INCOME TAXES	3,558,661	911,287	4,191,618	(2,380,990)
INCOME TAX EXPENSE (BENEFIT)	1,801,971	609,588	2,367,794	(529,860)
NET INCOME (LOSS)	$ 1,756,690	$ 301,699	$ 1,823,824	$ (1,851,130)
NET INCOME (LOSS) PER SHARE
Basic	$ 0.18	$ 0.03	$ 0.19	$ (0.19)
Diluted	$ 0.12	$ 0.03	$ 0.13	$ (0.19)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic	9,969,989	9,989,000	9,548,205	9,989,000
Diluted	15,022,198	9,989,000	14,580,506	9,989,000

XML

Fair Value Definition and Hierarchy

6 Months Ended

Jun. 30, 2013

Fair Value Definition and Hierarchy [Abstract]

Fair value definition and hierarchy

( 4 )       Fair value definition and hierarchy

ASC 820 establishes a hierarchical disclosure framework which prioritizes and ranks the level of market price observability used in measuring assets and liabilities at fair value. Market price observability is affected by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace including the existence and transparency of transactions between market participants. Assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices in an orderly market generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. ASC 820 establishes a three-level valuation hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The hierarchy is broken down into three levels based on the observability of inputs as follows:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.  Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

● Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary by types of assets and liabilities and is affected by a wide variety of factors, including, for example, whether an instrument is established in the marketplace, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for assets and liabilities categorized in Level 3.

Level 3 Valuation Process

The estimated fair value of the Company’s life settlements are determined on a quarterly basis by the Company’s portfolio management committee, taking into consideration changes in discount rate assumptions, estimated premium payments and life expectancy assumptions, as well as any changes in economic and other relevant conditions.  These inputs are then used to estimate the discounted cash flows using the MAPS probabilistic portfolio pricing model, which estimates the cash flows using various probabilities and scenarios.  The valuation process includes a review by senior management as of each valuation date.  Management will also engage a third party expert to independently test the accuracy of the valuations using the inputs provided by management.

Life insurance policies represent financial instruments recorded at fair value on a recurring basis. The following table reconciles the beginning and ending fair value of the Company’s Level 3 investments in life insurance policies for the three and six month periods ending June 30, as follows:

	Three month ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Beginning balance	$	185,020,000		$	128,112,000		$	164,317,000		$	122,169,000
Purchases		2,805,000			1,576,000			13,503,000			2,728,000
Maturities (cash in excess of carrying value)		(1,382,000	)		(416,000	)		(2,872,000	)		(416,000	)
Net change in fair value		7,449,000			4,576,000			18,944,000			9,367,000
Ending balance (June 30)	$	193,892,000		$	133,848,000		$	193,892,000		$	133,848,000

The fair value of a portfolio of life insurance policies is based on information available to the Company at the reporting date. Fair value is based upon a discounted cash flow model that incorporates life expectancy assumptions.  Life expectancy reports are obtained from independent and third-party widely accepted life expectancy providers at policy acquisition. The life expectancy values of each policy holder, as determined at policy acquisition, are rolled down monthly for the passage of time by the MAPS actuarial software the Company uses for ongoing valuation of its portfolio of life insurance policies.  The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium an investor in the portfolio of life insurance policies would require.

On January 22, 2013, one of the independent medical actuarial underwriting firms we utilize, 21st Services, announced advancements in its underwriting methodology, resulting in revised estimated life expectancy mortality tables for life settlement transactions.  We have been advised by 21st Services that the changes are very granular and relate to both specific medical conditions and lifestyles of insureds.  These changes are the result of the application of additional medical information that has been gathered by 21st Services over a period of time, and which has now been applied to the inputs and methodologies used to develop the actuarial life expectancies.   While we do not believe these revised methodologies indicate the previous estimated life expectancies were inaccurate, we believe the revised methodologies provide additional information that should be considered in updating our estimate of the life expectancies of the insureds within our portfolio of life settlement contracts as of June 30, 2013 and December 31, 2012.  Based upon our evaluation and analysis of data made available by 21st Services, as well as information regarding the insureds within our portfolio, we have estimated the impact of the changes in 21st Services’ methodologies for determining life expectancies on a policy-by-policy basis within our portfolio and applied such changes to the life expectancy inputs used to estimate fair value.  We have adjusted the original life expectancies provided by 21st Services based on four factors, the impact of each analyzed individually for each insured in the GWG portfolio.  The four factors are gender, anti-selection, age, and primary impairment.  While the analysis and adjustments were applied on an individual policy basis, the result was an average overall increase in the original life expectancy estimates of 8.67%.  We have a standard practice of obtaining two third-party life expectancy estimates for each policy in our portfolio.  As a result, the effective change in life expectancy on the portfolio was an average of approximately 4.33%, which resulted in an aggregate decrease in the fair value of our life settlements portfolio of $12.4 million as of December 31, 2012.  Life expectancy reports by their very nature are estimates.  Due to the estimating changes made by 21st Services, and because refinement in estimating methods is on-going, we plan to obtain new life expectancy reports for all policies purchased where we used a life expectancy report from 21st Services.  As part of our on-going process to maintain current information regarding the insureds included in our portfolio, we are updating the life expectancy estimates in our portfolio valuation process as new information becomes available.

The fair value of life insurance policies is estimated using present value calculations of estimated cash flows based on the data specific to each individual life insurance policy. Estimated future policy premium payments are calculated based on the terms of the policy and the premium payment history. The following summarizes the unobservable inputs utilized in estimating the fair value of the portfolio of life insurance policies:

	As of  June 30, 2013			As of December 31, 2012
Weighted average age of insured		81.7			81.3
Weighted average life expectancy, months*		90.4			91.6
Average face amount per policy	$	2,699,814		$	2,712,063
Discount rate		11.84	%		12.08	%
* Standard life expectancy as adjusted for insured’s specific circumstances.

These assumptions are, by their nature, inherently uncertain and the effect of changes in estimates may be significant. The techniques used in estimating the present value of estimated cash flows are derived from valuation techniques generally used in the industry that include inputs for the asset that are not based on observable market data. The extent to which the fair value could reasonable vary in the near term has been quantified by evaluating the effect of changes in significant underlying assumptions used to estimate the fair value. If the life expectancies were increased or decreased by 4 and 8 months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables are held constant, the fair value of the investment in life insurance policies would increase or (decrease) by the  amounts summarized below:

	Change in life expectancy
	plus 8 months				minus 8 months			plus 4 months				minus 4 months
June 30, 2013		$	(28,173,000	)		$	29,545,000		$	(14,258,000	)		$	14,601,000
December 31, 2012		$	(24,072,000	)		$	25,268,000		$	(12,185,000	)		$	12,484,000
	Change in discount rate
	plus 2%				minus 2%			plus 1%				minus 1%
June 30, 2013		$	(19,390,000	)		$	23,002,000		$	(10,098,000	)		$	10,998,000
December 31, 2012		$	(16,811,000	)		$	19,978,000		$	(8,759,000	)		$	9,547,000

Carrying value of receivables, prepaid expenses, accounts payable and accrued expenses approximate fair value due to their short-term maturities and low credit risk. The estimated fair value of the Company’s Series I Secured notes payable is approximately $35,703,000 based on a weighted-average market interest rate of 7.45% based on an income approach. The Company began issuing Renewable Secured Debentures in the first quarter of 2012. The current interest rates on the Renewable Secured Debentures approximate market rates. The carrying value of the Renewable Secured Debentures approximates fair value. The carrying value of the revolving credit facility reflects interest charged at the commercial paper rate plus an applicable margin. The margin represents our credit risk, and the strength of the portfolio of life insurance policies collateralizing the debt. The overall rate reflects market, and the carrying value of the revolver approximates fair value. All of the financial instruments are level 3 fair value measurements.

The Company has issued warrants to purchase common stock in connection with the issuance of its convertible, redeemable preferred stock. Warrants were determined by the Company as permanent equity. The fair value measurements associated with the warrants, measured at issuance represent level 3 instruments.

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		137,874	$	0.11		0.42	%		25.25	%	3 years
March 2012		76,260	$	0.26		0.38	%		36.20	%	3 years
June 2012		323,681	$	0.58		0.41	%		47.36	%	3 years
July 2012		289,093	$	0.58		0.41	%		47.36	%	3 years
September 2012		5,000	$	0.36		0.31	%		40.49	%	3 years
		831,908

Volatility is based upon the weekly percentage change in the stock price of selected comparable insurance companies. In June 2012, we evaluated the comparable companies used, and made certain changes to those used.  The percentage change is calculated on the average price of those selected stocks at the weekly close of business for the year preceding the balance sheet date.  We compare annual volatility based on this weekly information. 

XML

Fair Value Definition and Hierarchy (Tables)

6 Months Ended

Jun. 30, 2013

Fair Value Definition and Hierarchy [Abstract]

Reconciliation of investments in life insurance policies

	Three month ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Beginning balance	$	185,020,000		$	128,112,000		$	164,317,000		$	122,169,000
Purchases		2,805,000			1,576,000			13,503,000			2,728,000
Maturities (cash in excess of carrying value)		(1,382,000	)		(416,000	)		(2,872,000	)		(416,000	)
Net change in fair value		7,449,000			4,576,000			18,944,000			9,367,000
Ending balance (June 30)	$	193,892,000		$	133,848,000		$	193,892,000		$	133,848,000

Summary of inputs utilized in estimating the fair value

	As of  June 30, 2013			As of December 31, 2012
Weighted average age of insured		81.7			81.3
Weighted average life expectancy, months*		90.4			91.6
Average face amount per policy	$	2,699,814		$	2,712,063
Discount rate		11.84	%		12.08	%

Fair value sensitivity analysis on the investment in life insurance policies

	Change in life expectancy
	plus 8 months				minus 8 months			plus 4 months				minus 4 months
June 30, 2013		$	(28,173,000	)		$	29,545,000		$	(14,258,000	)		$	14,601,000
December 31, 2012		$	(24,072,000	)		$	25,268,000		$	(12,185,000	)		$	12,484,000
	Change in discount rate
	plus 2%				minus 2%			plus 1%				minus 1%
June 30, 2013		$	(19,390,000	)		$	23,002,000		$	(10,098,000	)		$	10,998,000
December 31, 2012		$	(16,811,000	)		$	19,978,000		$	(8,759,000	)		$	9,547,000

Warrants Level 3 instruments and measured at fair value upon issuance

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		137,874	$	0.11		0.42	%		25.25	%	3 years
March 2012		76,260	$	0.26		0.38	%		36.20	%	3 years
June 2012		323,681	$	0.58		0.41	%		47.36	%	3 years
July 2012		289,093	$	0.58		0.41	%		47.36	%	3 years
September 2012		5,000	$	0.36		0.31	%		40.49	%	3 years
		831,908

XML

Concentrations (Details)	Jun. 30, 2013	Dec. 31, 2012
Company A [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	15.18%	16.96%
Company B [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	12.14%	13.80%
Company C [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	10.33%	11.36%

XML

Commitments

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies [Abstract]

Commitments

( 12 )     Commitments

The Company entered into an office lease with U.S. Bank National Association as the landlord. The lease was effective April 22, 2012 with a term through August 31, 2015. The lease is for 8,881 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Rent expenses under this and previous agreements were $98,000 and $73,000 during the six-month periods ended June 30, 2013 and 2012, respectively.  Rent expenses under this and previous agreements were $50,000 and $36,000 during the three-month periods ended June 30, 2013 and 2012, respectively.  Minimum lease payments under the lease agreement effective April 22, 2012 are as follows:

Six months ending December 31, 2013	$	49,000
2014		104,000
2015		70,000
Total	$	223,000

XML

Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Taxes (Textual)
INCOME TAX EXPENSE (BENEFIT)	$ 1,801,971	$ 609,588	$ 2,367,794	$ (529,860)
Income tax expense benefit as a percentage of income before taxes	50.60%	66.90%	56.50%	22.30%

XML

Concentrations (Details 1)	Jun. 30, 2013	Dec. 31, 2012
California [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	29.88%	28.44%
Florida [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	12.45%	11.85%
New York [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	12.03%	13.27%

XML

Fair Value Definition and Hierarchy (Details 2) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Plus 8 months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	$ (28,173,000)	$ (24,072,000)
Minus 8 months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	29,545,000	25,268,000
Plus 4 Months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(14,258,000)	(12,185,000)
Minus 4 Months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	14,601,000	12,484,000
Plus 2% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(19,390,000)	(16,811,000)
Minus 2% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	23,002,000	19,978,000
Plus 1% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(10,098,000)	(8,759,000)
Minus 1% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	$ 10,998,000	$ 9,547,000

XML

Commitments (Tables)

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies [Abstract]

Summary of minimum lease payments under the lease agreement

Six months ending December 31, 2013	$	49,000
2014		104,000
2015		70,000
Total	$	223,000

XML

Renewable Secured Debentures (Tables)

6 Months Ended

Jun. 30, 2013

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures [Abstract]

Summary of Future maturities of renewable secured debentures

Years Ending December 31,
Six months ending December 31, 2013	$	11,839,000
2014		15,272,000
2015		30,085,000
2016		16,359,000
2017		6,529,000
Thereafter		15,774,000
	$	95,858,000

XML

Renewable Secured Debentures (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Renewable Secured Debentures (Textual)
Weighted average market interest rate of Secured notes payable	7.45%		7.45%
Proceeds from Issuance of Secured Debt	$ 18,588,867	$ 12,695,213	$ 42,439,661	$ 15,757,086
Renewable Secured Debentures [Member]
Renewable Secured Debentures (Textual)
Debentures offer for sale	250,000,000		250,000,000
Maturity period of debentures, Minimum			6 months
Maturity period of debentures, Maximum			7 years
Interest rates, minimum			4.75%
Interest rates, maximum			9.50%
Description of interest payment			Interest is payable monthly, annually or at maturity depending on the terms of the debenture.
Weighted average market interest rate of Secured notes payable	7.58%		7.58%		7.65%
Amount outstanding under Renewable Secured Debentures	95,858,000		95,858,000		57,609,000
Amortization of deferred issuance costs	344,000	44,000	622,000	47,000
Future expected amortization of deferred financing costs			4,114,000
Conditions for proceed from issuance of debenture			(1) payment of commissions on sales of Renewable Secured Debentures, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) Payment of premiums on life insurance policies, (5) payment of principal and interest on Renewable Secured Debentures, (6) payment of portfolio operations expenses, and (7) for general working capital.
Renewable Secured Debentures [Member] | Subsequent events [Member]
Renewable Secured Debentures (Textual)
Proceeds from Issuance of Secured Debt			$ 10,300,000

XML

Investment in Life Insurance Policies (Details 2) (USD $)	Jun. 30, 2013
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Six months ending December 31, 2013	$ 10,272,000
2014	21,206,000
2015	22,986,000
2016	25,222,000
2017	27,757,000
Estimated expected premium payments	$ 107,443,000

XML

Fair Value Definition and Hierarchy (Details Textual) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
Fair Value Definition and Hierarchy (Textual)
Percentage increase in life expectancy	8.67%
Percentage of effective change in life expectancy	4.33%
Decrease in fair value of portfolio of life settlements portfolio		$ 12,400,000
Description for change in discount factor	If the life expectancies were increased or decreased by 4 and 8 months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables are held constant.
Increase decrease in life expectancy	4 and 8 months
Increase decrease in discount rate	1% and 2
Estimated fair value of Series I Secured notes payable	$ 35,703,000
Weighted average market interest rate of Secured notes payable	7.45%

XML

Commitments (Details) (USD $)	Jun. 30, 2013
Summary of minimum lease payments under the lease agreement
Six months ending December 31, 2013	$ 49,000
2014	104,000
2015	70,000
Total	$ 223,000

XML

Restrictions on Cash (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Restrictions on Cash (Textual)
Restricted cash	$ 4,464,000	$ 2,093,000

XML

Series I Secured Notes Payable (Details) (Series I Secured Notes Payable [Member], USD $)	Jun. 30, 2013
Series I Secured Notes Payable [Member]
Summary of future contractual maturities of series I secured notes payable
Six months ending December 31, 2013	$ 9,358,000
2014	12,561,000
2015	6,675,000
2016	1,802,000
2017	4,085,000
Thereafter	818,000
Total	$ 35,299,000

XML

Series I Secured Notes Payable (Tables)

6 Months Ended

Jun. 30, 2013

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures [Abstract]

Future contractual maturities of series I secured notes payable

Years Ending December 31,
Six months ending December 31, 2013	$	9,358,000
2014		12,561,000
2015		6,675,000
2016		1,802,000
2017		4,085,000
Thereafter		818,000
	$	35,299,000

XML

Condensed Consolidated Statements of Changes in Equity (unaudited) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2011	$ 948,569	$ 9,989	$ 8,169,303	$ (7,230,723)
Beginning Balance, Shares at Dec. 31, 2011		9,989,000
Net income	(1,012,899)			(1,012,899)
Issuance of warrants to purchase common stock	380,946		380,946
Accretion of preferred stock to liquidation value	(1,578,405)		(1,578,405)
Balance at Dec. 31, 2012	(1,261,789)	9,989	6,971,844	(8,243,622)
Beginning Balance, Shares at Dec. 31, 2012		9,989,000
Net income	1,823,824			1,823,824
Accretion of preferred stock to liquidation value	(466,639)		(466,639)
Repurchase of common stock	(3,252,400)	(865)	(3,251,535)
Repurchase of common stock, Shares		(865,000)
Balance at Jun. 30, 2013	$ (3,157,004)	$ 9,124	$ 3,253,670	$ (6,419,798)
Balance, Shares at Jun. 30, 2013		9,124,000

XML

Restrictions on Cash

6 Months Ended

Jun. 30, 2013

Restrictions on Cash [Abstract]

Restrictions on cash

( 2 )       Restrictions on cash

The Company is required by its lenders to maintain collection and escrow accounts. These accounts are used to pay annual premiums of insurance policies, pay interest and other charges under the revolving credit facility, and collect policy benefits. DZ Bank AG, as agent for Autobahn Funding Company, LLC, the lender for the revolving credit facility as described in note 6, authorizes the disbursements from these accounts. At June 30, 2013 and December 31, 2012 there was a balance of $4,464,000, and $2,093,000, respectively, maintained in these restricted cash accounts.

XML

Notes Receivable from Related Parties

6 Months Ended

Jun. 30, 2013

Notes Receivable from Related Parties [Abstract]

Notes receivable from related parties

( 5 )       Notes receivable from related parties

As of June 30, 2013 and December 31, 2012, the Company had receivables totaling $5,000,000 due from an affiliate, Opportunity Finance, LLC, which were fully reserved. Opportunity Finance ceased operations in 2008.

XML

Investment in Life Insurance Policies

6 Months Ended

Jun. 30, 2013

Investment in Life Insurance Policies [Abstract]

Investment in life insurance policies

( 3 )       Investment in life insurance policies

The life insurance policies (Level 3 fair value measurements) are valued based on unobservable inputs that are significant to the overall fair value measurement. Changes in the fair value of these instruments are recorded in gain or loss on life insurance policies in the consolidated statements of operations (net of the cash premiums paid on the policies). The fair value is determined on a discounted cash flow basis that incorporates life expectancy assumptions.  Life expectancy reports have been obtained from widely accepted life expectancy providers. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. As a result of management’s analysis, discount rates of 11.84% and 12.08% were applied to the portfolio as of June 30, 2013 and December 31, 2012, respectively.

A summary of the Company’s life insurance policies accounted for under the fair value method and their estimated maturity dates, based on remaining life expectancy, is as follows:

	As of June 30, 2013						As of December 31, 2012
Years Ending December 31,	Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2013		-	$	-	$	-		-	$	-	$	-
2014		-		-		-		-		-		-
2015		2		1,239,000		2,000,000		2		1,163,000		2,000,000
2016		10		7,059,000		12,729,000		13		11,608,000		22,229,000
2017		18		25,099,000		56,173,000		17		21,155,000		53,439,000
2018		31		32,382,000		77,629,000		31		28,252,000		75,668,000
2019		40		34,198,000		99,668,000		35		26,947,000		84,579,000
Thereafter		140		93,915,000		402,456,000		113		75,192,000		334,331,000
Totals		241	$	193,892,000	$	650,655,000		211	$	164,317,000	$	572,246,000

The Company recognized death benefits of $6,600,000 and $4,500,000 during the three-month periods ended June 30, 2013 and 2012, respectively, related to policies with a carrying value of $1,382,000 and $417,000, respectively.  The Company recorded realized gains of $5,218,000 and $4,083,000 on such policies.  The Company recognized death benefits of $10,600,000 and $4,500,000 during the six-month periods ended June 30, 2013 and 2012, respectively, related to policies with a carrying value of $2,872,000 and $417,000, respectively.  The Company recorded realized gains of $7,728,000 and $4,083,000 on such policies.  Subsequent to June 30, 2013, two policies with an aggregate death benefit of $2,500,000 have matured.

Reconciliation of gain on life settlements:

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Change in fair value	$	7,449,000		$	4,576,000		$	18,944,000		$	9,367,000
Premiums and other annual fees		(4,934,000	)		(3,792,000	)		(10,598,000	)		(7,981,000	)
Policy maturities		5,218,000			4,083,000			7,728,000			4,083,000
Gain on life settlements, net	$	7,733,000		$	4,867,000		$	16,074,000		$	5,469,000

The estimated expected premium payments to maintain the above life insurance policies in force for the next five years, assuming no mortalities, are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	10,272,000
2014		21,206,000
2015		22,986,000
2016		25,222,000
2017		27,757,000
	$	107,443,000

Management anticipates funding the estimated premium payments as noted above with proceeds from the DZ Bank revolving credit facility and through additional debt and equity financing as well as from cash proceeds from maturities of life insurance policies. The proceeds of these capital sources are also intended to be used for the purchase, financing, and maintenance of additional life insurance policies.

XML

Notes Receivable from Related Parties (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Notes Receivable from Related Parties (Textual)
Receivables due from an affiliate, Opportunity Finance, LLC	$ 5,000,000	$ 5,000,000

XML

Guarantees of Secured Debentures (Tables)

6 Months Ended

Jun. 30, 2013

Guarantees of Secured Debentures [Abstract]

Condensed Consolidating Balance Sheets

June 30, 2013	Parent				Guarantor Sub			Non-Guarantor Sub			Eliminations				Consolidated
A S S E T S
Cash and cash equivalents		$	36,989,169			$	1,251,464		$	-		$	-			$	38,240,633
Restricted cash			-				2,501,500			1,962,367			-				4,463,867
Investment in life settlements, at fair value			-				-			193,891,894			-				193,891,894
Other assets			263,555				328,363			6,449,976			-				7,041,894
Investment in subsidiaries			88,702,942				122,020,978			-			(210,723,920	)			-
TOTAL ASSETS		$	125,955,666			$	126,102,305		$	202,304,237		$	(210,723,920	)		$	243,638,288
L I A B I L I T I E S & S T O C K H O L D E R S ' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility		$	-			$	-		$	79,000,000		$	-			$	79,000,000
Series I Secured notes payable			-				34,505,914			-			-				34,505,914
Secured renewable debentures			93,684,735				-			-							93,684,735
Interest payable			2,577,524				2,686,747			506,792			-				5,771,063
Accounts payable and accrued expenses			659,559				206,702			776,467			-				1,642,728
Deferred taxes, net			7,868,201				-			-			-				7,868,201
TOTAL LIABILITIES			104,790,019				37,399,363			80,283,259			-				222,472,641
CONVERTIBLE, REDEEMABLE PREFERRED STOCK			24,322,651				-			-			-				24,322,651
EQUITY (DEFICIT)
Member capital			-				88,702,942			122,020,978			(210,723,920	)			-
Common stock			9,124				-			-			-				9,124
Additional paid-in capital			3,253,670				-			-			-				3,253,670
Accumulated deficit			(6,419,798	)			-			-			-				(6,419,798	)
TOTAL EQUITY (DEFICIT)			(3,157,004	)			88,702,942			122,020,978			(210,723,920	)			(3,157,004	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)		$	125,955,666			$	126,102,305		$	202,304,237		$	(210,723,920	)		$	243,638,288

December 31, 2012	Parent				Guarantor Sub			Non-Guarantor Sub			Eliminations				Consolidated
A S S E T S
Cash and cash equivalents		$	25,035,579			$	2,461,465		$	-		$	-			$	27,497,044
Restricted cash			-				1,748,700			344,392							2,093,092
Investment in life settlements, at fair  value			-				-			164,317,183			-				164,317,183
Other assets			96,994				211,592			3,732,130			-				4,040,716
Investment in subsidiaries			60,608,585				96,914,613			-			(157,523,198	)			-
TOTAL ASSETS		$	85,741,158			$	101,336,370		$	168,393,705		$	(157,523,198	)		$	197,948,035
L I A B I L I T I E S & S T O C K H O L D E R S ' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility		$	-			$	-		$	71,000,000		$	-			$	71,000,000
Series I Secured notes payable			-				37,844,711			-			-				37,844,711
Secured renewable debentures			55,718,950				-			-							55,718,950
Interest payable			905,017				2,444,097			128,206			-				3,477,320
Accounts payable and accrued expenses			971,695				490,497			302,366			-				1,761,558
Deferred taxes, net			5,501,407				-			-			-				5,501,407
TOTAL LIABILITIES			63,097,069				40,776,305			71,430,572			-				175,303,946
CONVERTIBLE, REDEEMABLE PREFERRED STOCK			23,905,878				-			-			-				23,905,878
EQUITY (DEFICIT)
Member capital			-				60,560,065			96,963,133			(157,523,198	)			-
Common stock			9,989				-			-			-				9,989
Additional paid-in capital			6,971,844				-			-			-				6,971,844
Accumulated deficit			(8,243,622	)			-			-			-				(8,243,622	)
TOTAL EQUITY (DEFICIT)			(1,261,789	)			60,560,065			96,963,133			(157,523,198	)			(1,261,789	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)		$	85,741,158			$	101,336,370		$	168,393,705		$	(157,523,198	)		$	197,948,035

Condensed Consolidating Statements of Operations

For the six months ended June 30, 2013	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	1,814,202		$	-	$	(1,814,202	)	$	-
Gain on life settlements, net		-			-			16,073,601		-			16,073,601
Interest and other income		3,267,454			977,855			37,620		(840,935	)		3,441,994
TOTAL REVENUE		3,267,454			2,792,057			16,111,221		(2,655,137	)		19,515,595
EXPENSES
Origination and servicing fees		-			-			1,814,202		(1,814,202	)		-
Employee compensation and benefits		2,213,056			788,287			-		-			3,001,343
Legal and professional fees		672,317			116,883			-		-			789,200
Interest expense		4,976,599			1,849,861			2,582,697		-			9,409,157
Other expenses		1,283,269			816,009			865,934		(840,935	)		2,124,277
TOTAL EXPENSES		9,145,241			3,571,040			5,262,833		(2,655,137	)		15,323,977
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(5,877,787	)		(778,983	)		10,848,388		-			4,191,618
EQUITY IN INCOME OF SUBSIDIARIES		10,069,405			10,896,907			10,848,388		(20,966,312	)		-
INCOME BEFORE INCOME TAXES		4,191,618			10,117,924			10,848,388		(20,966,312	)		4,191,618
INCOME TAX EXPENSE		2,367,794			-			-		-			2,367,794
NET INCOME	$	1,823,824		$	10,117,924		$	10,848,388	$	(20,966,312	)	$	1,823,824

For the six months ended June 30, 2012	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	438,250		$	-	$	(438,250	)	$	-
Gain on life settlements, net		-			229,277			5,239,969		-			5,469,246
Interest and other income		3,049			3,192			42,653		-			48,894
TOTAL REVENUE		3,049			670,719			5,282,622		(438,250	)		5,518,140
EXPENSES
Origination and servicing fees		-			(6,500	)		444,750		(438,250	)		-
Employee compensation and benefits		-			1,117,084			-		-			1,117,084
Legal and professional fees		655,600			45,803			-		-			701,403
Interest expense		1,268,211			2,696,548			853,232		-			4,817,991
Other expenses		534,100			703,552			25,000		-			1,262,652
TOTAL EXPENSES		2,457,911			4,556,487			1,322,982		(438,250	)		7,899,130
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(2,454,862	)		(3,885,768	)		3,959,640		-			(2,380,990	)
EQUITY IN INCOME OF SUBSIDIARIES		73,872			4,017,864			-		(4,091,736	)		-
INCOME BEFORE INCOME TAXES		(2,380,990	)		132,096			3,959,640		(4,091,736	)		(2,380,990	)
INCOME TAX BENEFIT		(529,860	)		-			-		-			(529,860	)
NET INCOME (LOSS)	$	(1,851,130	)	$	132,096		$	3,959,640	$	(4,091,736	)	$	(1,851,130	)

For the three months ended June 30, 2013	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	536,100		$	-	$	(536,100	)	$	-
Gain on life settlements, net		-			-			7,733,245		-			7,733,245
Interest and other income		3,259,362			841,286			14,610		(840,935	)		3,274,323
TOTAL REVENUE		3,259,362			1,377,386			7,747,855		(1,377,035	)		11,007,568
EXPENSES
Origination and servicing fees		-			-			536,100		(536,100	)		-
Employee compensation and benefits		666,354			397,569			-		-			1,063,923
Legal and professional fees		272,794			79,116			-		-			351,910
Interest expense		2,655,430			942,686			1,343,826		-			4,941,942
Other expenses		649,112			429,520			853,435		(840,935	)		1,091,132
TOTAL EXPENSES		4,243,690			1,848,891			2,733,361		(1,377,035	)		7,448,907
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(984,328	)		(471,505	)		5,014,494		-			3,558,661
EQUITY IN INCOME OF SUBSIDIARIES		4,543,289			5,014,494			-		(9,557,783	)		-
INCOME BEFORE INCOME TAXES		3,558,961			4,542,989			5,014,494		(9,557,783	)		3,558,661
INCOME TAX EXPENSE (BENEFIT)		1,802,271			(300	)		-		-			1,801,971
NET INCOME	$	1,756,690		$	4,543,289		$	5,014,494	$	(9,557,783	)	$	1,756,690

For the three months ended June 30, 2012	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	290,050		$	-	$	(290,050	)	$	-
Gain on life settlements, net		-			79,307			4,788,171		-			4,867,478
Interest and other income		2,745			2,237			42,581		-			47,563
TOTAL REVENUE		2,745			371,594			4,830,752		(290,050	)		4,915,041
EXPENSES
Origination and servicing fees		-			-			290,050		(290,050	)		-
Employee compensation and benefits		-			583,338			-		-			583,338
Legal and professional fees		364,698			(27,519	)		-		-			337,179
Interest expense		814,038			1,140,239			425,301		-			2,379,578
Other expenses		387,691			303,468			12,500		-			703,659
TOTAL EXPENSES		1,566,427			1,999,526			727,851		(290,050	)		4,003,754
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(1,563,682	)		(1,627,932	)		4,102,901		-			911,287
EQUITY IN INCOME OF SUBSIDIARIES		2,474,969			4,132,013			-		(6,606,982	)		-
INCOME BEFORE INCOME TAXES		911,287			2,504,081			4,102,901		(6,606,982	)		911,287
INCOME TAX EXPENSE		609,588			-			-		-			609,588
NET INCOME	$	301,699		$	2,504,081		$	4,102,901	$	(6,606,982	)	$	301,699

Condensed Consolidating Statements of Cash Flows

For the six months ended June 30, 2013	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	1,823,824		$	10,117,924		$	10,848,388		$	(20,966,312	)	$	1,823,824
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(982,826	)		(867,920	)		-			1,850,746			-
Gain on life settlements		-			-			(18,943,905	)		-			(18,943,905	)
Amortization of deferred financing and issuance costs		737,959			434,431			758,490			-			1,930,880
Deferred income taxes		2,366,794			-			-			-			2,366,794
Preferred stock issued for dividends		261,937			-			-			-			261,937
(Increase) decrease in operating assets:
Other assets		(27,278,091	)		(24,355,215	)		(3,330,802	)		51,349,976			(3,614,132	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		1,485,107			119,503			90,187			-			1,694,797
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(21,585,296	)		(14,551,277	)		(10,577,642	)		32,234,410			(14,479,805	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(12,885,993	)		-			(12,885,993	)
Proceeds from settlement of life settlements		-			-			2,872,152			-			2,872,152
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(10,013,841	)		-			(10,013,841	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			8,000,000			-			8,000,000
Payments for redemption of Series I Secured notes payable		-			(3,930,876	)		-			-			(3,930,876	)
Proceeds from issuance of debentures		42,439,661			-			-			-			42,439,661
Payments from issuance and redemption of debentures		(5,336,571	)		-			-			-			(5,336,571	)
Payments from restricted cash		-			(752,800	)		(1,617,975	)		-			(2,370,775	)
Issuance of member capital		-			18,024,952			14,209,458			(32,234,410	)		-
Repurchase of common stock		(3,252,400	)		-			-			-			(3,252,400	)
Payments for redemption of preferred stock		(311,804	)		-			-			-			(311,804	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		33,538,886			13,341,276			20,591,483			(32,234,410	)		35,237,235
NET INCREASE IN CASH AND CASH EQUIVALENTS		11,953,590			(1,210,001	)		-			-			10,743,589
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		25,035,579			2,461,465			-			-			27,497,044
END OF THE PERIOD	$	36,989,169		$	1,251,464		$	-		$	-		$	38,240,633

For the six months ended June 30, 2012	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	(1,851,130	)	$	132,096		$	3,949,640		$	(4,091,736	)	$	(1,851,130	)
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(8,985,743	)		(238,602	)		5,132,609			4,091,736			-
(Gain) loss on life settlements		-			999,677			(11,989,926	)		-			(10,990,249	)
Amortization of deferred financing and issuance costs		46,622			746,387			116,448			-			909,457
Deferred income taxes		(529,860	)		-			-			-			(529,860	)
Preferred stock issued for dividends		421,010			-			-			-			421,010
(Increase) decrease in operating assets:
Other assets		(13,027	)		1,217,186			(146,874	)		-			1,057,285
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		606,991			39,087			13,056			-			659,134
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(10,305,137	)		2,895,831			(2,915,047	)		-			(10,324,353	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,622,030	)		-			(2,622,030	)
Proceeds from settlement of life settlements		-			-			416,665			-			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(2,205,365	)		-			(2,205,365	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			6,000,000			-			6,000,000
Proceeds from issuance of Series I Secured notes payable		-			50,000			-			-			50,000
Payments for redemption of Series I Secured notes payable		-			(3,468,957	)		-			-			(3,468,957	)
Proceeds from issuance of debentures		15,757,086			-			-			-			15,757,086
Payments from issuance of debentures		(712,587	)		-			-			-			(712,587	)
Proceeds (payments) from restricted cash		-			822,227			(879,588	)		-			(57,361	)
Proceeds from issuance of preferred stock		5,787,375			-			-			-			5,787,375
Payments for redemption of preferred stock		(1,609,362	)		-			-			-			(1,609,362	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		19,222,512			(2,569,730	)		5,120,412			-			21,746,194
NET INCREASE IN CASH AND CASH EQUIVALENTS		8,917,375			299,101			-			-			9,216,476
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		1,746,456			131,893			-			-			1,878,349
END OF THE PERIOD	$	10,663,831		$	430,994		$	-		$	-		$	11,094,825

For the three months ended June 30, 2013	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	1,756,690		$	4,543,289		$	5,014,494		$	(9,557,783	)	$	1,756,690
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		4,543,289			5,014,494			-			(9,557,783	)		-
(Gain) loss on life settlements		-			-			(7,449,180	)		-			(7,449,180	)
Amortization of deferred financing and issuance costs		344,482			161,926			330,725			-			837,133
Deferred income taxes		1,802,920			-			-			-			1,802,920
Preferred stock issued for dividends		178,235			-			-			-			178,235
(Increase) decrease in operating assets:
Other assets		(13,002,552	)		(13,654,889	)		(4,000,000	)		26,493,437			(4,164,004	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		639,763			(12,024	)		(225,000	)		-			402,739
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(3,737,173	)		(3,947,204	)		(6,328,961	)		7,377,871			(6,635,467	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,972,944	)		-			(2,972,944	)
Proceeds from settlement of life settlements		-			-			1,382,152			-			1,382,152
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(1,590,792	)		-			(1,590,792	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured notes payable		-			(2,423,052	)		-			-			(2,423,052	)
Proceeds from issuance of debentures		18,588,867			-			-			-			18,588,867
Payments from issuance and redemption of debentures		(3,033,303	)		-			-			-			(3,033,303	)
Proceeds (payments) from restricted cash		-			(2,222,476	)		4,382,809			-			2,160,333
Issuance of member capital		-			3,840,927			3,536,944			(7,377,871	)		-
Repurchase of common stock		(3,252,400	)		-			-			-			(3,252,400	)
Payments for redemption of preferred stock		(125,135	)		-			-			-			(125,135	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,178,029			(804,601	)		7,919,753			(7,377,871	)		11,915,310
NET INCREASE IN CASH AND CASH EQUIVALENTS		8,440,856			(4,751,805	)		-			-			3,689,051
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		28,548,313			6,003,269			-			-			34,551,582
END OF THE PERIOD	$	36,989,169		$	1,251,464		$	-		$	-		$	38,240,633

For the three months ended June 30, 2012	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	301,699		$	2,504,081		$	4,102,901		$	(6,606,982	)	$	301,699
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(7,602,533	)		(352,750	)		1,348,301			6,606,982			-
Gain on life settlements		-			(66,551	)		(4,509,390	)		-			(4,575,941	)
Amortization of deferred financing and issuance costs		46,622			237,451			58,224			-			342,297
Deferred income taxes		609,588			-			-			-			609,588
Preferred stock issued for dividends		294,935			-			-			-			294,935
(Increase) decrease in operating assets:
Other assets		(42,969	)		(95,216	)		(159,875	)		-			(298,060	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		152,299			(44,990	)		(5,857	)		-			101,452
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(6,240,359	)		2,182,025			(834,304	)		-			(3,224,030	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(1,468,770	)		-			(1,468,770	)
Proceeds from settlement of life settlements		-			-			416,665			-			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(1,052,105	)		-			(1,052,105	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			3,500,000			-			3.500,000
Proceeds from issuance of Series I Secured notes payable		-			-			-			-			-
Payments for redemption of Series I Secured notes payable		-			(1,918,420	)		-			-			(1,918,420	)
Proceeds from issuance of debentures		12,695,213			-			-			-			12,695,213
Payments from issuance of debentures		(712,587	)		-			-			-			(712,587	)
Payments from redemption of debentures		-			-			-			-			-
Payments from restricted cash		-			-			(3,282,199	)		-			(3,282,199	)
Proceeds from issuance of preferred stock		1,350,910			-			-			-			1,350,910
Payments for redemption of preferred stock		(810,722	)		-			-			-			(810,722	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,522,814			(1,918,420	)		217,801			-			10,822,195
NET INCREASE IN CASH AND CASH EQUIVALENTS		6,282,455			263,605			-			-			6,546,060
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		4,381,376			167,389			-			-			4,548,765
END OF THE PERIOD	$	10,663,831		$	430,994		$	-		$	-		$	11,094,825

XML

Investment in Life Insurance Policies (Details) (USD $)	Jun. 30, 2013 Contract	Dec. 31, 2012 Contract
Summary of Company's life insurance policies accounted for under fair value method and their estimated maturity dates, based on remaining life expectancy
Number of Contracts, 2013
Number of Contracts, 2014
Number of Contracts, 2015	2	2
Number of Contracts, 2016	10	13
Number of Contracts, 2017	18	17
Number of Contracts, 2018	31	31
Number of Contracts, 2019	40	35
Number of Contracts, Thereafter	140	113
Life Settlement Contracts, Number of Contracts, Total	241	211
Estimated Fair Value, 2013
Estimated Fair Value, 2014
Estimated Fair Value, 2015	1,239,000	1,163,000
Estimated Fair Value, 2016	7,059,000	11,608,000
Estimated Fair Value, 2017	25,099,000	21,155,000
Estimated Fair Value, 2018	32,382,000	28,252,000
Estimated Fair Value, 2019	34,198,000	26,947,000
Estimated Fair Value, Thereafter	93,915,000	75,192,000
Life Settlement Contracts, Estimated Fair Value, Total	193,892,000	164,317,000
Face Value, 2013
Face Value, 2014
Face Value, 2015	2,000,000	2,000,000
Face Value, 2016	12,729,000	22,229,000
Face Value, 2017	56,173,000	53,439,000
Face Value, 2018	77,629,000	75,668,000
Face Value, 2019	99,668,000	84,579,000
Face Value, Thereafter	402,456,000	334,331,000
Life Settlement Contracts, Face Value, Total	$ 650,655,000	$ 572,246,000

XML

Fair Value Definition and Hierarchy (Details 1) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
Summary of inputs utilized in estimating the fair value
Discount rate	11.84%	12.08%
Life Insurance policies [Member]
Summary of inputs utilized in estimating the fair value
Weighted average age of insured	81 months 21 days	81 months 6 days
Weighted average life expectancy, months*	90 months 12 days	91 months 6 days
Average face amount per policy	$ 2,699,814	$ 2,712,063
Discount rate	11.84%	12.08%

XML

Guarantees of Secured Debentures (Details Textual) (USD $)	6 Months Ended
	Jun. 30, 2013
Guarantees of secured debentures (Textual)
Maximum rate of return on equity fund amount	18.00%
Secured Debentures [Member]
Guarantees of secured debentures (Textual)
Debentures offer for sale	$ 250,000,000

XML

Commitments (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013 sqft	Jun. 30, 2012	Jun. 30, 2013 sqft	Jun. 30, 2012
Commitments (Textual)
Lease expiration date			Aug. 31, 2015
Office space in square feet	8,881		8,881
Rent expenses	$ 50,000	$ 36,000	$ 98,000	$ 73,000

XML

Renewable Secured Debentures (Details) (Renewable Secured Debentures [Member], USD $)	Jun. 30, 2013
Renewable Secured Debentures [Member]
Summary of Future maturities of renewable secured debentures
Six months ending December 31, 2013	$ 11,839,000
2014	15,272,000
2015	30,085,000
2016	16,359,000
2017	6,529,000
Thereafter	15,774,000
Total	$ 95,858,000

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Balance Sheets [Abstract]
Convertible redeemable preferred stock, par value	$ 0.001	$ 0.001
Convertible redeemable preferred stock, shares authorized	40,000,000	40,000,000
Convertible redeemable preferred stock, shares issued	3,356,787	3,361,076
Convertible redeemable preferred stock, shares outstanding	3,356,787	3,361,076
Convertible redeemable preferred stock, liquidation preference	$ 25,176,000	$ 5,208,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	210,000,000	210,000,000
Common stock, shares issued	9,124,000	9,989,000
Common stock, shares outstanding	9,124,000	9,989,000

XML

Renewable Secured Debentures

6 Months Ended

Jun. 30, 2013

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures [Abstract]

Renewable secured debentures

( 8 )       Renewable secured debentures

The Company has registered with the Securities and Exchange Commission, effective January 2012, the offer and sale of $250,000,000 of secured debentures. Renewable Secured Debentures have maturity dates ranging from six months to seven years with fixed interest rates varying from 4.75% to 9.50% depending on the term of the note. Interest is payable monthly, annually or at maturity depending on the terms of the debenture. At June 30, 2013 and December 31, 2012, the weighted-average interest rate of Renewable Secured Debentures was 7.58% and 7.65%, respectively. The debentures are secured by assets of GWG Life and GWG Holdings. The amount outstanding under these Renewable Secured Debentures was $95,858,000 and $57,609,000 at June 30, 2013 and December 31, 2012, respectively. The difference between the amount outstanding on the Renewable Secured Debentures and the carrying amount on the consolidated balance sheets is due to netting of unamortized deferred issuance costs and cash receipts for new issuances in process.  Amortization of deferred issuance costs was $344,000 and $622,000 for the three and six months ended June 30, 2013, respectively, and $44,000 and $47,000 for the three and six months ended June 30, 2012, respectively.  Future expected amortization of deferred financing costs is $4,114,000. Subsequent to June 30, 2013, the Company has issued approximately an additional $10,300,000 in principal amount of these secured debentures.

The use of proceeds from the issuances of Renewable Secured Debentures is limited to the following: (1) payment of commissions on sales of Renewable Secured Debentures, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) Payment of premiums on life insurance policies, (5) payment of principal and interest on Renewable Secured Debentures, (6) payment of portfolio operations expenses, and (7) for general working capital.

Future contractual maturities of Renewable Secured Debentures at June 30, 2013 are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	11,839,000
2014		15,272,000
2015		30,085,000
2016		16,359,000
2017		6,529,000
Thereafter		15,774,000
	$	95,858,000

The Company entered into an indenture effective October 19, 2011 with Holdings as obligor, GWG Life as guarantor, and Bank of Utah as trustee for the benefit of the debenture holders.  The indenture has certain financial and nonfinancial covenants.  The Company was in compliance with these covenants at June 30, 2013 and December 31, 2012. 

XML

Condensed Consolidated Statement of Cash Flows (unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 1,756,690	$ 301,699	$ 1,823,824	$ (1,851,130)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Gain on life settlements	(7,449,180)	(4,575,941)	(18,943,905)	(10,990,249)
Amortization of deferred financing and issuance costs	837,133	342,297	1,930,880	909,457
Deferred income taxes	1,802,920	609,588	2,366,794	(529,860)
Convertible, redeemable preferred stock dividends payable	178,235	294,935	261,937	421,010
(Increase) decrease in operating assets:
Other assets	(4,164,004)	(298,060)	(3,614,132)	1,057,285
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses	402,739	101,452	1,694,797	659,134
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(6,635,467)	(3,224,030)	(14,479,805)	(10,324,353)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(2,972,944)	(1,468,770)	(12,885,993)	(2,622,030)
Proceeds from settlement of life settlements	1,382,152	416,665	2,872,152	416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES	(1,590,792)	(1,052,105)	(10,013,841)	(2,205,365)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		3,500,000	8,000,000	6,000,000
Proceeds from issuance of Series I Secured notes payable				50,000
Payments for redemption of Series I Secured notes payable	(2,423,052)	(1,918,420)	(3,930,876)	(3,468,957)
Proceeds from issuance of renewable secured debentures	18,588,867	12,695,213	42,439,661	15,757,086
Payments for redemption and issuance of renewable secured debentures	(3,033,303)	(712,587)	(5,336,571)	(712,587)
Proceeds from restricted cash	2,160,333	(3,282,199)	(2,370,775)	(57,361)
Repurchase of common stock	(3,252,400)		(3,252,400)
Issuance (redemptions) of convertible, redeemable preferred stock	(125,135)	1,350,910	(311,804)	5,787,375
Payments of issuance cost for preferred stock		(810,722)		(1,609,362)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	11,915,310	10,822,195	35,237,235	21,746,194
NET INCREASE IN CASH AND CASH EQUIVALENTS	3,689,051	6,546,060	10,743,589	9,216,476
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	34,551,582	4,548,765	27,497,044	1,878,349
END OF PERIOD	38,240,633	11,094,825	38,240,633	11,094,825
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	3,214,000	1,313,000	6,512,000	2,462,000
Series I secured notes:
Non-cash conversion of accrued interest and commissions payable to principal	86,000	4,000	150,000	8,000
Renewable secured debentures:
Non-cash conversion of accrued interest and commissions payable to principal	59,000	37,000	100,000	70,000
Convertible, redeemable preferred stock
Non-cash conversion of dividends payable	178,000	138,000	262,000	250,000
Non-cash accretion of convertible, redeemable preferred stock to redemption value	209,000	435,000	467,000	775,000
Non-cash conversion of Series I secured notes		1,130,000		4,220,000
Investment In Life Settlements Included In Accounts Payable	$ 262,000	$ 108,000	$ 262,000	$ 108,000

XML

Condensed Consolidated Balance Sheets (USD $)	Jun. 30, 2013	Dec. 31, 2012
ASSETS
Cash and cash equivalents	$ 38,240,633	$ 27,497,044
Restricted cash	4,463,867	2,093,092
Investment in life settlements, at fair value	193,891,894	164,317,183
Other assets	7,041,894	4,040,716
TOTAL ASSETS	243,638,288	197,948,035
LIABILITIES
Revolving credit facility	79,000,000	71,000,000
Series I Secured notes payable	34,505,914	37,844,711
Renewable secured debentures	93,684,735	55,718,950
Interest payable	5,771,063	3,477,320
Accounts payable and accrued expenses	1,642,728	1,761,558
Deferred taxes, net	7,868,201	5,501,407
TOTAL LIABILITIES	222,472,641	175,303,946
CONVERTIBLE, REDEEMABLE PREFERRED STOCK (par value $0.001; shares authorized 40,000,000; shares issued and outstanding 3,356,787 and 3,361,076; liquidation preference of $25,176,000 and $25,208,000, respectively)	24,322,651	23,905,878
EQUITY
Common stock (par value $0.001: shares authorized 210,000,000; shares issued and outstanding is 9,124,000 and 9,989,000 on June 30, 2013 and December 31, 2012, respectively)	9,124	9,989
Additional paid-in capital	3,253,670	6,971,844
Accumulated deficit	(6,419,798)	(8,243,622)
TOTAL EQUITY (DEFICIT)	(3,157,004)	(1,261,789)
TOTAL LIABILITIES & EQUITY (DEFICIT)	$ 243,638,288	$ 197,948,035

XML

Contingencies (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2006
Contingencies (Textual)
Loaned to Opportunity Finance, LLC, Subject to clawback claims by the bankruptcy court		$ 1,000,000
Interest receivable from Opportunity Finance, LLC, Subject to clawback claims by the bankruptcy court	$ 177,000

XML

Concentrations (Tables)

6 Months Ended

Jun. 30, 2013

Concentration [Abstract]

Summary of the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company

	June 30, 2013		December 31, 2012
Life insurance company	%		%
Company A		15.18		16.96
Company B		12.14		13.80
Company C		10.33		11.36

Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company

	June 30, 2013		December 31, 2012
State of residence	%		%
California		29.88		28.44
Florida		12.45		11.85
New York		12.03		13.27

XML

Investment in Life Insurance Policies (Tables)

6 Months Ended

Jun. 30, 2013

Investment in Life Insurance Policies [Abstract]

Summary of life insurance policies, under the fair value method and estimated maturity dates organized by expected mortality date

	As of June 30, 2013						As of December 31, 2012
Years Ending December 31,	Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2013		-	$	-	$	-		-	$	-	$	-
2014		-		-		-		-		-		-
2015		2		1,239,000		2,000,000		2		1,163,000		2,000,000
2016		10		7,059,000		12,729,000		13		11,608,000		22,229,000
2017		18		25,099,000		56,173,000		17		21,155,000		53,439,000
2018		31		32,382,000		77,629,000		31		28,252,000		75,668,000
2019		40		34,198,000		99,668,000		35		26,947,000		84,579,000
Thereafter		140		93,915,000		402,456,000		113		75,192,000		334,331,000
Totals		241	$	193,892,000	$	650,655,000		211	$	164,317,000	$	572,246,000

Reconciliation of gain on life settlements

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Change in fair value	$	7,449,000		$	4,576,000		$	18,944,000		$	9,367,000
Premiums and other annual fees		(4,934,000	)		(3,792,000	)		(10,598,000	)		(7,981,000	)
Policy maturities		5,218,000			4,083,000			7,728,000			4,083,000
Gain on life settlements, net	$	7,733,000		$	4,867,000		$	16,074,000		$	5,469,000

Estimated expected premium payments to maintain the above life insurance policies assuming no mortalities

Years Ending December 31,
Six months ending December 31, 2013	$	10,272,000
2014		21,206,000
2015		22,986,000
2016		25,222,000
2017		27,757,000
	$	107,443,000

XML

Series I Secured Notes Payable (Details Textual) (USD $)	0 Months Ended	3 Months Ended		6 Months Ended
	Jun. 14, 2011	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Series I Secured Notes Payable (Textual)
Weighted average market interest rate of Secured notes payable		7.45%		7.45%
Secured notes		$ 93,684,735		$ 93,684,735		$ 55,718,950
Amortization of deferred financing and issuance costs		89,000	58,000	276,000	116,000
Series I Secured Notes Payable [Member]
Series I Secured Notes Payable (Textual)
Minimum maturity period of secured notes	6 months
Maximum maturity period of secured notes	7 years
Interest rate on secured notes, Minimum	5.65%
Interest rate on secured notes, Maximum	9.55%
Description of interest payment				Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note.
Weighted average market interest rate of Secured notes payable		8.27%		8.27%		8.22%
Secured notes		35,299,000		35,299,000		38,570,000
Amortization of deferred financing and issuance costs		161,000	237,000	217,000	746,000
Future expected amortization of deferred financing costs				$ 793,000
Conditions for proceed from issuance of debenture				1) payment of commissions of Series I Secured note sales, (2) purchase life insurance policies, (3) pay premiums of life insurance policies, (4) pay principal and interest to Senior Liquidity Provider (DZ Bank), (5) pay portfolio or note operating fees or costs, (6) pay trustee (Wells Fargo Bank, N.A.), (7) pay servicer and collateral fees, (8) pay principal and interest on Series I Secured notes, (9) make distributions to equity holders for tax liability related to portfolio, (10) purchase interest rate caps, swaps, or hedging instruments, (11) pay GWG Series I Trustee fees, and (12) pay offering expenses.
Amortizatoin period of deferred financing cost				6 years

XML

Guarantees of Secured Debentures (Details 2) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 1,756,690	$ 301,699	$ 1,823,824	$ (1,851,130)
Adjustments to reconcile net income to cash:
Equity income of subsidiaries
(Gain) loss on life settlements	(7,449,180)	(4,575,941)	(18,943,905)	(10,990,249)
Amortization of deferred financing and issuance costs	837,133	342,297	1,930,880	909,457
Deferred income taxes	1,802,920	609,588	2,366,794	(529,860)
Preferred stock issued for dividends	178,235	294,935	261,937
(Increase) decrease in operating assets:
Other assets	(4,164,004)	(298,060)	(3,614,132)	1,057,285
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses	402,739	101,452	1,694,797	659,134
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(6,635,467)	(3,224,030)	(14,479,805)	(10,324,353)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(2,972,944)	(1,468,770)	(12,885,993)	(2,622,030)
Proceeds from settlement of life settlements	1,382,152	416,665	2,872,152	416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES	(1,590,792)	(1,052,105)	(10,013,841)	(2,205,365)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		3,500,000	8,000,000	6,000,000
Proceeds from issuance of Series I Secured notes payable				50,000
Payments for redemption of Series I Secured notes payable	(2,423,052)	(1,918,420)	(3,930,876)	(3,468,957)
Proceeds from issuance of debentures	18,588,867	12,695,213	42,439,661	15,757,086
Payments from issuance of debentures		(712,587)		(712,587)
Payments for issuance and redemptions of renewable secured debentures	(3,033,303)		(5,336,571)
Proceeds (payments) from restricted cash	2,160,333	(3,282,199)	(2,370,775)	(57,361)
Issuance of member capital
Repurchase of common stock	(3,252,400)		(3,252,400)
Payments for redemption of preferred stock	(125,135)	1,350,910	(311,804)	5,787,375
Payments of issuance cost for preferred stock		(810,722)		(1,609,362)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	11,915,310	10,822,195	35,237,235	21,746,194
NET INCREASE IN CASH AND CASH EQUIVALENTS	3,689,051	6,546,060	10,743,589	9,216,476
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	34,551,582	4,548,765	27,497,044	1,878,349
END OF PERIOD	38,240,633	11,094,825	38,240,633	11,094,825
Parent [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	1,756,690	301,699	1,823,824	(1,851,130)
Adjustments to reconcile net income to cash:
Equity income of subsidiaries	(4,543,289)	(2,474,969)	(982,826)	(8,985,743)
(Gain) loss on life settlements
Amortization of deferred financing and issuance costs	344,482	46,622	737,959	46,622
Deferred income taxes	1,802,920	609,588	2,366,794	(529,860)
Preferred stock issued for dividends	178,235	294,935	261,937	421,010
(Increase) decrease in operating assets:
Other assets	(13,002,552)	(42,969)	(27,278,091)	(13,027)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses	639,763	152,299	1,485,107	606,991
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(3,737,173)	(6,240,359)	(21,585,296)	(10,305,137)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility
Proceeds from issuance of Series I Secured notes payable
Payments for redemption of Series I Secured notes payable
Proceeds from issuance of debentures	18,588,867	12,695,213	42,439,661	15,757,086
Payments from issuance of debentures		(712,587)		(712,587)
Payments for issuance and redemptions of renewable secured debentures	(3,033,303)		(5,336,571)
Proceeds (payments) from restricted cash
Issuance of member capital
Repurchase of common stock	(3,252,400)		(3,252,400)
Payments for redemption of preferred stock	(125,135)	1,350,910	(311,804)	5,787,375
Payments of issuance cost for preferred stock		(810,722)		(1,609,362)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	12,178,029	12,522,814	33,538,886	19,222,512
NET INCREASE IN CASH AND CASH EQUIVALENTS	8,440,856	6,282,455	11,953,590	8,917,375
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	28,548,313	4,381,376	25,035,579	1,746,456
END OF PERIOD	36,989,169	10,663,831	36,989,169	10,663,831
Guarantor Subsidiary [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	4,543,289	2,504,081	10,117,924	132,096
Adjustments to reconcile net income to cash:
Equity income of subsidiaries	(5,014,494)	(4,132,013)	(867,920)	(238,602)
(Gain) loss on life settlements		(66,551)		999,677
Amortization of deferred financing and issuance costs	161,926	237,451	434,431	746,387
Deferred income taxes
Preferred stock issued for dividends
(Increase) decrease in operating assets:
Other assets	(13,654,889)	(95,216)	(24,355,215)	1,217,186
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses	(12,024)	(44,990)	119,503	39,087
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(3,947,204)	2,182,025	(14,551,277)	2,895,831
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility
Proceeds from issuance of Series I Secured notes payable				50,000
Payments for redemption of Series I Secured notes payable	(2,423,052)	(1,918,420)	(3,930,876)	(3,468,957)
Proceeds from issuance of debentures
Payments from issuance of debentures
Payments for issuance and redemptions of renewable secured debentures
Proceeds (payments) from restricted cash	(2,222,476)		(752,800)	822,227
Issuance of member capital	3,840,927		18,024,952
Repurchase of common stock
Payments for redemption of preferred stock
Payments of issuance cost for preferred stock
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	(804,601)	(1,918,420)	13,341,276	(2,569,730)
NET INCREASE IN CASH AND CASH EQUIVALENTS	(4,751,805)	263,605	(1,210,001)	299,101
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	6,003,269	167,389	2,461,465	131,893
END OF PERIOD	1,251,464	430,994	1,251,464	430,994
Non-Guarantor Subsidiaries [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	5,014,494	4,102,901	10,848,388	3,959,640
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(1,348,301)	(10,848,388)	(5,132,609)
(Gain) loss on life settlements	(7,449,180)	(4,509,390)	(18,943,905)	(11,989,926)
Amortization of deferred financing and issuance costs	330,725	58,224	758,490	116,448
Deferred income taxes
Preferred stock issued for dividends
(Increase) decrease in operating assets:
Other assets	(4,000,000)	(159,875)	(3,330,802)	(146,874)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses	(225,000)	(5,857)	90,187	13,056
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(6,328,961)	(834,304)	(10,577,642)	(2,915,047)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(2,972,944)	(1,468,770)	(12,885,993)	(2,622,030)
Proceeds from settlement of life settlements	1,382,152	416,665	2,872,152	416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES	(1,590,792)	(1,052,105)	(10,013,841)	(2,205,365)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		3,500,000	8,000,000	6,000,000
Proceeds from issuance of Series I Secured notes payable
Payments for redemption of Series I Secured notes payable
Proceeds from issuance of debentures
Payments from issuance of debentures
Payments for issuance and redemptions of renewable secured debentures
Proceeds (payments) from restricted cash	4,382,809	(3,282,199)	(1,617,975)	(879,588)
Issuance of member capital	3,536,944		14,209,458
Repurchase of common stock
Payments for redemption of preferred stock
Payments of issuance cost for preferred stock
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	7,919,753	217,801	20,591,483	5,120,412
NET INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD
END OF PERIOD
Eliminations [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	(9,557,783)	(6,606,982)	(20,966,312)	(4,091,736)
Adjustments to reconcile net income to cash:
Equity income of subsidiaries	9,557,783	6,606,982	20,966,312	4,091,736
(Gain) loss on life settlements
Amortization of deferred financing and issuance costs
Deferred income taxes
Preferred stock issued for dividends
(Increase) decrease in operating assets:
Other assets	26,493,437		51,349,976
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses
NET CASH FLOWS USED IN OPERATING ACTIVITIES	7,377,871		32,234,410
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility
Proceeds from issuance of Series I Secured notes payable
Payments for redemption of Series I Secured notes payable
Proceeds from issuance of debentures
Payments from issuance of debentures
Payments for issuance and redemptions of renewable secured debentures
Proceeds (payments) from restricted cash
Issuance of member capital	(7,377,871)		(32,234,410)
Repurchase of common stock
Payments for redemption of preferred stock
Payments of issuance cost for preferred stock
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	(7,377,871)		(32,234,410)
NET INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD
END OF PERIOD

XML

Fair Value Definition and Hierarchy (Details 3) (Level 3 [Member], USD $)	6 Months Ended
	Jun. 30, 2013
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued	831,908
Warrants Issued One [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Dec. 31, 2011
Warrants issued	137,874
Fair value per share	$ 0.11
Risk free rate	0.42%
Volatility rate	25.25%
Term	3 years
Warrants Issued Two [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Mar. 31, 2012
Warrants issued	76,260
Fair value per share	$ 0.26
Risk free rate	0.38%
Volatility rate	36.20%
Term	3 years
Warrants Issued Three [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Jun. 30, 2012
Warrants issued	323,681
Fair value per share	$ 0.58
Risk free rate	0.41%
Volatility rate	47.36%
Term	3 years
Warrants Issued Four [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Jul. 31, 2012
Warrants issued	289,093
Fair value per share	$ 0.58
Risk free rate	0.41%
Volatility rate	47.36%
Term	3 years
Warrants Issued Five [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Sep. 30, 2012
Warrants issued	5,000
Fair value per share	$ 0.36
Risk free rate	0.31%
Volatility rate	40.49%
Term	3 years

XML

Investment in Life Insurance Policies (Details Textual) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013 Policy	Jun. 30, 2012	Dec. 31, 2012
Investment in Life Insurance Policies (Textual)
Discount rate applied to portfolio			11.84%		12.08%
Benefit recognized from insurance policy	$ 6,600,000	$ 4,500,000	$ 10,600,000	$ 4,500,000
Realized gains from life insurance policy	5,218,000	4,083,000	2,872,000	417,000
Carrying value of life insurance policy	1,382,000	417,000	7,728,000	4,083,000
Number of life insurance policy			2
Benefit recognized from two insurance policy			$ 2,500,000

XML

Fair Value Definition and Hierarchy (Details) (Life Insurance policies [Member], USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Life Insurance policies [Member]
Summary of reconciliation of investments in life insurance policies
Beginning balance	$ 185,020,000	$ 128,112,000	$ 164,317,000	$ 122,169,000
Purchases	2,805,000	1,576,000	13,503,000	2,728,000
Maturities (cash in excess of carrying value)	(1,382,000)	(416,000)	(2,872,000)	(416,000)
Net change in fair value	7,449,000	4,576,000	18,944,000	9,367,000
Ending balance (June 30)	$ 193,892,000	$ 133,848,000	$ 193,892,000	$ 133,848,000

XML

Series I Secured Notes Payable

6 Months Ended

Jun. 30, 2013

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures [Abstract]

Series I secured notes payable

( 7 )       Series I Secured notes payable

Series I Secured notes payable have been issued in conjunction with the GWG Series I Secured notes private placement memorandum dated August 25, 2009 (last revised November 15, 2010). On June 14, 2011 the Company closed the offering to additional investors, however, existing investors may elect to continue advancing amounts outstanding upon maturity subject to the Company’s option. Series I Secured notes have maturity dates ranging from six months to seven years with fixed interest rates varying from 5.65% to 9.55% depending on the term of the note. Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note. At June 30, 2013 and December 31, 2012 the weighted-average interest rates of Series I Secured notes were 8.27%, and 8.22% respectively. The notes are secured by assets of GWG Life. The principal amount outstanding under these Series I Secured notes was $35,299,000 and $38,570,000 at June 30, 2013, and December 31, 2012, respectively.  The difference between the amount outstanding on the Series I Secured notes and the carrying amount on the consolidated balance sheet is due to netting of unamortized deferred issuance costs. Overall, interest expense includes amortization of deferred financing and issuance costs of $161,000 and $217,000 for the three and six months ended June 30, 2013, respectively, and $237,000 and $746,000 for the three and six months ended June 30, 2012, respectively.  Future expected amortization of deferred financing costs is $793,000 over the next six years.

On November 15, 2010, the holders of a majority of the membership interests in the company (then a limited liability company), Messrs. Jon R. Sabes and Steven F. Sabes, pledged their ownership interests in the Company to the Series I Trust as security for advances under the Series I Trust arrangement.

The use of proceeds from the issuances of Series I Secured notes was limited to the following: (1) payment of commissions of Series I Secured note sales, (2) purchase life insurance policies, (3) pay premiums of life insurance policies, (4) pay principal and interest to Senior Liquidity Provider (DZ Bank), (5) pay portfolio or note operating fees or costs, (6) pay trustee (Wells Fargo Bank, N.A.), (7) pay servicer and collateral fees, (8) pay principal and interest on Series I Secured notes, (9) make distributions to equity holders for tax liability related to portfolio, (10) purchase interest rate caps, swaps, or hedging instruments, (11) pay GWG Series I Trustee fees, and (12) pay offering expenses.

On November 1, 2011, GWG entered into a Third Amended and Restated Note Issuance and Security Agreement with Lord Securities Corporation after receiving majority approval from the holders of Series I Secured notes. Among other things, the amended and restated agreement modified the use of proceeds and certain provisions relating to the distribution of collections and subordination of cash flow. Under the amended and restated agreement, GWG is no longer restricted as to its use of proceeds or subject to restrictions on certain distributions of collections and subordination of cash flows. 

Future contractual maturities of Series I Secured notes payable at June 30, 2013 are as follows:

Years Ending December 31,
Six months ending December 31, 2013	$	9,358,000
2014		12,561,000
2015		6,675,000
2016		1,802,000
2017		4,085,000
Thereafter		818,000
	$	35,299,000

XML

Nature of Business and Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		6 Months Ended			0 Months Ended			1 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012	Jul. 11, 2011 Purchase and Sale Agreement [Member]	Jun. 28, 2013 Athena Securities Group Ltd [Member] Purchase and Sale Agreement [Member]	Jul. 11, 2011 Athena Securities Group Ltd [Member] Purchase and Sale Agreement [Member]	Jul. 31, 2011 Series A 10 % convertible Preferred Stock [Member]
Nature of Business and Summary of Significant Accounting Policies (Textual)
Shares of common stock issued							865,000	989,000
Terms for acquisition of equity interest in subsidiary						Holdings issued to Athena Securities Group, LTD (Athena) 989,000 shares of common stock, which was equal to 9.9% of the outstanding shares in the Company in exchange for shares equal to 9.9% of the outstanding shares in Athena Structured Funds, PLC (Athena Funds) and cash of $5,000.
Amount of cash paid under acquisition terms								$ 5,000
Total value of common stock issued								3,600,000
Issuance of common stock	(3,252,400)		(3,252,400)					5,000	5,000,000
Non cash gain recorded pursuant to securities sale purchase agreement							3,252,000
Deposits and direct cost advances	431,000		431,000		785,000
Amortization of deferred financing costs	89,000	58,000	276,000	116,000
Future amortization of Financing cost for year ending December 31, 2013	179,000		179,000
Future amortization of Financing cost for year ending December 31, 2014	$ 358,000		$ 358,000
Redemption Period for amortization of discount related to financing cost			3 years

XML

Credit Facilities (Details) (USD $)	0 Months Ended		3 Months Ended		6 Months Ended
	Jan. 29, 2013	Jul. 15, 2008	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Credit Facilities (Textual)
Maximum borrowing amount under line of credit facility		$ 100,000,000
Expiry date of line of credit		Jul. 15, 2013
Extended date of line of credit facility	Dec. 31, 2014
Amount outstanding under line of credit facility			79,000,000		79,000,000		71,000,000
Effective rate of interest			6.27%		6.27%		2.02%
Weighted average effective interest rate			6.26%	2.12%	6.06%	2.19%
Minimum tangible net worth to be maintained by company					15,000,000
Consolidated net income under credit and security agreement					5,905,000
Consolidated tangible net worth under credit and security agreement					44,233,000
Total funds available for additional borrowings under the borrowing base formula criteria			$ 667,000		$ 667,000		$ 15,043,000

XML

Income Taxes

6 Months Ended

Jun. 30, 2013

Income Taxes [Abstract]

Income taxes

(10)       Income taxes

For the three and six months ended June 30, 2013, the Company recorded income tax expense of $1,802,000 and $2,368,000, or 50.6% and 56.5%, respectively, of income before taxes, compared to the recognition of an income tax expense of $610,000, or 66.9% for the three months ended June 30, 2012 and recognizing an income tax benefit of $530,000, or 22.3% for the six months ended June 30, 2012.  The primary differences between the Company’s June 30, 2013 effective tax rate and the statutory federal rate are the accrual of preferred stock dividend expense, state taxes, and other non-deductible expenses.

 The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

XML

Credit Facilities

6 Months Ended

Jun. 30, 2013

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures [Abstract]

Credit facilities

( 6 )       Credit facilities

Revolving credit facility – Autobahn Funding Company LLC

On July 15, 2008, DLP II and United Lending entered into a revolving credit facility pursuant to a Credit and Security Agreement (Agreement) with Autobahn Funding Company LLC (Autobahn), providing the Company with a maximum borrowing amount of $100,000,000. Autobahn is a commercial paper conduit that issues commercial paper to investors in order to provide funding to DLP II and United Lending.  DZ Bank AG acts as the agent for Autobahn. The original Agreement was to expire on July 15, 2013.  On January 29, 2013, Holdings, together with GWG Life and DLP II, entered into an Amended and Restated Credit and Security Agreement with Autobahn, extending the facility expiration date to December 31, 2014, and removing United Lending as a party to the amended and restated Agreement.  The amount outstanding under this facility as of June 30, 2013 and December 31, 2012, was $79,000,000 and $71,000,000, respectively.

The Agreement requires DLP II to pay, on a monthly basis, interest at the commercial paper rate plus an applicable margin, as defined in the Agreement. The effective rate was 6.27% and 2.02% at June 30, 2013 and December 31, 2012, respectively.  The weighted-average effective interest rate was 6.26% and 2.12% (excluding the unused line fee) for the three months ended June 30, 2013 and 2012, respectively, and 6.06% and 2.19% for the six months ended June 30, 2013 and 2012, respectively.  The Agreement also requires payment of an unused line fee on the unfunded amount under the revolving credit facility. The note is secured by substantially all of DLP II assets, which consist primarily of life settlement policies.

The Agreement has certain financial and nonfinancial covenants. The Company was in compliance with these covenants at June 30, 2013 and December 31, 2012. The Agreement generally prohibits the Company from:

● changing its corporate name, offices, and jurisdiction of incorporation

● changing any deposit accounts or payment instructions to insurers;

● changing any operating policies and practices such that it would be reasonably likely to adversely affect the collectability of any asset in any material respect;

● merging or consolidating with, or selling all or substantially all of its assets to, any third party;

● selling any collateral or creating or permitting to exist any adverse claim upon any collateral;

● engaging in any other business or activity than that contemplated by the Agreement;

● incurring or guaranteeing any debt for borrowed money;

● amending the Company’s certificate of incorporation or bylaws, making any loans or advances to, investments in, or paying any dividends to, any person unless both before and after any such loan, advance, investment or dividend there exists no actual event of default, potential event of default or termination event;

● removing an independent director on the board of directors except for cause or with the consent of the lender; or

● making payment on or issuing any subsidiary secured notes or debentures, or amending any agreements respecting such notes or debentures, if an event of default, potential event of default or termination event exists or would arise from any such action.

In addition, the Company has agreed to maintain (i) a positive consolidated net income (as defined and calculated under the Agreement) for each complete fiscal year and (ii) a tangible net worth (again, as defined and calculated under the Agreement) of not less than $15 million, and (iii) maintain a borrowing base surplus or cash cushion sufficient to pay three to twelve months (increasing throughout 2013) of premiums and facility fees.

Consolidated net income and tangible net worth as of and for the 4 quarter period ended June 30, 2013, as calculated under the agreement, were $5,905,000 and $44,233,000, respectively.

Advances under the Agreement are subject to a borrowing base formula, which limits the availability of advances on the borrowing base calculation based on attributes of policies pledged to the facility. Over-concentration of policies by insurance carrier, over-concentration of policies by insurance carriers with ratings below a AA- rating, and the premiums and facility fees reserve are the three primary factors with the potential of limiting availability of funds on the facility. Total funds available for additional borrowings under the borrowing base formula criteria at June 30, 2013 and December 31, 2012, were $667,000 and $15,043,000 respectively.

On July 15, 2008, Holdings delivered a performance guaranty in favor of Autobahn pursuant to which it guaranteed the obligations of GWG Life, in its capacity as the seller and master servicer, under the Credit and Security Agreement and related documents.  On January 29, 2013 and in connection with the Amended and Restated Credit and Security Agreement, Holdings delivered a reaffirmation of its performance guaranty.  The obligations of Holdings under the performance guaranty and subsequent reaffirmation do not extend to the principal and interest owed by DLP II as the borrower under the credit facility.

XML

Nature of Business and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2013

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Nature of business and summary of significant accounting policies

( 1 )       Nature of business and summary of significant accounting policies

Nature of business - GWG Holdings, Inc. (Holdings) (previously GWG Holdings, LLC) and Subsidiaries, located in Minneapolis, Minnesota, facilitates the purchase of life insurance policies for its own investment portfolio through its wholly owned subsidiary, GWG Life Settlements, LLC (GWG Life), and its subsidiaries, GWG Trust, LLC (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II). Holdings converted from a limited liability company into a corporation effective June 10, 2011 and as a result of this change all member units were converted into common stock.  Holdings finances the acquisition of life insurance policies, and pays policy premiums, through funds available on its line of credit and the issuance of debt and equity securities. GWG Member, LLC a wholly owned subsidiary formed November 2010 to facilitate the acquisition of policies, has not commenced operations as of June 30, 2013.  The entities were legally organized in Delaware and are collectively referred herein to as GWG, or the Company.

On July 11, 2011 the Company entered into a Purchase and Sale Agreement with Athena Securities Group, LTD and Athena Structured Funds PLC. Under this agreement, Holdings issued to Athena Securities Group, LTD (Athena) 989,000 shares of common stock, which was equal to 9.9% of the outstanding shares in the Company in exchange for shares equal to 9.9% of the outstanding shares in Athena Structured Funds, PLC (Athena Funds) and cash of $5,000. In accordance with Accounting Standards Codification (ASC) 505-50, the Company recorded the share-based payment transaction with Athena at the fair value of the Company’s 989,000 shares of common stock issued as it was the most reliable measurable form of consideration in this exchange the total value ascribed to the common stock issued to Athena was $3.6 million. The $5,000 cash paid by Athena, which represents the fair value of the shares of Athena Funds, is included in financing activities of the Consolidated Statement of Cash Flows.

On June 28, 2013, GWG Holdings, Inc. entered into a new Purchase and Sale Agreement with Athena Securities Limited and Athena Securities Group Limited. The June 28, 2013 agreement terminated the parties’ original Purchase and Sale Agreement dated July 11, 2011. Under the new agreement, GWG Holdings appointed Athena Securities Group Limited (i) as GWG Holdings’ exclusive representative for the offer and sale of GWG Holdings’ Renewable Secured Debentures in Ireland, and (ii) as a distributor for the offer and sale of those debentures in Europe and the Middle East, in each case until May 8, 2014. Any compensation payable to Athena Securities Group Limited will be in accordance with the compensation disclosures set forth in GWG Holdings’ prospectus for the offering filed with the SEC on dated June 4, 2013. In addition, the new agreement effected the sale by Athena Securities Limited to GWG Holdings of 865,000 shares of GWG Holdings’ common stock, and GWG Holdings’ sale back to Athena Securities Group Limited of certain shares of GWG Securities International Public Limited Company (formerly known as Athena Structured Funds PLC) originally transacted under the original July 11, 2011 agreement. The Company recorded a non-cash gain on the transaction of $3,252,000.

Basis of presentation - The condensed consolidated balance sheet as of June 30, 2013 and December 31, 2012, the condensed consolidated statements of operations for the three and six months ended June 30, 2013 and 2012, the condensed consolidated statements of cash flows for the three and six months ended June 30, 2013 and 2012, the condensed consolidated statement of changes in equity for the twelve months ended December 31, 2012 and six months ended June 30, 2013, and the related information presented in these notes, have been prepared by management in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, without audit. To the extent that information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements are contained in or are consistent with the consolidated audited financial statements in the Company’s Form 10-K for the year ended December 31, 2012, such information and notes have not been duplicated herein. In the opinion of management, all adjustments considered necessary for a fair presentation of results have been included. The condensed consolidated balance sheet at December 31, 2012 was derived from the audited consolidated financial statements as of that date. Operating results for the three and six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1)  the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1)           Receipt of death notice or verified obituary of insured

2)           Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized.  In an event of a sale of a policy the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company.  Such deposits and direct cost advances were $431,000 and $785,000 at June 30, 2013 and December 31, 2012, respectively.

Deferred financing and issuance costs – Financing costs incurred to obtain financing under the revolving credit facility, as described in note 6, have been capitalized and are amortized using the straight-line method (which approximated the interest method) over the term of the revolving credit facility.  Amortization of deferred financing costs was $89,000 and $58,000 for the three months ended June 30, 2013 and 2012, respectively, and $276,000 and $116,000 for the six months ended June 30, 2013 and 2012, respectively.  The future amortization is $179,000 and $358,000 for the six months ending December 31, 2013 and the year ending December 31, 2014, respectively.  The Series I Secured notes payable, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Renewable Secured Debentures, as described in note 8, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Series A preferred stock, as described in note 9, is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Earnings (loss) per share – Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period.  Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock and outstanding warrants.

Recently adopted pronouncements - In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS”, which amends disclosure requirements related to categorization within the fair value hierarchy. This update results in common principles and requirements for measuring fair value and disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. The guidance became effective for the annual period beginning January 1, 2012. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company.

XML

Guarantees of Secured Debentures (Details) (USD $)	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011
ASSETS
Cash and cash equivalents	$ 38,240,633	$ 34,551,582	$ 27,497,044	$ 11,094,825	$ 4,548,765	$ 1,878,349
Restricted cash	4,463,867		2,093,092
Investment in life settlements, at fair value	193,891,894		164,317,183
Other assets	7,041,894		4,040,716
Investment in subsidiaries
TOTAL ASSETS	243,638,288		197,948,035
LIABILITIES
Revolving credit facility	79,000,000		71,000,000
Series I Secured notes payable	34,505,914		37,844,711
Renewable secured debentures	93,684,735		55,718,950
Interest payable	5,771,063		3,477,320
Accounts payable and accrued expenses	1,642,728		1,761,558
Deferred taxes, net	7,868,201		5,501,407
TOTAL LIABILITIES	222,472,641		175,303,946
CONVERTIBLE, REDEEMABLE PREFERRED STOCK	24,322,651		23,905,878
EQUITY (DEFICIT)
Member capital
Common stock	9,124		9,989
Additional paid-in capital	3,253,670		6,971,844
Accumulated deficit	(6,419,798)		(8,243,622)
TOTAL EQUITY (DEFICIT)	(3,157,004)		(1,261,789)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	243,638,288		197,948,035
Parent [Member]
ASSETS
Cash and cash equivalents	36,989,169	28,548,313	25,035,579	10,663,831	4,381,376	1,746,456
Restricted cash
Investment in life settlements, at fair value
Other assets	263,555		96,994
Investment in subsidiaries	88,702,942		60,608,585
TOTAL ASSETS	125,955,666		85,741,158
LIABILITIES
Revolving credit facility
Series I Secured notes payable
Renewable secured debentures	93,684,735		55,718,950
Interest payable	2,577,524		905,017
Accounts payable and accrued expenses	659,559		971,695
Deferred taxes, net	7,868,201		5,501,407
TOTAL LIABILITIES	104,790,019		63,097,069
CONVERTIBLE, REDEEMABLE PREFERRED STOCK	24,322,651		23,905,878
EQUITY (DEFICIT)
Member capital
Common stock	9,124		9,989
Additional paid-in capital	3,253,670		6,971,844
Accumulated deficit	(6,419,798)		(8,243,622)
TOTAL EQUITY (DEFICIT)	(3,157,004)		(1,261,789)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	125,955,666		85,741,158
Guarantor Sub [Member]
ASSETS
Cash and cash equivalents	1,251,464	6,003,269	2,461,465	430,994	167,389	131,893
Restricted cash	2,501,500		1,748,700
Investment in life settlements, at fair value
Other assets	328,363		211,592
Investment in subsidiaries	122,020,978		96,914,613
TOTAL ASSETS	126,102,305		101,336,370
LIABILITIES
Revolving credit facility
Series I Secured notes payable	34,505,914		37,844,711
Renewable secured debentures
Interest payable	2,686,747		2,444,097
Accounts payable and accrued expenses	206,702		490,497
Deferred taxes, net
TOTAL LIABILITIES	37,399,363		40,776,305
CONVERTIBLE, REDEEMABLE PREFERRED STOCK
EQUITY (DEFICIT)
Member capital	88,702,942		60,560,065
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL EQUITY (DEFICIT)	88,702,942		60,560,065
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	126,102,305		101,336,370
Non-Guarantor Sub [Member]
ASSETS
Cash and cash equivalents
Restricted cash	1,962,367		344,392
Investment in life settlements, at fair value	193,891,894		164,317,183
Other assets	6,449,976		3,732,130
Investment in subsidiaries
TOTAL ASSETS	202,304,237		168,393,705
LIABILITIES
Revolving credit facility	79,000,000		71,000,000
Series I Secured notes payable
Renewable secured debentures
Interest payable	506,792		128,206
Accounts payable and accrued expenses	776,467		302,366
Deferred taxes, net
TOTAL LIABILITIES	80,283,259		71,430,572
CONVERTIBLE, REDEEMABLE PREFERRED STOCK
EQUITY (DEFICIT)
Member capital	122,020,978		96,963,133
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL EQUITY (DEFICIT)	122,020,978		96,963,133
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	202,304,237		168,393,705
Eliminations [Member]
ASSETS
Cash and cash equivalents
Restricted cash
Investment in life settlements, at fair value
Other assets
Investment in subsidiaries	(210,723,920)		(157,523,198)
TOTAL ASSETS	(210,723,920)		(157,523,198)
LIABILITIES
Revolving credit facility
Series I Secured notes payable
Renewable secured debentures
Interest payable
Accounts payable and accrued expenses
Deferred taxes, net
TOTAL LIABILITIES
CONVERTIBLE, REDEEMABLE PREFERRED STOCK
EQUITY (DEFICIT)
Member capital	(210,723,920)		(157,523,198)
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL EQUITY (DEFICIT)	(210,723,920)		(157,523,198)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ (210,723,920)		$ (157,523,198)

XML

Convertible, Redeemable Preferred Stock (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended	0 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012	Sep. 02, 2012 Series A 10 % convertible Preferred Stock [Member]	Jun. 30, 2013 Series A 10 % convertible Preferred Stock [Member]
Convertible, Redeemable Preferred Stock (Textual)
Series A preferred stock shares sold for cash						3,278,000
Consideration received on sale of Series A preferred stock						$ 24,582,000
Series A preferred stock shares issued in conversion of dividends							121,000
Series A preferred stock value issued in conversion of dividends							846,000
Conversion term for series A preferred stock							Each share has the right to convert into 1.5 shares of the Company's common stock.
Maturity period of warrant			3 years
Exercise price of warrants			$ 6.25
Conversion of Series A preferred stock into common stock, description			One share of common stock for every 20 shares of Series A preferred stock purchased.
Redemption price of preferred shares			Stated value of $7.50 per share, plus accrued dividends.
Percentage of unredeemed shares redeemed one year after issuance			33.00%
Percentage of unredeemed shares redeemed two year after issuance			66.00%
Percentage of unredeemed shares redeemed three year after issuance			100.00%
Redemption price of shares			The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time after December 15, 2012.
Number of Series A preferred shares redeemed			43,000
Shareholder redemptions of Series A preferred shares			322,000
Number of shares outstanding after redemption			3,357,000
Value of shares outstanding after redemption			25,115,000
Preferred stock, liquidation preference per share	$ 7.50		$ 7.50
Minimum offering price of common stock			$ 5.50
Preferred Stock, Shares Issued	3,400,000		3,400,000
Proceeds from issuance of convertible preferred stock			25,437,000
Series A preferred stock issuance costs	2,838,000		2,838,000
Amortization of stock issuance costs			2,045,000
Net preferred stock capital balance	24,323,000		24,323,000
Fair value of outstanding warrants attached to Series A preferred stock			395,000
Term of redemption of warrants prior to expiration			The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted average sale price per share of common stock equals or exceeds $7.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.
Warrant outstanding	831,909		831,909		831,909
Weighted average remaining life of warrants outstanding			1 year 10 months 6 days		2 years 4 months 2 days
Declared and accrued dividends	628,000	573,000	1,263,000	990,000
Cash dividend rate, per share			$ 7.00
Preferred stock issued in lieu of cash dividend	25,000	20,000	37,000	35,000
Accrued preferred dividend	$ 627,000		$ 627,000
Payable date of accrued preferred dividends			Jul. 15, 2013

XML

Investment in Life Insurance Policies (Details 1) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Summary of reconciliation of gain on life settlements
Change in fair value	$ 7,449,000	$ 4,576,000	$ 18,944,000	$ 9,367,000
Premiums and other annual fees	(4,934,000)	(3,792,000)	(10,598,000)	(7,981,000)
Policy maturities	5,218,000	4,083,000	7,728,000	4,083,000
Gain on life settlements, net	$ 7,733,000	$ 4,867,000	$ 16,074,000	$ 5,469,000

XML

Contingencies

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies [Abstract]

Contingencies

( 13 )     Contingencies

Litigation - In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from such proceedings would not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Opportunity Finance, LLC, owned by Jon Sabes and Steven Sabes, is subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments that may have been deemed preference payments. In addition, Jon Sabes and Steven Sabes are subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments received from Opportunity Finance that may have been deemed preference payments. If the parties are unsuccessful in defending against these claims, their equity ownership in the Company may be sold or transferred to other parties to satisfy such claims. In addition, the Company loaned $1,000,000 to Opportunity Finance, LLC in 2006, and was repaid in full plus interest of $177,000. This investment amount may also be subject to clawback claims by the bankruptcy court. These matters may also distract management and reduce the time and attention that they are able to devote to the Company’s operations.

XML

Convertible, Redeemable Preferred Stock

6 Months Ended

Jun. 30, 2013

Convertible, Redeemable Preferred Stock [Abstract]

Convertible, redeemable preferred stock

( 9 )       Convertible, redeemable preferred stock

The Company began offering 3,333,333 shares of convertible redeemable preferred stock (Series A preferred stock) for sale to accredited investors in a private placement on July 31, 2011. The offering of Series A preferred stock concluded on September 2, 2012 and resulted in 3,278,000 shares being issued for gross consideration of $24,582,000. As of June 30, 2013, 121,000 shares have been issued as a result of conversion of $846,000 in dividends into shares of Series A preferred stock.  The Series A preferred stock was sold at an offering price of $7.50 per share. Series A preferred stock has a preferred yield of 10% per annum, and each share has the right to convert into 1.5 shares of the Company’s common stock. The Company may elect to automatically convert the Series A preferred stock to common stock as described below. Series A preferred shareholders also received three-year warrants to purchase, at an exercise price per share of $6.25, one share of common stock for every 20 shares of Series A preferred stock purchased.  The warrants are exercisable immediately. In the Certificate of Designations for the Series A preferred stock dated July 31, 2011, the Company has agreed to permit preferred shareholders to sell their shares back to the Company for the stated value of $7.50 per share, plus accrued dividends, according to the following schedule:

● Up to 33% of the holder’s unredeemed shares one year after issuance:

● Up to 66% of the holder’s unredeemed shares two years after issuance; and

● Up to 100% of the holder’s unredeemed shares three years after issuance.

The Company’s obligation to redeem Series A preferred shares will terminate upon the Company completing a registration of its common stock with the SEC. The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time after December 15, 2012.

At the election of the Company, the Series A preferred shares may be automatically converted into the common stock of the Company in the event of either (1) a registered offering of the Company’s common stock with the SEC aggregating gross proceeds of at least $5.0 million at a price equal to or greater than $5.50 per share of common stock, or (2) the consent of shareholders holding at least a majority of the then-outstanding shares of Series A preferred stock. As of June 30, 2013, the Company had issued 3,400,000 preferred shares resulting in gross consideration of $25,437,000 (including cash proceeds, conversion of Series I Secured notes and accrued interest on Series I notes, and conversion of preferred dividends payable). In 2013, the Company redeemed 43,000 shares valued at $322,000 resulting in 3,357,000 shares outstanding with the gross value of $25,115,000. The Company incurred Series A preferred stock issuance costs of $2,838,000, of which $2,045,000 was amortized to additional paid in capital as of June 30, 2013, resulting in a carrying amount of $24,323,000.

The Company determined that the grant date fair value of the outstanding warrants attached to the Series A preferred stock was $395,000 for warrants issued through June 30, 2013. The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted average sale price per share of common stock equals or exceeds $7.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption. Total warrants outstanding as of June 30, 2013, were 831,909 with a weighted average remaining life of 1.85 years. Total warrants outstanding at December 31, 2012, were 831,909 with a weighted average remaining life of 2.34 years.

Dividends on the Series A preferred stock may be paid in either cash or additional shares of Series A preferred stock at the election of the holder and approval of the Company. The dividends are reported as an expense and included in the caption interest expense in the consolidated statements of operations.

The Company declared and accrued dividends of $628,000 and $573,000 during the three months ended June 30, 2013 and 2012, respectively, and $1,263,000 and $990,000 during the six months ended June 30, 2013 and 2012, respectively, pursuant to a board resolution declaring the dividend.  25,000 and 20,000 shares of Series A preferred stock were issued in lieu of cash dividends in the three month periods ended June 30, 2013 and 2012, and 37,000 and 35,000 shares of Series A preferred stock were issued in lieu of cash dividends in the six month periods ended June 30, 2013 and 2012 respectively. The shares issued in lieu of cash dividends were issued at $7.00 per share.  As of June 30, 2013, Holdings has $628,000 of accrued preferred dividends which were paid or converted to shares of Series A preferred stock on July 15, 2013.

XML

Nature of Business and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2013

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Nature of business

Nature of business - GWG Holdings, Inc. (Holdings) (previously GWG Holdings, LLC) and Subsidiaries, located in Minneapolis, Minnesota, facilitates the purchase of life insurance policies for its own investment portfolio through its wholly owned subsidiary, GWG Life Settlements, LLC (GWG Life), and its subsidiaries, GWG Trust, LLC (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II). Holdings converted from a limited liability company into a corporation effective June 10, 2011 and as a result of this change all member units were converted into common stock.  Holdings finances the acquisition of life insurance policies, and pays policy premiums, through funds available on its line of credit and the issuance of debt and equity securities. GWG Member, LLC a wholly owned subsidiary formed November 2010 to facilitate the acquisition of policies, has not commenced operations as of June 30, 2013.  The entities were legally organized in Delaware and are collectively referred herein to as GWG, or the Company.

On July 11, 2011 the Company entered into a Purchase and Sale Agreement with Athena Securities Group, LTD and Athena Structured Funds PLC. Under this agreement, Holdings issued to Athena Securities Group, LTD (Athena) 989,000 shares of common stock, which was equal to 9.9% of the outstanding shares in the Company in exchange for shares equal to 9.9% of the outstanding shares in Athena Structured Funds, PLC (Athena Funds) and cash of $5,000. In accordance with Accounting Standards Codification (ASC) 505-50, the Company recorded the share-based payment transaction with Athena at the fair value of the Company’s 989,000 shares of common stock issued as it was the most reliable measurable form of consideration in this exchange the total value ascribed to the common stock issued to Athena was $3.6 million. The $5,000 cash paid by Athena, which represents the fair value of the shares of Athena Funds, is included in financing activities of the Consolidated Statement of Cash Flows.

On June 28, 2013, GWG Holdings, Inc. entered into a new Purchase and Sale Agreement with Athena Securities Limited and Athena Securities Group Limited. The June 28, 2013 agreement terminated the parties’ original Purchase and Sale Agreement dated July 11, 2011. Under the new agreement, GWG Holdings appointed Athena Securities Group Limited (i) as GWG Holdings’ exclusive representative for the offer and sale of GWG Holdings’ Renewable Secured Debentures in Ireland, and (ii) as a distributor for the offer and sale of those debentures in Europe and the Middle East, in each case until May 8, 2014. Any compensation payable to Athena Securities Group Limited will be in accordance with the compensation disclosures set forth in GWG Holdings’ prospectus for the offering filed with the SEC on dated June 4, 2013. In addition, the new agreement effected the sale by Athena Securities Limited to GWG Holdings of 865,000 shares of GWG Holdings’ common stock, and GWG Holdings’ sale back to Athena Securities Group Limited of certain shares of GWG Securities International Public Limited Company (formerly known as Athena Structured Funds PLC) originally transacted under the original July 11, 2011 agreement. The Company recorded a non-cash gain on the transaction of $3,252,000.

Basis of presentation

Basis of presentation - The condensed consolidated balance sheet as of June 30, 2013 and December 31, 2012, the condensed consolidated statements of operations for the three and six months ended June 30, 2013 and 2012, the condensed consolidated statements of cash flows for the three and six months ended June 30, 2013 and 2012, the condensed consolidated statement of changes in equity for the twelve months ended December 31, 2012 and six months ended June 30, 2013, and the related information presented in these notes, have been prepared by management in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, without audit. To the extent that information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements are contained in or are consistent with the consolidated audited financial statements in the Company’s Form 10-K for the year ended December 31, 2012, such information and notes have not been duplicated herein. In the opinion of management, all adjustments considered necessary for a fair presentation of results have been included. The condensed consolidated balance sheet at December 31, 2012 was derived from the audited consolidated financial statements as of that date. Operating results for the three and six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Use of estimates

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1)  the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Life settlements

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1)           Receipt of death notice or verified obituary of insured

2)           Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized.  In an event of a sale of a policy the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company.  Such deposits and direct cost advances were $431,000 and $785,000 at June 30, 2013 and December 31, 2012, respectively.

Deferred financing and issuance costs

Deferred financing and issuance costs – Financing costs incurred to obtain financing under the revolving credit facility, as described in note 6, have been capitalized and are amortized using the straight-line method (which approximated the interest method) over the term of the revolving credit facility.  Amortization of deferred financing costs was $89,000 and $58,000 for the three months ended June 30, 2013 and 2012, respectively, and $276,000 and $116,000 for the six months ended June 30, 2013 and 2012, respectively.  The future amortization is $179,000 and $358,000 for the six months ending December 31, 2013 and the year ending December 31, 2014, respectively.  The Series I Secured notes payable, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Renewable Secured Debentures, as described in note 8, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing.  The Series A preferred stock, as described in note 9, is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Earnings (loss) per share

Earnings (loss) per share – Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period.  Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock and outstanding warrants.

Recently adopted pronouncements

Recently adopted pronouncements - In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS”, which amends disclosure requirements related to categorization within the fair value hierarchy. This update results in common principles and requirements for measuring fair value and disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. The guidance became effective for the annual period beginning January 1, 2012. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company.

XML

Guarantees of Secured Debentures

6 Months Ended

Jun. 30, 2013

Guarantees of Secured Debentures [Abstract]

Guarantees of secured debentures

( 14 )     Guarantees of secured debentures

Holdings has registered with the Securities and Exchange Commission the offer and sale $250,000,000 of secured debentures as described in note 8. The secured debentures are secured by the assets of Holdings as described in note 8 and a pledge of all the common stock by the largest shareholders. Obligations under the debentures are guaranteed by Holding’s subsidiary GWG Life. This guarantee involves the grant of a security interest in all the assets of GWG Life. GWG Life is a wholly owned subsidiary of Holdings and the payment of principal and interest on the secured debentures is fully and unconditionally guaranteed by GWG Life. Substantially all of the Company’s life insurance policies are held by DLP II, a wholly owned subsidiary of GWG Life. The policies held by DLP II are not collateral for the debenture obligations as such policies are collateral for the credit facility.

The consolidating financial statements are presented in lieu of separate financial statements and other related disclosures of the subsidiary guarantors and issuer because management does not believe that separate financial statements and related disclosures would be material to investors. There are currently no significant restrictions on the ability of Holdings or GWG Life, the guarantor subsidiary, to obtain funds from its subsidiaries by dividend or loan, except as follows. DLP II is a borrower under a credit agreement with Autobahn, with DZ Bank AG as agent, as described in note 6. The significant majority of insurance policies owned by the Company are subject to a collateral arrangement with DZ Bank AG described in notes 3 and 6. Under this arrangement, collection and escrow accounts are used to fund premiums of the insurance policies and to pay interest and other charges under the revolving credit facility. DZ Bank AG and Autobahn must authorize all disbursements from these accounts, including any distributions to GWG Life. Distributions are limited to an amount that would result in the borrowers (GWG DLP Funding II, LLC, GWG Life Settlements, LLC, and GWG Holdings, Inc.) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by DZ Bank AG. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made.

The following represents consolidating financial information as of June 30, 2013 and December 31, 2012, with respect to the financial position, and for the three and six months ended June 30, 2013 and 2012 with respect to results of operations and cash flows of Holdings and its subsidiaries. The parent column presents the financial information of Holdings, the primary obligor of the secured debentures. The guarantor subsidiary column presents the financial information of GWG Life, the guarantor subsidiary of the secured debentures, presenting its investment in DLP II and Trust under the equity method. The non-guarantor subsidiaries column presents the financial information of all non-guarantor subsidiaries including DLP II and Trust.

Condensed Consolidating Balance Sheets

June 30, 2013	Parent				Guarantor Sub			Non-Guarantor Sub			Eliminations				Consolidated
A S S E T S
Cash and cash equivalents		$	36,989,169			$	1,251,464		$	-		$	-			$	38,240,633
Restricted cash			-				2,501,500			1,962,367			-				4,463,867
Investment in life settlements, at fair value			-				-			193,891,894			-				193,891,894
Other assets			263,555				328,363			6,449,976			-				7,041,894
Investment in subsidiaries			88,702,942				122,020,978			-			(210,723,920	)			-
TOTAL ASSETS		$	125,955,666			$	126,102,305		$	202,304,237		$	(210,723,920	)		$	243,638,288
L I A B I L I T I E S & S T O C K H O L D E R S ' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility		$	-			$	-		$	79,000,000		$	-			$	79,000,000
Series I Secured notes payable			-				34,505,914			-			-				34,505,914
Secured renewable debentures			93,684,735				-			-							93,684,735
Interest payable			2,577,524				2,686,747			506,792			-				5,771,063
Accounts payable and accrued expenses			659,559				206,702			776,467			-				1,642,728
Deferred taxes, net			7,868,201				-			-			-				7,868,201
TOTAL LIABILITIES			104,790,019				37,399,363			80,283,259			-				222,472,641
CONVERTIBLE, REDEEMABLE PREFERRED STOCK			24,322,651				-			-			-				24,322,651
EQUITY (DEFICIT)
Member capital			-				88,702,942			122,020,978			(210,723,920	)			-
Common stock			9,124				-			-			-				9,124
Additional paid-in capital			3,253,670				-			-			-				3,253,670
Accumulated deficit			(6,419,798	)			-			-			-				(6,419,798	)
TOTAL EQUITY (DEFICIT)			(3,157,004	)			88,702,942			122,020,978			(210,723,920	)			(3,157,004	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)		$	125,955,666			$	126,102,305		$	202,304,237		$	(210,723,920	)		$	243,638,288

December 31, 2012	Parent				Guarantor Sub			Non-Guarantor Sub			Eliminations				Consolidated
A S S E T S
Cash and cash equivalents		$	25,035,579			$	2,461,465		$	-		$	-			$	27,497,044
Restricted cash			-				1,748,700			344,392							2,093,092
Investment in life settlements, at fair  value			-				-			164,317,183			-				164,317,183
Other assets			96,994				211,592			3,732,130			-				4,040,716
Investment in subsidiaries			60,608,585				96,914,613			-			(157,523,198	)			-
TOTAL ASSETS		$	85,741,158			$	101,336,370		$	168,393,705		$	(157,523,198	)		$	197,948,035
L I A B I L I T I E S & S T O C K H O L D E R S ' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility		$	-			$	-		$	71,000,000		$	-			$	71,000,000
Series I Secured notes payable			-				37,844,711			-			-				37,844,711
Secured renewable debentures			55,718,950				-			-							55,718,950
Interest payable			905,017				2,444,097			128,206			-				3,477,320
Accounts payable and accrued expenses			971,695				490,497			302,366			-				1,761,558
Deferred taxes, net			5,501,407				-			-			-				5,501,407
TOTAL LIABILITIES			63,097,069				40,776,305			71,430,572			-				175,303,946
CONVERTIBLE, REDEEMABLE PREFERRED STOCK			23,905,878				-			-			-				23,905,878
EQUITY (DEFICIT)
Member capital			-				60,560,065			96,963,133			(157,523,198	)			-
Common stock			9,989				-			-			-				9,989
Additional paid-in capital			6,971,844				-			-			-				6,971,844
Accumulated deficit			(8,243,622	)			-			-			-				(8,243,622	)
TOTAL EQUITY (DEFICIT)			(1,261,789	)			60,560,065			96,963,133			(157,523,198	)			(1,261,789	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)		$	85,741,158			$	101,336,370		$	168,393,705		$	(157,523,198	)		$	197,948,035

Condensed Consolidating Statements of Operations

For the six months ended June 30, 2013	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	1,814,202		$	-	$	(1,814,202	)	$	-
Gain on life settlements, net		-			-			16,073,601		-			16,073,601
Interest and other income		3,267,454			977,855			37,620		(840,935	)		3,441,994
TOTAL REVENUE		3,267,454			2,792,057			16,111,221		(2,655,137	)		19,515,595
EXPENSES
Origination and servicing fees		-			-			1,814,202		(1,814,202	)		-
Employee compensation and benefits		2,213,056			788,287			-		-			3,001,343
Legal and professional fees		672,317			116,883			-		-			789,200
Interest expense		4,976,599			1,849,861			2,582,697		-			9,409,157
Other expenses		1,283,269			816,009			865,934		(840,935	)		2,124,277
TOTAL EXPENSES		9,145,241			3,571,040			5,262,833		(2,655,137	)		15,323,977
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(5,877,787	)		(778,983	)		10,848,388		-			4,191,618
EQUITY IN INCOME OF SUBSIDIARIES		10,069,405			10,896,907			10,848,388		(20,966,312	)		-
INCOME BEFORE INCOME TAXES		4,191,618			10,117,924			10,848,388		(20,966,312	)		4,191,618
INCOME TAX EXPENSE		2,367,794			-			-		-			2,367,794
NET INCOME	$	1,823,824		$	10,117,924		$	10,848,388	$	(20,966,312	)	$	1,823,824

For the six months ended June 30, 2012	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	438,250		$	-	$	(438,250	)	$	-
Gain on life settlements, net		-			229,277			5,239,969		-			5,469,246
Interest and other income		3,049			3,192			42,653		-			48,894
TOTAL REVENUE		3,049			670,719			5,282,622		(438,250	)		5,518,140
EXPENSES
Origination and servicing fees		-			(6,500	)		444,750		(438,250	)		-
Employee compensation and benefits		-			1,117,084			-		-			1,117,084
Legal and professional fees		655,600			45,803			-		-			701,403
Interest expense		1,268,211			2,696,548			853,232		-			4,817,991
Other expenses		534,100			703,552			25,000		-			1,262,652
TOTAL EXPENSES		2,457,911			4,556,487			1,322,982		(438,250	)		7,899,130
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(2,454,862	)		(3,885,768	)		3,959,640		-			(2,380,990	)
EQUITY IN INCOME OF SUBSIDIARIES		73,872			4,017,864			-		(4,091,736	)		-
INCOME BEFORE INCOME TAXES		(2,380,990	)		132,096			3,959,640		(4,091,736	)		(2,380,990	)
INCOME TAX BENEFIT		(529,860	)		-			-		-			(529,860	)
NET INCOME (LOSS)	$	(1,851,130	)	$	132,096		$	3,959,640	$	(4,091,736	)	$	(1,851,130	)

For the three months ended June 30, 2013	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	536,100		$	-	$	(536,100	)	$	-
Gain on life settlements, net		-			-			7,733,245		-			7,733,245
Interest and other income		3,259,362			841,286			14,610		(840,935	)		3,274,323
TOTAL REVENUE		3,259,362			1,377,386			7,747,855		(1,377,035	)		11,007,568
EXPENSES
Origination and servicing fees		-			-			536,100		(536,100	)		-
Employee compensation and benefits		666,354			397,569			-		-			1,063,923
Legal and professional fees		272,794			79,116			-		-			351,910
Interest expense		2,655,430			942,686			1,343,826		-			4,941,942
Other expenses		649,112			429,520			853,435		(840,935	)		1,091,132
TOTAL EXPENSES		4,243,690			1,848,891			2,733,361		(1,377,035	)		7,448,907
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(984,328	)		(471,505	)		5,014,494		-			3,558,661
EQUITY IN INCOME OF SUBSIDIARIES		4,543,289			5,014,494			-		(9,557,783	)		-
INCOME BEFORE INCOME TAXES		3,558,961			4,542,989			5,014,494		(9,557,783	)		3,558,661
INCOME TAX EXPENSE (BENEFIT)		1,802,271			(300	)		-		-			1,801,971
NET INCOME	$	1,756,690		$	4,543,289		$	5,014,494	$	(9,557,783	)	$	1,756,690

For the three months ended June 30, 2012	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	290,050		$	-	$	(290,050	)	$	-
Gain on life settlements, net		-			79,307			4,788,171		-			4,867,478
Interest and other income		2,745			2,237			42,581		-			47,563
TOTAL REVENUE		2,745			371,594			4,830,752		(290,050	)		4,915,041
EXPENSES
Origination and servicing fees		-			-			290,050		(290,050	)		-
Employee compensation and benefits		-			583,338			-		-			583,338
Legal and professional fees		364,698			(27,519	)		-		-			337,179
Interest expense		814,038			1,140,239			425,301		-			2,379,578
Other expenses		387,691			303,468			12,500		-			703,659
TOTAL EXPENSES		1,566,427			1,999,526			727,851		(290,050	)		4,003,754
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(1,563,682	)		(1,627,932	)		4,102,901		-			911,287
EQUITY IN INCOME OF SUBSIDIARIES		2,474,969			4,132,013			-		(6,606,982	)		-
INCOME BEFORE INCOME TAXES		911,287			2,504,081			4,102,901		(6,606,982	)		911,287
INCOME TAX EXPENSE		609,588			-			-		-			609,588
NET INCOME	$	301,699		$	2,504,081		$	4,102,901	$	(6,606,982	)	$	301,699

Condensed Consolidating Statements of Cash Flows

For the six months ended June 30, 2013	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	1,823,824		$	10,117,924		$	10,848,388		$	(20,966,312	)	$	1,823,824
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(982,826	)		(867,920	)		-			1,850,746			-
Gain on life settlements		-			-			(18,943,905	)		-			(18,943,905	)
Amortization of deferred financing and issuance costs		737,959			434,431			758,490			-			1,930,880
Deferred income taxes		2,366,794			-			-			-			2,366,794
Preferred stock issued for dividends		261,937			-			-			-			261,937
(Increase) decrease in operating assets:
Other assets		(27,278,091	)		(24,355,215	)		(3,330,802	)		51,349,976			(3,614,132	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		1,485,107			119,503			90,187			-			1,694,797
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(21,585,296	)		(14,551,277	)		(10,577,642	)		32,234,410			(14,479,805	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(12,885,993	)		-			(12,885,993	)
Proceeds from settlement of life settlements		-			-			2,872,152			-			2,872,152
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(10,013,841	)		-			(10,013,841	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			8,000,000			-			8,000,000
Payments for redemption of Series I Secured notes payable		-			(3,930,876	)		-			-			(3,930,876	)
Proceeds from issuance of debentures		42,439,661			-			-			-			42,439,661
Payments from issuance and redemption of debentures		(5,336,571	)		-			-			-			(5,336,571	)
Payments from restricted cash		-			(752,800	)		(1,617,975	)		-			(2,370,775	)
Issuance of member capital		-			18,024,952			14,209,458			(32,234,410	)		-
Repurchase of common stock		(3,252,400	)		-			-			-			(3,252,400	)
Payments for redemption of preferred stock		(311,804	)		-			-			-			(311,804	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		33,538,886			13,341,276			20,591,483			(32,234,410	)		35,237,235
NET INCREASE IN CASH AND CASH EQUIVALENTS		11,953,590			(1,210,001	)		-			-			10,743,589
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		25,035,579			2,461,465			-			-			27,497,044
END OF THE PERIOD	$	36,989,169		$	1,251,464		$	-		$	-		$	38,240,633

For the six months ended June 30, 2012	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	(1,851,130	)	$	132,096		$	3,949,640		$	(4,091,736	)	$	(1,851,130	)
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(8,985,743	)		(238,602	)		5,132,609			4,091,736			-
(Gain) loss on life settlements		-			999,677			(11,989,926	)		-			(10,990,249	)
Amortization of deferred financing and issuance costs		46,622			746,387			116,448			-			909,457
Deferred income taxes		(529,860	)		-			-			-			(529,860	)
Preferred stock issued for dividends		421,010			-			-			-			421,010
(Increase) decrease in operating assets:
Other assets		(13,027	)		1,217,186			(146,874	)		-			1,057,285
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		606,991			39,087			13,056			-			659,134
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(10,305,137	)		2,895,831			(2,915,047	)		-			(10,324,353	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,622,030	)		-			(2,622,030	)
Proceeds from settlement of life settlements		-			-			416,665			-			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(2,205,365	)		-			(2,205,365	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			6,000,000			-			6,000,000
Proceeds from issuance of Series I Secured notes payable		-			50,000			-			-			50,000
Payments for redemption of Series I Secured notes payable		-			(3,468,957	)		-			-			(3,468,957	)
Proceeds from issuance of debentures		15,757,086			-			-			-			15,757,086
Payments from issuance of debentures		(712,587	)		-			-			-			(712,587	)
Proceeds (payments) from restricted cash		-			822,227			(879,588	)		-			(57,361	)
Proceeds from issuance of preferred stock		5,787,375			-			-			-			5,787,375
Payments for redemption of preferred stock		(1,609,362	)		-			-			-			(1,609,362	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		19,222,512			(2,569,730	)		5,120,412			-			21,746,194
NET INCREASE IN CASH AND CASH EQUIVALENTS		8,917,375			299,101			-			-			9,216,476
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		1,746,456			131,893			-			-			1,878,349
END OF THE PERIOD	$	10,663,831		$	430,994		$	-		$	-		$	11,094,825

For the three months ended June 30, 2013	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	1,756,690		$	4,543,289		$	5,014,494		$	(9,557,783	)	$	1,756,690
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		4,543,289			5,014,494			-			(9,557,783	)		-
(Gain) loss on life settlements		-			-			(7,449,180	)		-			(7,449,180	)
Amortization of deferred financing and issuance costs		344,482			161,926			330,725			-			837,133
Deferred income taxes		1,802,920			-			-			-			1,802,920
Preferred stock issued for dividends		178,235			-			-			-			178,235
(Increase) decrease in operating assets:
Other assets		(13,002,552	)		(13,654,889	)		(4,000,000	)		26,493,437			(4,164,004	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		639,763			(12,024	)		(225,000	)		-			402,739
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(3,737,173	)		(3,947,204	)		(6,328,961	)		7,377,871			(6,635,467	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,972,944	)		-			(2,972,944	)
Proceeds from settlement of life settlements		-			-			1,382,152			-			1,382,152
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(1,590,792	)		-			(1,590,792	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured notes payable		-			(2,423,052	)		-			-			(2,423,052	)
Proceeds from issuance of debentures		18,588,867			-			-			-			18,588,867
Payments from issuance and redemption of debentures		(3,033,303	)		-			-			-			(3,033,303	)
Proceeds (payments) from restricted cash		-			(2,222,476	)		4,382,809			-			2,160,333
Issuance of member capital		-			3,840,927			3,536,944			(7,377,871	)		-
Repurchase of common stock		(3,252,400	)		-			-			-			(3,252,400	)
Payments for redemption of preferred stock		(125,135	)		-			-			-			(125,135	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,178,029			(804,601	)		7,919,753			(7,377,871	)		11,915,310
NET INCREASE IN CASH AND CASH EQUIVALENTS		8,440,856			(4,751,805	)		-			-			3,689,051
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		28,548,313			6,003,269			-			-			34,551,582
END OF THE PERIOD	$	36,989,169		$	1,251,464		$	-		$	-		$	38,240,633

For the three months ended June 30, 2012	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	301,699		$	2,504,081		$	4,102,901		$	(6,606,982	)	$	301,699
Adjustments to reconcile net income to cash:
Equity income of subsidiaries		(7,602,533	)		(352,750	)		1,348,301			6,606,982			-
Gain on life settlements		-			(66,551	)		(4,509,390	)		-			(4,575,941	)
Amortization of deferred financing and issuance costs		46,622			237,451			58,224			-			342,297
Deferred income taxes		609,588			-			-			-			609,588
Preferred stock issued for dividends		294,935			-			-			-			294,935
(Increase) decrease in operating assets:
Other assets		(42,969	)		(95,216	)		(159,875	)		-			(298,060	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		152,299			(44,990	)		(5,857	)		-			101,452
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(6,240,359	)		2,182,025			(834,304	)		-			(3,224,030	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(1,468,770	)		-			(1,468,770	)
Proceeds from settlement of life settlements		-			-			416,665			-			416,665
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(1,052,105	)		-			(1,052,105	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from revolving credit facility		-			-			3,500,000			-			3.500,000
Proceeds from issuance of Series I Secured notes payable		-			-			-			-			-
Payments for redemption of Series I Secured notes payable		-			(1,918,420	)		-			-			(1,918,420	)
Proceeds from issuance of debentures		12,695,213			-			-			-			12,695,213
Payments from issuance of debentures		(712,587	)		-			-			-			(712,587	)
Payments from redemption of debentures		-			-			-			-			-
Payments from restricted cash		-			-			(3,282,199	)		-			(3,282,199	)
Proceeds from issuance of preferred stock		1,350,910			-			-			-			1,350,910
Payments for redemption of preferred stock		(810,722	)		-			-			-			(810,722	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,522,814			(1,918,420	)		217,801			-			10,822,195
NET INCREASE IN CASH AND CASH EQUIVALENTS		6,282,455			263,605			-			-			6,546,060
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		4,381,376			167,389			-			-			4,548,765
END OF THE PERIOD	$	10,663,831		$	430,994		$	-		$	-		$	11,094,825

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2013	Aug. 14, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	GWG Holdings, Inc.
Entity Central Index Key	0001522690
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		9,124,000

XML

Concentrations

6 Months Ended

Jun. 30, 2013

Concentration [Abstract]

Concentration

( 15 )     Concentrations

GWG purchases life insurance policies written by life insurance companies having investment grade ratings by independent rating agencies.  As a result, there may be certain concentrations of contracts with life insurance companies.  The following summarizes the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company.

	June 30, 2013		December 31, 2012
Life insurance company	%		%
Company A		15.18		16.96
Company B		12.14		13.80
Company C		10.33		11.36

The following summarizes the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company:

	June 30, 2013		December 31, 2012
State of residence	%		%
California		29.88		28.44
Florida		12.45		11.85
New York		12.03		13.27